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The results described in this thesis strongly hint towards the importance of considering 
diet as a whole, instead of focusing on separate components, which is in line with the 
current dietary guidelines. Sedentary behaviour should be replaced with moderate 
to vigorous physical activity rather than light physical activity. Alcohol should not be 
replaced with sugar sweetened beverages, but rather with milk, coffee or tea. 
ABSTRACT
The prevalence of obesity is increasing in most places in the world. In particular 
abdominal obesity is a well-established risk factor for cardiometabolic diseases. This 
excess risk due to abdominal obesity is due to fat in the visceral area and in and around 
the organs (ectopic fat), such as in the liver. The main aim of this thesis was therefore to 
study whether lifestyle changes can reduce the amount of visceral fat and liver fat.
Firstly, from a systematic review and meta-analysis of randomized controlled trials we 
concluded that a diet high in proteins decreases liver fat compared with a diet high in 
carbohydrates. A diet high in fat, however did not lead to changes in liver fat compared 
with a diet high in carbohydrates. Within fat types, saturated fat led to more liver fat 
accumulation than unsaturated fat. Secondly, we studied diet at multiple levels in the 
Netherlands Epidemiology of Obesity study, which is a population based cohort study 
of middle-aged men and women in the Leiden area with directly assessed measured 
of adiposity. When studying food groups rather than nutrients, we observed that 
consumption of sweet snacks was positively associated with liver fat content, also after 
we took total body fat into account. Likewise, consumption of fruit and vegetables and 
plant-based fats and oils was associated with a reduced amount of visceral fat. Adherence 
to the current Dutch dietary guidelines, as indicated by a high score on the 15-component 
Dutch Healthy Diet Index, was associated with less total body fat, less visceral fat and 
less liver fat. The associations with visceral fat and liver fat remained present after 
adjustment for total body fat, which suggests that the associations are indeed specific 
for visceral and liver fat rather than merely representing associations with overall 
adiposity. These associations were not driven by one component in particular, which 
stresses the importance of an overall healthy diet. When we studied alcohol intake 
separate from other dietary components, each additional serving of alcohol per day was 
also associated with an increase in liver fat. Furthermore , when one alcoholic serving 
is replaced with a non-alcoholic one, liver fat is also reduced . However, when alcoholic 
beverages were replaced with sugar sweetened beverages of the same caloric content, 
liver fat amounts were the same, whereas replacement with milk was associated with 
a reduced amount of liver fat. Lastly, we observed that objectively measured sedentary 
time was associated with an increase in total body fat, visceral fat and liver fat. Replacing 
30 minutes of sedentary time per day with moderate to vigorous physical activity, but 
not light physical activity was associated with reduced total body fat, visceral fat and 
liver fat. These associations with visceral fat and liver fat disappeared after additional 
adjustment for total body fat, which indicates there is no extra effect on visceral fat and 
liver fat beyond effects via total body fat.
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Obesity and weight gain have been associated with an increased risk of diabetes (7, 8), and 
those with a BMI of 40 or higher are 7 times more likely to be diagnosed with diabetes 
than those with a normal BMI (9). The relation is so strong, that it is thought that 90% of 
type 2 diabetes is attributable to excess weight (10). Both overweight and obesity are also 
related to the risk of developing cardiovascular risk factors such as hypertension, and as 
a consequence a BMI of 25 accounts for 35% of hypertension diagnoses in men and 60% in 
women (11). An increased risk due to overweight was also found for coronary heart disease 
and cerebrovascular disease in both men and women in large cohort studies such as 
the Nurses’ Health Study, the Dallas Heart Study and the Physicians’ Healthy Study (12). 
At a global level, 41% of high BMI-related deaths were caused by cardiovascular disease 
among people with obesity, and diabetes was the second largest cause (6). In both men 
and women, a high BMI has also been associated with an increased risk of death due 
cancer of the esophagus, colon and rectum, liver, gallbladder, pancreas and kidney, and 
with non-Hogdkin’s lymphoma and multiple myeloma (13). A dose-response relationship, 
in which the risk of death increases with higher BMI, was found for stomach and prostate 
cancer in men and breast, uterus, cervix and ovary cancer in women (13).
Multiple studies have found that a high BMI is a strong risk factor for end stage renal 
disease (14). Obesity has also been linked to knee osteoarthritis due to the increased 
load on these weight-bearing joints, and other joint-related disorders such as gout (12). 
Additionally, excess body weight increases the risk of pancreatitis, ischemic dementia, 
Alzheimer’s disease and psychological problems, such as mood and anxiety disorders (12).
Body fat distribution and ectopic fat
Although BMI is a widely-used and easy to measure proxy for overall adiposity, it does 
not take body composition into account. A high BMI does not necessarily indicate a 
high body fat percentage, as it might also be the consequence of larger muscle mass. 
Moreover, BMI does not consider where exactly the fat is stored in the body.
Already in 1947, Vague discovered that patients with hypertension, diabetes or 
cardiovascular disease were not per definition more obese than those without 
complications (15). He did, however, observe that individuals who had more fat stored in 
the trunk area had an increased risk of diabetes and cardiovascular disease. As a result, 
he identified two body shapes and formulated the terms gynoid obesity and android obesity 
(15). Nowadays, we still use these terms: android obesity is characterized by a large waist 
circumference with the majority of the adipose tissue centering around the abdomen, 
more commonly found in men. In contrast, in a gynoid or pear shaped body type most 
adipose tissue is stored subcutaneously at the hips, buttocks and thighs, often going 
The objective of this thesis was to study the role of dietary habits and physical activity in 
abdominal fat accumulation, which is a well-established risk factor for cardiometabolic 
diseases. This general introduction describes the epidemiology and historical perspective 
of overweight and obesity, the current knowledge about how diet and physical activity 
may influence visceral fat and liver fat, and how the research described in this thesis may 
contribute to addressing the gaps in knowledge that still exist. 
Overweight and obesity: prevalence and relation to disease
Obesity is characterized as a condition in which excess energy is stored in the form 
of triglycerides in adipose tissue, which may ultimately cause health impariment (1). 
In order to classify obesity the World Health Organization uses the body mass index 
(BMI). It is defined as the weight in kilograms divided by the square of the height in 
meters (kg/m2). Based on this index, the World Health Organization has made the 
following classification: underweight (<18.5 kg/m2), normal weight (18.5-24.99 kg/m2) 
and overweight (>25.0 kg/m2). Because management options regarding prevention and 
treatment of obesity differ above a BMI of 35, the overweight category can be further 
subdivided into the following categories: preobese (25.0-29.99 kg/m2), obese class I (30.0-
34.99 kg/m2), obese class II (35.0-39.99 kg/m2) and obese class III (≥40.0 kg/m2). In a large 
systematic analysis of health examination surveys and epidemiological studies it has 
been shown that between 1980 and 2008 the age-standardized mean global BMI has 
increased by 0.5 kg/m2 in both men and women per decade (2). 
In 1980, the global prevalence of overweight was 25% and that of obesity 6%. These 
numbers have increased to 34% for overweight and 12% for obesity in 2008 (3). In absolute 
numbers this represents an increase from 572 million adults with overweight worldwide 
in 1980 to almost 1.5 billion in 2008, of whom 508 million with obesity (3). This number 
has continued to rise even further to 670 million adult obese individuals in 2016, of 
whom 390 million were women and 280 million men. By 2020 2.2 billion adults will have 
overweight and 1.1 billion of them obesity when recent secular trends are taken into 
account (4). This trend is also visible in the Netherlands: in 2018 half of all adults (50.2%) 
had overweight and 15% of them had obesity (5). 
Excess body fat is an established strong risk factor for multiple chronic diseases, such as 
type 2 diabetes, cardiovascular disease and certain types of cancer. In 2015, overweight 
and obesity accounted for 4 million deaths, which contributed to a little over 7% of 
the deaths from any cause that year. Overweight was also responsible for 120 million 
disability-adjusted life-years (6). 
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as differences between men and women in basal fatty acid oxidation, postprandrial fatty 
acid storage, and regional differences in the regulation of lipolysis (23). As postmenopausal 
women are more likely to store fat viscerally than premenopausal women, testosterone 
levels also seem to be important in body fat distribution (25).
Furthermore, studies in identical twins have shown that the susceptibility to store fat 
either viscerally or subcutaneously is partly determined by genetics (26-28), and multiple 
loci associated with visceral adipose tissue have been identified in genome wide 
association studies, of which some appear sex-specific (29). Additionally, age, ethnicity, 
physical activity and levels of glucocorticoids have also been associated with visceral 
fat accumulation (30). Due to the large individual variation in adipose tissue depots and 
various factors contributing to these differences in deposition, obesity is a surprisingly 
heterogeneous condition iwhenit is defined based on BMI alone (30), as it has been shown 
that patients with similar BMI values present different levels of health risk (31). 
In parallel to the increase in obesity over the past decades, the prevalence of non-
alcoholic fatty liver disease (NAFL) also continues to rise and is now present in 25% of 
the general adult population, and 65% to 85% in adults with obesity (32). Non-alcoholic 
fatty liver disease is defined as having more than 5.56% of liver fat not due to excessive 
alcohol consumption (33) and may lead to non-alcoholic steatohepatitis (NASH) and liver 
cirrhosis. It also increases the risk of end-stage liver disease and liver-related and all-cause 
mortality (34-37). Currently, it is the leading cause of chronic liver diseases worldwide (38), 
and is also strongly related with the metabolic syndrome (39) and cardiovascular diseases 
(40). In previous research, visceral adipose tissue and hepatic triglyceride content have 
both been associated with insulin resistance, metabolic risk factors and cardiovascular 
disease (41-44). Since the first state of NAFL, simple steatosis, is still reversible, adequate 
treatment is needed (45, 46).
The overflow hypothesis explains fat accumulation in liver and visceral area, and states 
that the body’s response to excess calories may determine the risk of the metabolic 
syndrome (47). When the caloric surplus is led into the subcutaneous adipose tissue, 
which is sensitive to insulin, the individual is unlikely to develop the metabolic 
syndrome as the subcutaneous fat can expand. When, however, this adipose tissue 
is not functioning properly or if it is insulin resistant with an insufficient capacity to 
store the extra energy, the fatty acids will be stored in visceral adipose depots, in turn 
leading to ectopic fat disposition. Therefore, according to the lipid overflow hypothesis, 
accumulation of visceral fat is a marker of dysfunctional subcutaneous fat (30). In the 
liver, the increased free fatty acid flux observed in individuals with obesity (47) leads to 
hand in hand with a smaller waist circumference. This body type is more common in 
women. 
In the early 1980s, another breakthrough in the field of obesity was accomplished. 
Björntorp and his group discovered that body shape, and thereby the regional 
accumulation of body fat, and the morphology of this fat were closely related to 
metabolic diseases (16). Subsequently, they described that men with a high proportion 
of abdominal fat had a substantially increased risk of developing diabetes (17). These 
discoveries have sparked the interest of the medical community and laid the foundation 
for the research on body fat distribution we do today. 
After the development of imaging techniques such as computed tomography (CT), it 
became possible to scan the whole body and discriminate between different types of 
tissue. Researchers from the University of Osaka were the first to use the CT for this 
purpose, and were able to distinguish the fat located in the abdominal cavity, or visceral 
fat, from the fat located subcutaneously (18). A few years later, in 1987, they were the first to 
show the detrimental effects of viscerally stored adipose tissue, by demonstrating that 
subjects with more visceral adipose tissue displayed higher fasting plasma triglycerides 
levels and higher plasma glucose responses following an oral glucose challenge than 
those with the same BMI but fat mainly stored subcutaneously (19). In 1989, Seidell showed 
that visceral fat area as measured with CT was also associated with serum triglycerides, 
plasma insulin, glucose and diastolic and systolic blood pressure (20).
These landmark studies in combination with more recent developments have shown 
that the majority of lipids accumulate in subcutaneous adipose tissue, which is located 
just below the skin and amounts to 82-97% of total body fat. Subcutaneous adipose 
tissue has the capability to expand when there is a positive energy balance. However, 
the response to excess caloric intake might vary, and there is considerable variation 
between individuals where the fat is stored (21). Lipids can also accumulate in visceral 
adipose tissue, which is located deeper in the body and situated around the organs, and 
amounts to 10 to 15% of all fat (22). Additionally, lipids can be stored in non-adipose tissue 
cells, such as in the liver (intrahepatic fat) or the muscles (intramuscular fat). This is 
referred to as ectopic fat. 
There are large sex-related differences in the location of fat deposition. On average, 
women have a higher percentage of body fat than men for the same BMI and are more 
likely to store fat subcutaneously in the femoral gluteal region. Men, however, store 
more fat in the visceral area (23, 24). These differences are caused by multiple factors, such 
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subcutaneous and visceral fat, one systematic review on the effects of dietary aspects has 
already been published (55), and described an inverse relation between intake of medium 
chain triglycerides and dietary patterns recognized as healthy and subcutaneous fat 
and visceral fat. Dietary fiber and calcium were found to be negatively associated with 
visceral fat only. For liver fat, however, such an overview does not yet exist. Besides 
omega-3 polyunsaturated fatty acids and fructose consumption, little is known about 
the association between other macronutrient and macronutrient subtypes and liver fat. 
As foods are not merely the sum of their nutrients, health effects of diet can be studied at 
the level of foods and food groups rather than single nutrients (56-58). The food matrix may 
play a role, or interactions between the separate nutrients within a food item might occur 
(57-59). In line with this, several European countries and the United States have published 
dietary guidelines that are based on food products and groups instead of single nutrients 
(60). Previous studies have shown that major food groups such as meat, dairy and fruit and 
vegetables are associated with body weight (61), diabetes (62) and cardiometabolic diseases 
such as coronary heart disease (CHD) (63). However, it remains unclear to what extent 
these food groups are specifically associated with visceral fat and liver fat. Knowledge 
on these potential associations might contribute to the development of new preventive 
guidelines regarding healthy dietary habits, or the adjustment of current guidelines in 
relation to cardio metabolic diseases. 
Combining multiple food items or groups makes it possible to study dietary patterns as 
a whole. Dietary guidelines that have been developed on the basis of previous research 
state the optimal consumption of several food items and food groups. Adherence to 
these guidelines can be assessed using an index. Numerous dietary indices of adherence 
to a healthy diet have been developed recently, among which the (Alternative) Healthy 
Eating Index (HEI) (64), the Healthy Diet Indicator (65) and the Diet Quality Index (DQI) 
(66). Research has shown that a higher index, indicating a better adherence to the dietary 
guidelines and therefore a healthier diet, is associated with a lower risk of obesity, 
cardiovascular disease and all-cause mortality (67). In the Netherlands, the Health Council 
of the Netherlands has developed the Dutch Guidelines for a Healthy Diet, of which the 
newest version appeared in 2015 (68). These new guidelines are mostly foods-based and 
describe the optimal consumption for food groups such as fruit and vegetables and 
dairy, but also consumption of unsalted nuts, green tea and filtered coffee. Adherence 
to these guidelines can be assessed using the Dutch Healthy Diet Index, which scores 
each component of the Dutch Guidelines for Healthy Diet. Using this index makes it 
possible to study to what extent adherence to the guidelines is associated with multiple 
health-related outcomes. Although the 2015 DHD-index is still recent, a higher score on 
increased hepatic lipase activity. In turn, this causes reduced hepatic degradation of 
insulin and apolipoprotein B and increased hepatic glucose production, leading to 
glucose intolerance (48). Moreover, visceral fat is also associated with an increased risk 
of respiratory diseases such as sleep apnoea or chronic obstructive pulmonary disease 
(COPD), dementia, reduced bone density, polycystic ovary syndrome and different types 
of cancer (49). It decreases adiponectin secretion, and together with liver fat thereby brings 
about hypertension, insulin resistance, dyslipidaemia, and ultimately atherosclerosis 
(50). Both visceral fat and liver fat have been associated also with coronary artery disease 
and cardiovascular disease (41, 43). 
Figure 1. Subcutaneous fat and visceral fat in the abdomen
Diet as a modifiable risk factor for visceral fat and liver fat 
Visceral fat and liver fat are key targets in the prevention and treatment of cardiometabolic 
diseases. Due to a lack of drug-based treatments, modifiable lifestyle factors such 
as dietary habits and physical activity are key when it comes to the prevention and 
treatment of abdominal obesity (45). Dietary habits can be studied on multiple levels. 
To understand how particular components of food are related to disease, studying diet 
on a micro- or macronutrient level is useful. The main focus regarding decreasing body 
weight concerns caloric restriction. However, besides diet quantity, diet quality may 
also be important for health. An overfeeding trial of saturated and polyunsaturated fatty 
acids has shown distinct effects on visceral fat and liver fat (51), indicating the importance 
of dietary macronutrient composition for the accumulation of adipose tissue. Moreover, 
it has been proposed that specific nutrients, such as fructose, increase hepatic de novo 
lipogenesis (52). Increased lipolysis of visceral fat can contribute to an increased flux of 
free fatty acids in the liver, which may ultimately lead to accumulation of triglycerides 
and other lipids in the liver (53). Although some meta-analyses have been performed 
on specific micronutrients in relation to NAFL, results were inconclusive (54). For 
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activity is defined as activities lower than 3.0 METs and includes activities such as 
sitting (1.5 MET), walking slowly (2.0 MET) or playing a musical instrument (2.5 MET). 
Moderate physical activity is defined as 3.0 to 6.0 MET, such as cleaning (3.0 MET), playing 
recreational badminton (4.5 MET) or mowing the lawn (5.5 MET). All activities above 6.0 
MET are defined as vigorous (82). 
Most European guidelines on physical activity recommend to perform at least 150 
minutes of moderate to vigorous physical activity per week. Additionally, they state 
sedentary time should be limited (83), as this behaviour has been associated with 
increased risk of type 2 diabetes, cardiovascular disease and cancer (84). A meta-analysis 
has shown that exercise is able to reduce both visceral fat and liver fat, although the 
studies that were included focused on structured exercise instead of habitual daily 
activities. Therefore, the evidence on the potential association between these so-called 
unstructured activities and sedentary time as assessed with accelerometry and different 
adipose depots is still lacking. Furthermore, less time spent sedentary inevitably means 
more time is spent performing other activities. In the study of a decrease of time spent in 
particular activity, it is therefore important to take into account with which activity this 
is being replaced (e.g., replacing sedentary time with the same time spent on moderate 
to vigorous physical activity). This can be done using isotemporal substitution analysis. 
However, most studies using this type of statistical model use surrogate outcomes for 
adiposity such as body mass index or waist circumference instead of directly assessed 
measures of adiposity (85). Only one study has combined objectively measured physical 
activity and direct measures of visceral fat, and observed that isotemporal substitution 
of one hour per day of sedentary and light intensity physical activity with moderate to 
vigorous physical activity was associated with reduced visceral fat (86). However, liver 
fat was not assessed in this study and no adjustment for total body fat was performed. 
Therefore, evidence on how replacing sedentary time with other activities is associated 
with directly assessed visceral fat and liver fat is still largely lacking.
OUTLINE OF THIS THESIS
Although many previous studies have investigated the health-related consequences of a 
healthy lifestyle, there is still much to be learned. Up to date, not much is known about 
how diet and physical activity affect visceral fat and liver fat. Therefore, the objective of 
this thesis was to study the role of dietary habits and physical activity in abdominal fat 
accumulation, more specifically in the visceral area and in the liver.
the Dutch Healthy Diet Index 2015 has been associated with a decreased risk of stroke, 
chronic obstructive pulmonary disease, colorectal cancer and all-cause mortality (69). 
However, it remains unclear to what extent adherence to the 2015 Dutch Guidelines for a 
Healthy Diet is specifically associated with the amount of visceral fat and liver fat. 
Alcoholic and non-alcoholic beverages in relation to liver fat
Excessive alcohol consumption is a well-established risk factor for both hepatic steatosis 
(liver fattening) and liver disease (70). Although current guidelines aim at preventing or 
reducing liver fat accumulation recommend to refrain from heavy alcohol consumption, 
it remains unclear whether moderate alcohol consumption should also be discouraged. 
Several studies have shown a beneficial effect of light to moderate alcohol consumption 
in relation to fatty liver and extra-hepatic complications (71-74). However, a study using 
a genetic variant in the alcohol dehydrogenase gene as a proxy of long-term alcohol 
exposure showed no beneficial effect of moderate alcohol consumption on the severity 
of non-alcoholic fatty liver disease (75). Even when alcohol use is discouraged, it it is 
unclear with what beverages patients with non-alcoholic fatty liver should replace their 
alcoholic drinks. We hypothesize that non-alcoholic energy containing beverages may 
also contribute to liver fat accumulation, as calories from these beverages contribute 
to the total energy intake and liquid food leads to less satiety and more postprandial 
hunger (76). Knowledge on the association between different beverages and their mutual 
replacement with liver fat may contribute to lifestyle guidelines for both primary and 
secondary prevention. 
Physical activity in relation to abdominal fat
Besides healthy dietary habits, physical activity is a key modifiable risk factor for obesity 
and cardiovascular disease. Energy balance within the body reflects a harmony between 
of energy intake, energy expenditure and energy storage. While diet provides the energy 
intake, energy expenditure consists of three components: the energy it takes to fuel the 
body at rest (resting metabolic rate, approximately 60-75% of total energy expenditure), 
the energy it costs to absorb and metabolize the food that is consumed (thermic effect 
of food, approximately 10% of total energy expenditure) and the energy expended by 
undertaking physical activity (approximately 15-30% of total energy expenditure) (77, 78). 
When the energy intake is greater than the energy expenditure over a longer period 
of time, this will lead to excess storage of fat and thereby an increase in body weight 
(79). Physical activity has been defined as ‘any bodily movement produced by skeletal 
muscles that results in energy expenditure (80) and can be subdivided into multiple 
activity intensities. activity levels are usually expressed in Metabolic Equivalents of 
Task (METs), which assign an intensity value to each specific activity (81). Light physical 
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Besides consumption of certain nutrients and food items or groups, excessive alcohol 
consumption is a well-known risk factor for liver fattening and liver disease (70). Current 
guidelines to prevent or reduce liver fat accumulation recommend that heavy drinking 
should be refrained from (92). However, it remains unclear what beverages should replace 
the alcohol when people are advised to refrain from further alcohol consumption. We 
hypothesized that energy-containing non-alcoholic beverages, such as sugar sweetened 
beverages, also contribute to the accumulation of liver fat, and investigated the association 
between both alcoholic and non-alcoholic beverages and liver fat in Chapter 5. We also 
assessed how replacing alcohol with non-alcoholic beverages is associated with liver fat. 
Besides dietary habits, physical activity is another key modifiable risk factor for obesity 
and cardio metabolic diseases. In Chapter 6 we investigated different levels of physical 
activity, such as sedentary behaviour, light, moderate and vigorous physical activity, 
in relation to total body fat, visceral fat and liver fat. In this study we have also used 
isotemporal substitution analysis to study the association between replacing 30 minutes 
of sedentary time with 30 minutes of another activity and the body fat measurements. 
Lastly, Chapter 7 summarizes important findings of this thesis and discusses their 
interpretation and clinical implications. 
Population and design of the Netherlands Epidemiology of Obesity study
All studies described in this thesis, except for the meta-analysis, have been performed 
in the Netherlands Epidemiology of Obesity (NEO) study. This is a population-based 
prospective cohort study in 6 671 individuals aged 45 to 65 years, with an oversampling 
of persons with a BMI of 27 kg/m2 or higher. All studies described in this thesis are 
based on the baseline measurements and therefore of a cross-sectional nature. Men 
and women aged between 45 and 65 years with a self-reported BMI of 27 kg/m2 or higher 
living in the greater area of Leiden (in the West of The Netherlands) were eligible to 
participate in the NEO study. In addition, all inhabitants aged between 45 and 65 years 
from one municipality (Leiderdorp) were invited irrespective of their BMI, allowing for 
a reference distribution of BMI. To be able to make inferences on the general population, 
we weighted all analyses towards the BMI distribution of the Dutch general population 
using the distribution of the Leiderdorp participants. Consequently, all results described 
in this thesis apply to the general population. 
Participants visited the NEO study center of the Leiden University Medical Center after 
an overnight fast. Prior to the NEO study visit, participants completed a questionnaire 
about demographic, lifestyle, and clinical information, in addition to a food frequency 
questionnaire. At the study center, the participants completed a screening form, asking 
Figure 2. Visual representation of hypothesized association between dietary habits and physical activity 
and visceral fat and liver fat, ultimately leading to cardiometabolic diseases
In order to prevent non-alcoholic fatty liver from progressing to more severe forms 
of hepatic fat storage, such as non-alcoholic steatohepatitis or even liver cirrhosis, 
adequate treatment is needed. 
The current treatment for non-alcoholic fatty liver disease is mainly focused on weight 
loss by means of calorie restricted diets (87-89). However, besides diet quantity in the form 
of caloric restriction, the macronutrient composition of a diet may be important. In 
Chapter 2 we performed a systematic review and meta-analysis on the effect of dietary 
macronutrient composition on liver fat in randomized controlled trials. Studies 
included in this meta-analysis compared diets high in one macronutrient and low in 
another with diets with the opposite composition and their effect on liver fat content. 
As foods are not merely the sum of their nutrients, studying foods and food groups 
may be important in relation to multiple health outcomes (57) and is becoming more 
important in the development of dietary guidelines. In Chapter 3 we examined the 
association between dietary intake of certain food groups, such as meat, fruit and 
vegetables and dairy, and visceral fat and liver fat specifically. We also investigated a finer 
categorization of these main food groups, to assess whether associations were driven by 
one component of that food group in particular. 
Adherence to the Dutch Guidelines for a Healthy Diet, which are dietary guidelines that 
aim to decrease the risk of chronic diseases (90), can be measured using the Dutch Healthy 
Diet Index (91). In Chapter 4, we aimed to examine whether the 2015 Dutch Healthy Diet 
Index is associated with both total body fat, visceral fat and liver fat. By leaving each 
component out one at a time, we tried to examine which component is most important 
in these associations. 
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INTRODUCTION
Non-alcoholic fatty liver (NAFL) is clinically defined as a liver fat content of more than 
5.6%, not due to excessive alcohol consumption (1). It is a major cause of chronic liver 
disease worldwide, associated with an increased risk of liver- and cardiovascular disease-
related mortality (2-5). Moreover, obesity and other features of the metabolic syndrome 
such as dyslipidaemia, insulin resistance and diabetes mellitus, are associated with 
NAFL (6-10). The prevalence of NAFL continues to rise (2, 3) and has been estimated at 25% in 
adults (2), and between 65% and 85% in adults with obesity (11).
Since NAFL is still reversible, adequate treatment is needed to prevent the development 
into more severe forms of hepatic fat storage such as non-alcoholic steatohepatitis 
(NASH)(12, 13). Drug-based treatments are primarily recommended for patients with 
a later stage of NAFL, whereas lifestyle changes are a cornerstone in guidelines on 
treatment of NAFL, including weight loss, eating healthier, and increasing physical 
exercise (12). To date, interventions on NAFL mainly focus on decreasing total body fat by 
recommending calorie restricted diets in overweight or obese patients (14-16). However, 
besides diet quantity in the form of caloric restriction, macronutrient composition may 
be of importance, although evidence on this is scarce. Recent meta-analyses have shown 
that supplementation of omega-3 polyunsaturated fatty acids (PUFAs) is an effective 
intervention for reducing NAFL (17, 18).
Besides specific types of macronutrient such as omega-3 polyunsaturated fatty acids 
and fructose consumption, there are no meta-analyses on other macronutrients and 
other macronutrient types. In only one review on the effects of macronutrients on liver 
fat it has been described that a relatively high consumption of saturated fat increases 
the percentage of liver fat, whereas an increased consumption of refined sugars had 
no influence on liver fat (19). However, the search of this review was limited and was 
not substantiated by a meta-analysis. Therefore, it remains unclear whether dietary 
macronutrients and their composition affect liver fat content. We aimed to assess 
the effect of dietary macronutrient composition on liver fat content, as measured by 
magnetic resonance imaging, proton magnetic resonance spectroscopy, computed 
tomography or liver biopsy, by performing a systematic review and meta-analysis of 
isocaloric randomized controlled trials in adults.
ABSTRACT
Dietary macronutrient composition may affect hepatic liver content and its associated 
diseases, but the results from human intervention trials have been equivocal or 
underpowered. We aimed to assess the effects of dietary macronutrient composition on 
liver fat content by conducting a systematic review and meta-analysis of randomized 
controlled trials in adults. Four databases (PubMed, Embase, Web of Science and 
COCHRANE Library) were systematically searched for trials with isocaloric diets 
evaluating the effect of dietary macronutrient composition (energy percentages of fat, 
carbohydrates and protein, and their specific types) on liver fat content as assessed by 
magnetic resonance techniques, computed tomography or liver biopsy. Data on change 
in liver fat content were pooled by random or fixed-effects meta-analyses and expressed 
as standardized mean difference (SMD). We included 21 randomized controlled trials 
providing data for 25 comparisons on dietary macronutrient composition. A high-
carbohydrate low-fat diet did not change liver fat content as compared with a low-
carbohydrate high-fat diet (12 comparisons, SMD 0.01 (95% CI -0.36; 0.37)). Heterogeneity 
was substantial (I2 67.8%, p<0.001). Unsaturated fat as compared with saturated fat 
reduced liver fat content (3 comparisons, SMD -0.75 (95% CI -1.11; -0.39)). A high-protein 
low-carbohydrate diet reduced liver fat content as compared with a low-protein high-
carbohydrate diet (3 comparisons, SMD -0.32 (95% CI -0.58; -0.05)). Our meta-analyses 
showed that replacing carbohydrates with total fat on liver fat content was not effective, 
while replacing carbohydrates with proteins was. We showed that unsaturated fat 
consumption leads to less liver fat content compared with saturated fat consumption. Too 
few studies were included to perform separate meta-analyses on types of carbohydrates 
and proteins, and therefore more well-performed and well-described studies on the 
effect of types of carbohydrates and proteins on liver fat content are needed, especially 
studies comparing proteins with fats.
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COCHRANE Library. The search query consisted of a combination of the following 
concepts: macronutrients (exposure terms), liver fat (outcome terms) and (randomized 
controlled) trials. The search strategy was adjusted for all consulted databases, taking 
into account the differences of the various controlled vocabularies as well the differences 
of database specific technical variations (e.g., the use of quotation marks). Case reports, 
animal-only studies and conference abstracts were excluded. No restrictions were made 
on language and publication year. The final search was performed on February 19th, 2018 
and repeated on June 17, 2019. All search strings used can be found in the supplementary 
data.
Study selection process
First, duplicate publications were removed. Titles and abstracts of remaining identified 
publications were screened for eligibility by 6 reviewers (BdR, EvE, HP, IV, KR, MA) in 
preassembled pairs. Each reviewer of a pair independently screened and coded an 
assigned part of the articles ‘include’, ‘unclear’ or ‘exclude’. Disagreements on inclusion 
were discussed in the pre-assembled pairs until consensus was reached. Subsequently, 
potentially relevant publications were independently assessed in full-text by three 
reviewers (BdR, IV, EvE). In case of multiple publications of a single trial, the first 
published version was included. Discrepancies on the eligibility of articles were resolved 
by discussion until consensus was reached. The selection of publications was managed 
by the Rayyan QCRI web application (Qatura Computing Research Institute, 2016) (30).
Data collection and extraction
Data extraction was independently performed by two reviewers (EvE and IV) using a 
predefined sheet in Microsoft Excel, Version 15.40. Extracted data were compared and 
discrepancies were resolved. Data were extracted on four categories following the 
recommendations of the Cochrane Collaboration; characteristics of the study (i.e., 
dietary comparison, location, design), the participants (i.e., number of randomized/
analyzed participants, sex, mean age, mean body weight, mean BMI), the dietary 
interventions (i.e., compositions, follow-up time) and the outcomes per arm of the trial 
(21). 
Risk of bias assessment
Two reviewers (EvE and IV) independently assessed the risk of bias for included studies, 
using the Cochrane ‘Risk of bias’ tool for randomized controlled trials (24). This tool 
involved a classification of six different domains of bias (i.e., selection bias, performance 
bias, attrition bias, detection bias, reporting bias and (design-specific) other sources 
of bias) with seven corresponding domains: random sequence generation, allocation 
METHODS
This systematic review and meta-analysis on dietary macronutrient composition and 
liver fat content was reported according to the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA-) guidelines and the recommendations of the 
Cochrane Collaboration (20, 21). The protocol is registered at PROSPERO with registry ID 
number 100356. 
Eligibility criteria
Databases were systematically searched for eligible publications based on a priori 
determined eligibility criteria. We systematically searched for randomized controlled 
dietary intervention trials evaluating the effect of macronutrient composition on liver 
fat content in adults. Studies including healthy adults as well as patients with obesity, 
metabolic syndrome, (pre)diabetes, NAFL or NASH and/or cardiovascular disease, were 
considered eligible. Trials that included individuals with malignant diseases or with 
alcoholic, drug-induced, viral or genetic causes of liver injury, were excluded.
Both macronutrient comparisons (carbohydrates versus fat, carbohydrates versus 
protein, protein versus fat) and macronutrient types comparisons (types of fat, types 
of carbohydrates and types of protein) were assessed. Since several reviews and meta-
analyses on omega-3 fatty acids and fructose have been published recently (17, 22-26), studies 
were excluded when the dietary intervention was primarily focused on these types of 
macronutrient comparisons. Studies that used hyper- or hypo-caloric interventions 
were only eligible when caloric intake was equal in both study arms. Furthermore, 
the interventions had to be provided for at least one week, since seven days of dietary 
intervention was deemed necessary to influence fat oxidation in the liver (27). In addition, 
trials that involved co-interventions, such as exercise or other lifestyle interventions, 
were only included when similar in both arms of the trial. Trials solely providing their 
participants with dietary advice rather than food items, as well as trials presenting 
insufficient information on macronutrient composition were not eligible. Assessment 
methods of liver fat content were predefined: only trials in which liver fat content was 
measured by magnetic resonance imaging (MRI), magnetic resonance spectroscopy 
(MRS), computed tomography (CT) or liver biopsy were considered (28, 29). 
Search strategy
We conducted a systematic search to identify eligible publications. In cooperation 
with a trained librarian (JWS), a detailed search strategy was composed for the four 
bibliographic databases: PubMed, Embase (OVID-version), Web of Science, and 
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difference represents a smaller increase in liver fat in the intervention arm compared to 
the control arm. A positive standardized mean difference indicates that the control arm 
is favoured. Guidelines state that an SMD of 0.2 can be considered small, 0.5 as medium 
and 0.8 as high (33).
Statistical heterogeneity was assessed using the I-squared statistic (37). Heterogeneity 
was considered to be low if the I2 value was under 40%, moderate if between 30% to 60%, 
substantial if between 50% to 90% and considerable when between 75% and 100% (24). All 
statistical analyses were conducted using Stata statistical Software (Statacorp, College 
Station, Texas, USA) version 14. 
Handling missing data
In case of unreported or incomplete data on mean changes (or SD) in liver fat content 
between baseline and follow-up, the original investigators were contacted and asked to 
provide missing data. When no response was received, we calculated mean differences 
using standard deviations based on the information that was provided (baseline or 
follow-up value with corresponding SD), as described in a previous meta-analysis 
(34). Trials were not included when relevant data to calculate mean differences was not 
provided (21).
Small-study effects
A funnel plot was used for graphical examination of small-study effects (39, 40). In addition, 




Of the 4.291 publications retrieved, a total of 3.320 unique publications were screened on 
title and abstract (Figure 1). Of those, 3.215 publications were excluded after screening 
of titles and abstracts for eligibility. A total of 105 articles were assessed for eligibility 
based on full text, of which 84 were excluded due to the following reasons: no dietary 
intervention (n=23), interventions not isocaloric (n=10), multiple publications from a 
single trial (n=4), no original research paper (n=7), co-interventions not equal in both 
arms (n=2), no adequate comparison (n=3), no MRI/MRS/CT/biopsy liver fat outcome 
(n=24), population younger than 18 years (n=3) or no RCT design (n=8), leaving a total of 
21 included articles (32, 35-54) (Figure 1). 
concealment, blinding of participants and personnel, blinding of outcome assessment, 
incomplete outcome data, selective reporting and “other sources of bias”. For detection 
of the “other sources of bias”, reviewers were in particular alert to (self )reporting bias, 
compliance assessment and carry-over effects in cross-over trials, with trials lacking a 
wash-out period being at higher risk. Each domain was separately judged as having a 
“low”, “high” or “unclear” risk of bias. In addition, a support for judgement was given 
and summarised following the criteria outlined by the Cochrane Collaboration (21). Any 
discrepancies in bias coding were resolved by discussion. 
Direct pairwise meta-analyses
To perform meta-analyses for continuous outcomes measured with different measuring 
instruments of liver fat on different scales (i.e., MRS/MRI (%) and CT-scans (Hounsfield 
Units)), effect estimates were expressed as standardized mean difference (SMD) with 
corresponding 95% confidence interval (95% CI). When studies only reported relative 
changes in liver fat, the absolute change based on the relative change and the baseline 
value was calculated. If trials presented medians and interquartile ranges (IQRs), 
values were converted into means and standard deviations according to the Cochrane 
Collaboration (24). 
Intervention effects were pooled by performing standard pairwise meta-analyses for all 
comparisons that contained at least three comparisons between diets. A random-effects 
model was used (method of DerSimonian and Laird (31)) for the comparison between a 
low-carbohydrate high-fat and a high-carbohydrate low-fat diet and due to the limited 
number of included studies a fixed-effect model for the other two comparisons. For the 
study of Luukkonen et al.(32), two interventions (saturated fat and unsaturated fat) were 
compared against the same control group (carbohydrates). To correct for these multiple 
correlated comparisons the number of participants in the control arm was divided by 
the number of comparisons (i.e. two) thereby creating two (reasonably independent) 
comparisons (Cochrane handbook Chapter 16.5.4). We performed a sensitivity analysis 
in which the two groups with physical activity as a co-intervention from the study of 
Bozzetto et al were excluded to eliminate the potential effect of physical activity on the 
results. The diet that was expected to be beneficial, as described in the rationale of the 
included studies, was considered as the intervention arm (high unsaturated fat-low 
saturated fat, high protein-low carbohydrates and high-carbohydrates low-fat), and 
the other the control arm (saturated fat, high carbohydrates and high fat). As a result, a 
negative standardized mean difference can be interpreted as a decrease in liver fat in the 
intervention arm compared with the control arm, which means that the intervention 
arm is favoured. In case of an overfeeding design, a negative standardized mean 




Table 1 shows the characteristics of the 21 randomized controlled trials. Studies were 
published between 2002 and 2019 and the number of participants ranged from 7 to 166. 
The duration of the studies varied between 7 days and two years. With regard to the 
macronutrient comparisons, ten studies reported effects of a low-carbohydrate high-
fat (LCHF)-diet compared with a high-carbohydrate low-fat (HCLF)-diet (32, 38-43, 51-53). Three 
studies compared a low-protein high-carbohydrate (LPHC)-diet with a high-protein low-
carbohydrate (HPLC)-diet (45, 48, 49). There were no studies on the comparisons between fat 
and protein content of the diet.
The other studies performed comparisons between types of macronutrients. A total of 
five studies compared different types of dietary fat, of which three studies compared a 
diet high in saturated fatty acids (SFAs) with a diet high in unsaturated fatty acids (UFAs) 
(32, 37, 50), one study compared trans fatty acids with palm- and sunflower oil (36) and one 
study looked at replacement of long chain fatty acids with medium chain fatty acids (47). 
In two studies dietary fibres were compared with other carbohydrates (35, 39), one study 
compared whole grain wheats with refined wheats (54) and in two studies diets containing 
animal protein was compared with diets containing plant/soy protein (44, 46). 
In total, sixteen studies used a parallel design, whereas five had a cross-over design (35, 43, 
46, 49, 52). Two studies assessed the liver fat content using CT (47, 48), whereas all other studies 
used MRS/MRI. One study assessed liver fat content both with MRI and MRS, of which we 
chose to use the MRS results in the meta-analysis as this is considered the most reliable 
method (11). Most studies mainly included participants with overweight or obesity, 
varying from adolescents to elderly, except for six studies that included lean participants 
(35, 43, 45, 47, 49, 50)(Table 1). The amount of (macro)nutrients exchanged varies considerably 
between studies (Supplemental table 1). Additional information on the macronutrient 
composition per study arm can be found in Supplemental table 1.
Risk of bias 
The risk of bias assessment for included studies can be found in Table 2. In six studies 
there was high risk of performance bias, in two studies there was high risk of detection 
bias, in four studies of attrition bias, in seven studies of reporting bias and in six studies 
there was a high risk of other bias. 
The majority of the studies had an unclear risk of selection bias due to a lack of information 
on concealment of allocation. Overall, there was unclear risk of selection bias and detection 
bias, and substantial risk of performance, attrition, reporting and other types of bias. 
For one study, only two out of three arms were incorporated into the meta-analysis, 
as the diet in one arm contained less calories than the diet in the other two arms (49). 
Ultimately, 25 eligible comparisons remained for analyses as three studies contained 
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Figure 3. Study flowchart  
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(n = 105) 
Low fat vs low carb 
(n=12) 
High protein vs high 
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Within carbs (n=3) Within proteins (n=2) 
Figure 1. Flowchart of included randomized controlled trials in meta-analysis on dietary macronutrient 
composition in relation to liver fat
40 | CHAPTER 2 DIETARY EFFECTS OF MACRONUTRIENTS AND MACRONUTRIENT TYPES ON LIVER FAT CONTENT IN ADULTS | 41
2
2
Table 2. Risk of bias of randomized controlled trials included in systematic review and meta-analysis on 
macronutrient and macronutrient types composition in relation to liver fat content in adults of 18 years 
and older
Selection bias Performance bias Detection bias Attrition bias Reporting bias Other bias 




















Bawden, 2017 Unclear Unclear Unclear Low Unclear Unclear Low
Bendsen, 2011 Low Low Low Low Low Unclear Unclear
Bjermo, 2012 Unclear Unclear High Low High Unclear High
Bozzetto, 2012 Low Low  Unclear Low Low Unclear High
Errazuriz, 2007 Unclear Unclear Unclear Low Low High Low
Haufe, 2017 Low Low High Unclear High Unclear Unclear
Gepner, 2019 Unclear Unclear High Low High Unclear High
Herpen, 2011 Low Unclear Unclear Unclear Low High High
Kirk, 2009 Unclear Unclear Unclear Unclear Low Unclear High
Luukkonen, 
2018 
Unclear Unclear High High Low Low Low
Marina, 2014 Unclear Unclear Unclear Low High High High
Markova, 2017 Low Unclear High High Unclear Low Unclear
Martens, 2014 Low Low High Unclear High High Low
van Nielen, 
2014
Unclear Unclear High Low Unclear Low Low
Nosaka, 2002 Low Unclear Low Unclear Low Unclear Unclear
Ooi, 2015 Low Low Low Low Low High Low
Rietman, 2014 Low Low Low Unclear Low High Unclear
Rosqvist, 2014 Low Unclear Low Low Unclear Unclear Unclear
Schutte, 2018 Unclear Unclear Low Unclear High Unclear Low
Utzschneider, 
2012
Unclear Unclear Low Low Low Unclear Unclear
Effects of interventions
Table 3 provides a summary of findings for all included trials. It also shows the changes 
in liver fat content and corresponding SMDs for all studies individually. Based on all 
included trials, we were able to perform three meta-analyses, as described below. A total 
of 21 studies were included, comprising a total of 25 comparisons between different 
diets. As we decided to only perform a meta-analysis on exchanges that contained at 
least three comparisons between dietary intervention arms, we could not meta-analyse 
comparisons of trans fats with palm- and sunflower oil, long chain with medium chain 
fat, dietary fibre with other carbohydrates, whole grain wheats with refined wheats, and 
animal protein with plant protein. Due to the limited number of included trials, we were 
not able to perform subgroup analyses on disease state, sex, ethnicity or study duration. 
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perform a network meta-analysis in which all macronutrients could be compared both 
directly and indirectly (35, 36, 39, 44, 46, 47). 
High-carbohydrate low-fat versus low-carbohydrate high-fat diets 
Out of 12 comparisons for a low-carbohydrate high-fat with a high-carbohydrate low-
fat diet, three comparisons favoured a low-carbohydrate high-fat diet over a high-
carbohydrate low-fat diet (38, 39), while two other comparisons showed the opposite (41, 
52) (Figure 2). The other studies showed no difference. Heterogeneity was substantial 
(67.8%). No small study effects seemed to be present (Supplemental figure 1) (P-value 
for Egger’s test 0.58). The overall pooled effect of high-carbohydrate low-fat versus high-
fat low-carbohydrate was: SMD 0.01, 95% CI -0.36; 0.37 (Figure 2). 
After excluding the two groups with a co-intervention of physical exercise from the 
study of Bozzetto, results were similar (data not shown).
Figure 2. Difference between effects of a low-carbohydrate high-fat diet (LCHF) and a high-carbohydrate 
low-fat (HCLF) on liver fat content in studies included in meta-analysis: a random effects model. 
Standardized mean difference (SMD) was calculated by dividing the mean difference between the 
arms by the standardized deviation of the difference between the arms. A negative standardized mean 
difference can be interpreted as a decrease in liver fat in the intervention arm compared with the control 
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-0.32, 95%CI -0.58; -0.05). A funnel plot is shown in Supplemental figure 3, Egger’s test was 
not performed due to an insufficient number of included studies.
Figure 4. Difference between effects of a low-protein high-carbohydrate (LPHC) diet and a high-protein 
low-carbohydrate (HPLC) diet on liver fat content in studies included in meta-analysis: a fixed effects 
model. Standardized mean difference (SMD) was calculated by dividing the mean difference between the 
arms by the standardized deviation of the difference between the arms. A negative standardized mean 
difference can be interpreted as a decrease in liver fat in the intervention arm compared with the control 
arm, which means that the intervention arm is favoured.
DISCUSSION
With this systematic review and meta-analysis including randomized controlled trials 
we have provided a summary of the evidence on the effect of dietary macronutrient 
composition on the amount of liver fat, as assessed by 1H-MRS, MRI or CT. Our results 
show that replacing dietary fat with carbohydrates did not result in changes in liver 
fat. Diets high in unsaturated fat lead to a larger decrease (or smaller increase in case 
of an overfeeding design) in liver fat content than diets high in saturated fat. A high-
protein low-carbohydrate diet reduces liver fat as compared with a low-protein high-
carbohydrate diet.
Dietary saturated fat versus unsaturated fat 
Only three studies examined the effect of unsaturated fat compared to saturated fat, 
of which all three found that an unsaturated fat diet reduces liver fat compared with 
saturated fat (32, 37, 50)(Figure 3). The overall effect showed that unsaturated fat as compared 
with saturated fat reduced liver fat to a large extent (SMD -0.75, 95% CI -1.11; -0.39. A funnel 
plot is shown in Supplemental figure 2; Egger’s test was not performed due to an 
insufficient number of included studies.
Figure 3. Difference between effects of a diet high in saturated fats (SFA) and a diet high in unsaturated 
fat (UFA) on liver fat content in studies included in meta-analysis: a fixed effects model. Standardized 
mean difference (SMD) was calculated by dividing the mean difference between the arms by the 
standardized deviation of the difference between the arms. A negative standardized mean difference can 
be interpreted as a decrease in liver fat in the intervention arm compared with the control arm, which 
means that the intervention arm is favoured.
High-protein low-carbohydrate versus low-protein high-carbohydrate diets
Three studies assessed the effect of a high protein-low carbohydrate compared to a 
low-protein high-carbohydrate diet on liver fat. One study found that a high-protein 
low-carbohydrate diet resulted in reduced liver fat content compared to a low-protein 
high-carbohydrate diet (45), whereas the other two studies did not find a difference (48, 49)
(Figure 4). The overall pooled effect showed that a high-protein low-carbohydrate diet 
moderately reduced liver fat as compared to a low-protein high-carbohydrate diet (SMD 
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hypo- or isocaloric). Firstly, whereas some studies specified which subtypes of dietary fats 
or carbohydrates were replaced, others did not, making the interpretation of the results 
difficult. As our results on exchanging unsaturated with saturated fat have shown, the fat 
type that is replacing the carbohydrates is likely relevant. Three randomized trials (32, 38, 
39) replaced carbohydrates with unsaturated fats and show that a low-carbohydrate high-
fat diet leads to less liver fat compared with a high-carbohydrate low-fat diet, whereas 
most other studies suggest that a high-carbohydrate low-fat diet leads to less liver fat. 
However, information on the type of fat used to replace carbohydrates in most studies 
lacking.
Secondly, this meta-analysis focused on the exchange between two macronutrient 
(subtypes) irrespective of the energy percentage derived from these specific 
macronutrients. Therefore, the studies show marked heterogeneity in the percentual 
energy contribution of the macronutrient subtypes that were exchanged. Studies with 
a larger exchanged energy percentage of macronutrients between the compared diets 
may have resulted in larger effect estimates than studies with smaller exchanges in 
energy percentages. However, the effect sizes of the studies were not proportional to the 
amount of energy percentage that was exchanged. 
Thirdly, total caloric intake varied considerably between studies. Whereas some studies 
used an overfeeding design in which participants were instructed to consume more 
calories than their usual diet, other studies used an isocaloric or hypocaloric diet. Our 
only criterion regarding energy intake was that it should be equal in both study arms 
within a trial, regardless of whether energy intake was below, above or equal to the 
energy requirement of the participants. Therefore, mean caloric intake varied from 1.100 
kilocalories per day (42)  to over 3.400 kilocalories per day (49). Although the number of 
included arms was too small to perform stratified analyses, the effect of macronutrient 
composition did not seem to be modified by caloric intake after visual inspection in the 
meta-analysis on dietary carbohydrates versus fat, which included the most comparisons. 
A second limitation of this review is that data of variance within the dietary arms of 
the included trials (e.g. variance of mean change in liver fat or variance of mean 
difference) were not always reported. Therefore, P-values of the mean differences in 
change in liver fat – that were converted to corresponding t-values – had to be used to 
calculate the standard deviations, standard error of the means and the 95% CIs of the 
mean differences in change in liver fat by Cochrane equations (59). With these calculated 
values, mean differences could be converted to standardized mean differences and their 
corresponding 95% CIs. However, some studies did not present exact P-values of the mean 
difference, but exclusively presented the level of significance (e.g., P < 0.05 or P < 0.01). As 
Our results focusing on liver fat content are in line with the review of Parry and Hodson, 
in which the authors describe that most studies suggest no influence on liver fat by 
diets that are high in carbohydrates in the form of free sugars (19). The increase in liver 
fat observed in diets high in fat seems to be attributable to an increased saturated fat 
consumption, while increased consumption of mono- or polyunsaturated fat may 
reduce liver fat content (19), which supports the results of our meta-analysis. The beneficial 
effects of unsaturated fat on liver fat content compared to saturated fat were also 
reported in another recent review (55). Additionally, results from this meta-analysis are 
in agreement with the findings from a meta-analysis on the effects of mutual exchanges 
of different dietary fats and carbohydrates on glucose-insulin homeostasis, an outcome 
strongly related to NAFL. The authors of this meta-analysis found that replacement 
of carbohydrates or saturated fat with polyunsaturated fat led to an improved insulin 
secretion capacity, lower fasting glucose, improved Homeostatic Model Assessment for 
Insulin Resistance (HOMA-IR) and lower haemoglobin A1C (HbA1c)(55). The exchange of 
saturated fat for carbohydrates did not affect most outcomes, except for a decrease in 
fasting insulin (56). 
Although the pathogenesis of liver fat accumulation is not completely elucidated yet, 
it is assumed that both high caloric intake and dietary composition influence liver 
fat content. Dietary intake of specific nutrients (e.g. fructose) may increase de novo 
lipogenesis, and together with increased lipolysis of visceral fat this may contribute to 
an increased flux of free fatty acids in the liver, leading to hepatic fat accumulation (10, 57). 
Additionally, n-6 polyunsaturated fatty acids have been suggested to suppress lipogenic 
gene expression and could thereby decrease de novo lipogenesis and thereby decrease 
accumulation of liver fat (58), which is consistent with the findings of this meta-analysis 
showing that this holds true more generally for unsaturated fat and that exchanging 
saturated for unsaturated fat can lower liver fat. 
A strength of this study is that it is the first comprehensive meta-analysis on the effect 
of macronutrient composition and macronutrient types on liver fat. The review process 
has been performed systematically and only studies in which liver fat was measured 
with either MRI, 1H-MRS or CT were included. Moreover, we only included studies that 
performed a dietary intervention rather than only providing dietary advice. 
This study also has some limitations. The first one is that comparing and meta-analysing 
data from different dietary intervention trials appeared challenging, as there was 
considerable heterogeneity in study duration and composition of the diets, percentages 
of macronutrients exchanged, and total amount of energy of provided diets (hyper-, 
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described by the Cochrane Handbook, the limits of the significance level were used for 
these trials as a conservative approach (59). This approach may have caused imprecision 
of the variance for each trial, which is reflected in a larger confidence interval around 
the SMD and a decreased weight of the study (59). 
As only a limited number of studies could be included in this meta-analysis, we 
recommend that more large randomized controlled dietary trials with a low risk of bias 
and of sufficient power are performed, in which complete and transparent reporting of 
results is of great importance in order to address this gap in knowledge. Especially trials 
in which proteins and fats are exchanged are warranted, as they were completely lacking, 
and then preferably with three arms to compare carbohydrates, fats and proteins in one 
study in which the sources and types of these macronutrients are specified. Bridging 
this gap in research is essential for the development of preventive strategies for fatty 
liver in the future.
In conclusion, this systematic review and meta-analysis of randomized controlled 
trials showed that replacing total carbohydrates with total fats has no effect on liver fat 
content. Replacing saturated fat with unsaturated fat resulted in a decrease or a smaller 
increase in liver fat content, and replacing carbohydrates with proteins also seems to 
lead to less liver fat. Only a limited number of eligible studies could be included, which 
supports an essential need for additional experimental studies on dietary macronutrient 
composition and liver fat content in order to provide optimal prevention and treatment 
for non-alcoholic fatty liver by dietary interventions.
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Supplemental figure 1. Funnel plot of studies comparing a low-carbohydrate high-fat (LCHF) diet and a 
high-carbohydrate low-fat (HCLF) diet
Supplemental figure 2. Funnel plot of studies comparing a unsaturated fat (UFA) diet and a saturated 
fat (SFA) diet
Supplemental figure 3. Funnel plot of studies comparison a high-protein low-carbohydrate (HPLC) diet 
and a low-protein high-carbohydrate (LPHC) diet
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INTRODUCTION 
Obesity, in particular abdominal obesity, is increasingly prevalent worldwide and 
is a major risk factor for type 2 diabetes and cardiovascular diseases (1, 2). The excess 
cardiometabolic risk associated with abdominal obesity is hypothesized to be due to the 
accumulation of fat in non-adipose tissue (2). Visceral adipose tissue (VAT) and hepatic 
triglyceride content (HTGC) have been associated with a cluster of metabolic risk 
factors, insulin resistance, coronary artery disease and cardiovascular disease in general 
(3-6). Furthermore, visceral adipose tissue is thought to possibly contribute to the excess 
cardiometabolic risk due to a high free fatty acid (FFA) release and a high rate of cytokine 
secretion (2). In addition, high concentrations of free fatty acids and insulin resistance 
are related to fat deposition in the liver (7) and are strongly related to type 2 diabetes and 
cardiovascular disease (8, 9).
Due to the many health-related consequences, both visceral fat and liver fat might 
be a key targets in the prevention or treatment of cardiometabolic disease and its 
consequences. In addition to physical activity, diet is a key modifiable lifestyle risk factor 
for obesity and chronic diseases (10-12). A recent systematic review has shown that dietary 
patterns recognized as healthy and intake of medium-chain triacylglycerols (MCTG) 
display an inverse association with visceral and subcutaneous fat. For visceral fat only, 
inverse associations were also shown with dietary fiber, calcium and phytochemicals 
(13). Interestingly, an overfeeding study of saturated and polyunsaturated fat showed 
distinct effects on visceral and liver fat (11). Most previous studies have assessed the role of 
nutrients in fat deposition (14-18), although higher energy intake during childhood has been 
suggested to be associated with greater NAFLD risk irrespective of the macronutrients 
this energy intake comes from (19). However, it is increasingly recognized that studying 
foods and food groups rather than single nutrients may be important in relation 
to health outcomes, as foods are not merely the sum of their nutrients (20-23). Within a 
food item, there may be unknown effects of other nutrients, or interactions between 
the separate nutrients, and the food matrix may play a role (22-24). Countries throughout 
Europe as well as the United States now have published dietary guidelines based on 
whole food products and groups rather than single nutrients (25). While evidence on 
major food groups (e.g. dairy, meat, fruit and vegetables) in relation to body weight (26) 
and clinical cardiometabolic outcomes including CHD (27) and diabetes (28) is increasing, 
knowledge of the relationships between food groups and ectopic fat deposition is 
scarce. We therefore aimed to investigate the associations between dietary intake of the 
main food groups and visceral fat and liver fat content in a population-based cohort of 
middle-aged men and women. 
ABSTRACT 
Background
Visceral adipose tissue (VAT) and hepatic triglyceride content (HTGC) are major risk 
factors for cardiometabolic diseases. 
Objective
We aimed to investigate the association of dietary intake of the main food groups with 
VAT and HTGC in middle-aged men and women. 
Methods
We used data from the Netherlands Epidemiology of Obesity Study, a population-based 
study including 6,671 participants aged 45-65 years at baseline. In this cross-sectional 
analysis, VAT and HTGC were assessed by magnetic resonance imaging and spectroscopy, 
respectively, as the primary outcomes. Habitual intake of main food groups (dairy, meat, 
fish, fruits and vegetables, sweet snacks, and fats and oils) was estimated using a food 
frequency questionnaire. We examined associations of intake of different food groups 
with VAT and HTGC by linear regression analysis stratified by sex and adjusted for age, 
smoking, education, ethnicity, physical activity, basal metabolic rate, energy-restricted 
diet, menopausal state and total energy intake, stratified by sex. 
Results
In women, a 100-g/d higher intake of dairy was associated with 2.0 cm2 less VAT (95% CI: 
−3.4, −0.7 cm2) and a 0.95-fold lower HTGC (95% CI: 0.90-, 0.99-fold). Moreover, a 100-g/d 
higher intake of fruit and vegetables was associated with 1.6 cm2 less VAT (95% CI: −2.9, 
−0.2 cm2) in women. Fruit and vegetables were negatively associated (0.95; 95% CI: 0.91, 
1.00) with HTGC, and sweet snacks were positively associated (1.29; 95% CI: 1.03, 1.63). 
Patterns were weaker but similar in men. Fish intake was not associated with VAT or 
HTGC and plant-based fat and oil intake were only associated with VAT after adjustment 
for total body fat.
Conclusions
Despite some variation in the strength of the associations between men and women, 
dietary intake of sweet snacks was positively associated with HTGC, and fruit and 
vegetable intake were inversely associated with visceral fat and liver fat content. 
Prospective studies are needed to confirm these results. 
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system and grouped into high (including higher vocational school, university, and 
postgraduate education) versus low education (reference). Participants reported their 
medical history of diabetes and cardiovascular diseases. Body weight and percent body 
fat were assessed by the Tanita bio impedance balance (TBF-310, Tanita International 
Division, UK) without shoes, and one kilogram was subtracted from the body weight. 
BMI was calculated by dividing the weight in kilograms by the height in meters 
squared. The menopausal state was categorized as pre-, or postmenopausal according to 
information on ovariectomy, hysterectomy and the self-reported state of menopause in 
the questionnaire. The basal metabolic rate was calculated based on age, sex, height and 
weight according to the Mifflin-St Jeor equation. Participants reported the frequency 
and duration of their physical activity during leisure time, which was expressed in hours 
per week of metabolic equivalents (MET h/week) (30).
Dietary intake of food groups
Habitual dietary intake of all participants was estimated using a self-administered, 
semiquantitative 125-item food frequency questionnaire (FFQ) (31, 32). In this FFQ , 
participants were asked about the frequency of intake of foods during the past month 
(times per day, week, month, never). Additionally, the serving size was estimated 
(spoons of potatoes, pieces of fruit). In a random subsample of 110 men and 119 women, 
the relative validity of the FFQ against two 24-h dietary recalls was assessed regarding 
total fatty acids, saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and 
polyunsaturated fatty acids (PUFAs). The correlation coefficients corrected for within-
person variation for total fatty acids, SFAs, MUFAs and PUFAs were approximately 0.5 (33). 
Intake of nutrients and total energy was calculated using the Dutch Food Composition 
Table (NEVO-2011).
 
Based on the FFQ , products were categorized into food groups on the basis of similar 
source, nutrient characteristics or hypothesized biological effects (28). Hereby, we 
followed the categorization of food groups of the Netherlands Nutrition Center (34) as 
much as possible based on the distinctive capabilities of the FFQ used. Food groups 
were categorized into dairy (including milk, cheese, yogurt and butter), meat, fruits and 
vegetables, sweet snacks (chocolate, cake, pie, candy bars and candy), fish and plant-
based fats and oils (margarine, cooking oils). Additionally, subdivisions were made: 
dairy was also subdivided into cheese, milk, butter and yogurt; fruit and vegetables 
were studied separately; fats and oils were divided into margarine and oils; and sweet 
snacks were divided into cake and candy. The caloric intake of products within these 
food groups was summed and converted into percent of total energy intake (En%) by 
dividing the caloric intake of the food groups by the total caloric intake per day. 
SUBJECTS AND METHODS
Study design and study population
The Netherlands Epidemiology of Obesity (NEO) study is a population-based prospective 
cohort study in 6,671 individuals aged 45 to 65 years, with an oversampling of persons 
with a BMI of 27 kg/m2 or higher. Detailed information about the study design and data 
collection has been described elsewhere (29). Men and women aged between 45 and 65 
years with a self-reported BMI of 27 kg/m2 or higher living in the greater area of Leiden (in 
the west of The Netherlands) were eligible to participate in the NEO study. In addition, 
all inhabitants aged between 45 and 65 years from one municipality (Leiderdorp) were 
invited irrespective of their BMI, allowing a reference distribution of BMI.
Participants visited the NEO study center of the Leiden University Medical Center 
(LUMC) after an overnight fast. Prior to the NEO study visit, participants completed a 
questionnaire about demographic and clinical information, as well as a food frequency 
questionnaire. At the study center, the participants completed a screening form asking 
about anything that might create a health risk or interfere with magnetic resonance 
imaging (MRI) (most notably metallic devices, claustrophobia, or a body circumference 
of more than 1.70 m). Of the participants who were eligible for MRI, approximately 35% 
were randomly selected to undergo direct assessment of abdominal fat. 
The present study is a cross-sectional analysis of the baseline measurements of the 
participants with a measurement of visceral adipose tissue. We excluded participants 
with self-reported diabetes prior to the study visit, participants with missing data on 
dietary intake, participants with implausibly high or low total energy intake (<600 kcal/
day or >5,000 kcal/day) or participants with missing data on potential confounding 
factors. For the analyses on hepatic triglyceride content, we additionally excluded 
participants without assessment of hepatic triglyceride content and those who 
consumed more than four units of alcoholic beverages per day.
The study was approved by the medical ethics committee of the Leiden University 
Medical Center and all participants gave written informed consent.
Data collection
On the questionnaire, participants reported ethnicity by self-identification in eight 
categories which we grouped into white (reference) and other ethnicity. Tobacco 
smoking was categorized as current, former, or never smoking (reference). The highest 
level of education was reported in 10 categories according to the Dutch education 
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We performed linear regression analyses with multiple models to examine the associations 
between dietary intake of the food groups with visceral fat and liver fat content. First, we 
examined the crude associations of dietary intake of 100 grams/day of each food group 
with visceral fat and liver fat content. Second, we adjusted the models for age, smoking, 
education, ethnicity, physical activity, basal metabolic rate, menopausal state, total energy 
intake and adherence to an energy restricted diet and liver fat models were also adjusted 
for alcohol intake. Third, we additionally adjusted the models for total body fat, to examine 
whether the associations were specific for visceral fat and liver fat instead of merely 
reflecting associations with overall adiposity. Fourth, to examine whether associations 
were specific for the food groups and not merely reflecting a healthy diet, we additionally 
adjusted all models for the food group fruit and vegetables, and the food group fruit and 
vegetables model for the food sweet snacks. As secondary analyses, we subdivided several 
food groups into a finer categorization: dairy into milk, cheese, yogurt and butter; sweet 
snacks into cake and candy; plant-based fat and oils into margarine and oils; and fruit 
and vegetables into fruit and vegetables separately. We performed subgroup analyses 
and stratified the multivariable model 2 (not including total body fat and markers of a 
healthy diet) by and menopausal state (pre- and postmenopausal). This stratification was 
done because for example visceral fat may differ greatly between pre- and postmenopausal 
women (41). We additionally stratified the same multivariable models of hepatic triglyceride 
content by the rs738409 single nucleotide polymorphism in the PNPLA3 gene to examine 
whether associations would be different in carriers of the risk allele that is associated with 
high liver fat content (42). Due to a skewed distribution of hepatic triglyceride content, 
we used the natural logarithm of this variable in the analyses. For interpretation of the 
results, we back transformed the regression coefficients of hepatic triglyceride content 
toward a ratio with 95% confidence interval, which can be interpreted as a ratio in hepatic 
triglyceride content associated with dietary intake of 100 grams/day of the food groups 
(for example 1.2, can be interpreted as a 1.2-fold higher hepatic triglyceride content, which 
in a person with a hepatic triglyceride content of 5% would reflect an increase to 6%). 
The regression coefficients of visceral adipose tissue represent an absolute difference in 
visceral adipose tissue in cm2 per 100 grams/day of the food groups.  
As a means of sensitivity analysis, we additionally performed two types of isocaloric 
substitution analyses in which dairy was specifically replaced by the other food groups: 
one per 100 grams per day and one per 10% of the energy (En%) derived from the food 
groups.
In these substitution models, we included all the food groups under study (meat, fruits 
and vegetables, sweet snacks, fish, and plant-based fats and oils), except dairy, the food 
Visceral adipose tissue and hepatic triglyceride content assessment by imaging 
techniques
Imaging was performed on a 1.5 Tesla MR system (Philips Medical Systems, Best, The 
Netherlands). Visceral adipose tissue was quantified by a turbo spin echo imaging 
protocol using MRI. At the level of the fifth lumbar vertebra, three transverse images 
each with a slice thickness of 10 mm were obtained during a breath-hold. Visceral fat 
area was converted from the number of pixels to centimeters squared using in-house-
developed software (MASS, Medis, Leiden, The Netherlands) and the average of the three 
slices was used in the analyses (29). 
Hepatic triglyceride content was quantified by proton spectroscopy (1H-MRS) of the liver 
(35). An 8 ml voxel was positioned in the right lobe of the liver, avoiding gross vascular 
structures and adipose tissue depots. Sixty-four averages were collected with water 
suppression. Spectra were obtained with an echo time of 26 ms and a repetition time 
of 3,000 ms. Data points (1,024) were collected using a 1,000 Hz spectral line. Without 
changing any parameters, spectra without water suppression, with a repetition time of 
10 s and four averages were obtained as an internal reference. 1H-MRS data were fitted 
using Java-based magnetic resonance user interface software (jMRUI version 2.2, Leuven, 
Belgium), as described previously (36). Hepatic triglyceride content relative to water was 
calculated as the sum of the signal amplitudes of methyl and methylene divided by the 
signal amplitude of water and then multiplied by 100.
Statistical analysis
In the NEO study, there is an oversampling of persons with a BMI of 27 kg/m2 or higher. 
To correctly represent associations in the general population (37), adjustments for the 
oversampling of individuals with a BMI ≥ 27 kg/m2 were made by weighting individuals 
toward the BMI distribution of participants from the Leiderdorp municipality (38), which 
was similar to that of the general Dutch population (39). All results were based on the 
weighted analyses, and consequently, the results apply to a population-based study 
without oversampling of individuals with a BMI ≥ 27 kg/m2. As a result of the weighted 
analyses, percentages and proportions are given instead of numbers of participants. 
Other characteristics are expressed as percentages or means (standard deviations). 
We tested for interactions with sex and performed all analyses for the total population 
and for men and women separately due to major differences in body fat distribution 
between men and women and previously observed gender differences in the relation 
between food group scores and abdominal obesity (40). Linearity of the main food groups 
was checked by adding a quadratic term to the main multivariable adjusted model and 
visual inspection of scatter plots. 
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cm2 versus 87 cm2), total body fat (30.7% versus 30.9%) or any of the food groups. Lastly, 
participants who drank more than 4 units of alcohol per day (n=165) were excluded for 
the analyses of hepatic triglyceride content. 
The baseline characteristics of the study population participants are shown in Table 
1. Whereas women had more total body fat, men had more visceral adipose tissue and 
hepatic triglyceride content. 
Table 1. Baseline characteristics of of participants of the Netherlands Epidemiology of Obesity study, men 
and women between 45 and 65 years of age with direct assessment of abdominal fat depots and who were 
not using glucose-lowering therapy1
Total population Men (46.4%) Women (53.6%)
Demographic variables
Age (year) 55 (6) 56 (6) 55 (6)
Ethnicity (% white) 96 96 95
Education level (% high)2 47 51 43
Tobacco smoking (% current) 15 16 13
Menopausal state (% post) 58
Physical activity in leisure time (MET h/wk) 38.3 (33.1) 40.0 (38.8) 36.9 (28.1)
Dietary variables
Dairy intake (g/d) 322 (196) 341 (223) 306 (172)
Meat intake (g/d) 83 (46) 96 (50) 72 (38)
Fish intake (g/d) 18 (17) 19 (19) 16 (15)
Fruit and vegetable intake (g/d) 326 (163) 304 (169) 345 (154)
Sweet snack intake (g/d) 82 (57) 89 (59) 75 (54)
Fat and oil intake (g/d) 35 (22) 41 (26) 29 (17)
Energy restricted diet (%) 10 6 14
Basal metabolic rate (MJ/d) 6.3 (1.1) 7.3 (0.7) 5.5 (0.6)
Body fat measures
BMI (kg/m2) 25.8 (3.9) 26.5 (3.5) 25.2 (4.0)
Total body fat (%) 30.7 (8.3) 24.5 (5.7) 36.1 (6.1)
Visceral adipose tissue (cm2) 87.6 (54.2) 113.0 (58.7) 65.5 (39.8)
Hepatic triglyceride content (%)3 5.6 (7.7) 6.8 (8.2) 4.5 (7.2)
Fatty liver (HTGC>5.56%) (%) 28.2 37.5 20.2
Waist circumference (cm) 90.9 (12.6) 97.3 (10.4) 85.3 (11.3)
CVD risk factors
CVD (%) 3.8 3.9 3.7
Lipid lowering medication (%) 7 11 4
Total serum cholesterol (mmol/L) 5.75 (1.04) 5.63 (1.04) 5.86 (1.03)
Fasting serum triglycerides (mmol/L) 1.23 (0.82) 1.43 (0.97) 1.06 (0.64)
HDL serum cholesterol (mmol/L) 1.58 (0.46) 1.35 (0.36) 1.79 (0.43)
1 Values are means ± SDs. Results are based on analyses weighted toward the BMI distribution of the general population 
(n=2,304). BMI, body mass index; CVD, cardiovascular disease; HDL, high-density lipoproteins; MET, metabolic 
equivalent of task. 
2Low education: none, primary school, or lower vocational education as highest level of education.
3Mean HTGC only calculated in persons with HTGC measurement (n=1880)
group to be substituted, in addition to all other food consumed that was not categorized 
in one of the food groups, and all confounding factors. Finally, we performed a sensitivity 
analysis including a variable in our fully adjusted model that divides energy intake by 
basal metabolic rate, to adjust for potential under- and overreporting.
We performed all analyses using STATA statistical software (Statacorp, College Station, 
Texas, USA), version 14.
RESULTS 
In total, 6,671 participants were included in the NEO study between September 2008 
and October 2012, of whom 2,580 underwent an MRI of the abdomen. For 11 of those 
participants, the quality of the MRI images was insufficient for quantification of 
abdominal visceral adipose tissue. MRI was performed in random subsample of those 
without contraindications. As a result, those who underwent the MRI have a slightly 
lower BMI (26.0 kg/m2 versus 26.6 kg/m2) and slightly less often a medical history of 
cardiovascular disease (4.1% versus 6.8%).
After exclusion of participants with a medical history of diabetes (n=161), extreme 
energy intake (<600 kcal/day or >5,000 kcal/day (n=19)), an incomplete FFQ (n=16) or 
missing data on smoking (n=2), education (n=22), ethnicity (n=3), energy-restricted 
diet (n=4) and physical activity (n=38), 2,304 participants were included in the analyses 
on visceral adipose tissue. Participants included in the analyses did not substantially 
differ from those excluded due to missing data regarding total body fat (30.7% for those 
without missing data versus 30.6% for those with missing data), visceral fat (87.6 cm2 
versus 88.2 cm2), nor regarding dietary intake of the food groups. Liver fat was slightly 
lower in the participants with missing data (4.3% compared to 5.6%).
For the analyses with hepatic triglyceride content as an outcome, we excluded 424 
participants without hepatic triglyceride content measurement. Due to the limited time 
available per subject it was not possible to check the spectra during the measurement 
and repeat the measurement when technical failures were present. As a consequence, 
1H-MRS of the liver could not be completed in 424 participants, for whom the majority 
were due to technical failures. However, the failure rate of the MR spectroscopy was not 
related to age (56 years for participants with hepatic triglyceride content measurement 
versus 55 years for participants without hepatic triglyceride content measurement), sex 
(47% male versus 46%), BMI (26.0 kg/m2 versus 25.8 kg/m2), visceral adipose tissue (90.1 
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After the finer categorization, vegetables were more strongly associated with hepatic 
triglyceride content than fruit, and yogurt was most strongly associated with liver fat of 
all the dairy components (Table 5). The association between sweet snacks and hepatic 
triglyceride content was stronger in premenopausal women than in postmenopausal 
women (P-value for interaction 0.59) (Supplemental table 2). 
Dietary intake of the main food groups in relation to visceral adipose tissue
We assessed the reproducibility of the dietary intake of the food groups in 100 
participants who completed the FFQ twice with approximately three months in between. 
The individual measurement intraclass correlation coefficients of the food group dairy 
were 0.80, of fruit and vegetables 0.56, meat 0.83, sweet snacks 0.59, fish 0.64 and fats and 
oils 0.65. The individual intraclass correlation coefficient for total energy intake was 0.68. 
In the total population, after adjustment for confounding factors, total body fat and a 
marker for an (un)healthy lifestyle, dietary intake of fruit and vegetables was associated 
with 1.2 cm2 (95% CI -2.4, 0.0) less visceral adipose tissue (Table 2). Intake of plant-based 
fats and oils was also associated with 13.9 cm2 less visceral adipose tissue (-23.7, -4.1). 
Dietary intake of dairy, fish, meat and sweet snacks was not associated with visceral 
adipose tissue (Table 2). 
Tests for an interaction between the food groups and sex were nonsignificant, but we 
a priori decided to perform the analyses separately for men and women because of 
the large differences in body fat distribution. All associations were attenuated in the 
stratified analyses, although in women intake of dairy remained associated with visceral 
adipose tissue (-1.2 cm2, -2.5, 0.0) (Table 2)
After a finer categorization of the food groups, yogurt seemed to drive the negative 
association between dairy and visceral adipose tissue in women (Table 4). Dietary 
intake of dairy, meat, and fruit and vegetables was more strongly associated with visceral 
adipose tissue in postmenopausal women than in premenopausal women (P-values for 
interactions: 0.56, 0.09 and 0.21) (Supplemental table 1). The results remained similar 
after substituting dairy with other food groups (Supplemental table 3) and when 
including participants with diabetes (Supplemental table 5). The results did not differ 
when adjusting for potential under- or overreporting (data not shown).
Dietary intake of main food groups in relation to hepatic triglyceride content
In the total population of 1,715 participants with hepatic triglyceride content measurements, 
after adjustment for confounding factors, total body fat and a marker for an (un)healthy 
lifestyle, dietary intake of sweet snacks were associated with a 1.19-fold (95% CI 1.04, 1.37) 
higher hepatic triglyceride content (Table 3). The intake of dairy, fruit and vegetables, fish, 
meat, and fats and oils was not associated with hepatic triglyceride content (Table 3). In 
men and women separately, the associations were attenuated (Table 3). 
Table 2. Difference in VAT (cm2) with 95% confidence intervals per 100 g/day consumption of the food 
groups in of participants of the Netherlands Epidemiology of Obesity study, men and women between 
45 and 65 years of age with direct assessment of abdominal fat depots and who were not using glucose-
lowering therapy1
Crude Multivariable Multivariable + TBF
Multivariable + TBF + 
healthy diet
Food groups
Difference in VAT (cm2)
with 95% CI
Difference in VAT (cm2)
with 95% CI
Difference in VAT (cm2)
with 95% CI




Total 0.1 (-1.3; 1.6) -1.4 (-2.5; -0.3)* -0.6 (-1.6; 0.4) -0.6 (-1.6; 0.4)
Men -0.6 (-2.6; 1.3) -0.8 (-2.5; 0.9) 0.0 (-1.4; 1.5) 0.0 (-1.4; 1.5)
Women -1.3 (-2.7; 0.2) -2.0 (-3.4; -0.7)* -1.3 (-2.5; 0.0) -1.2 (-2.5; 0.0)
Meat
Total 26.1 (20.2; 31.9)* 5.4 (0.1; 10.6)* 1.5 (-3.1; 6.0) 1.0 (-3.5; 5.6)
Men 10.9 (2.3; 19.4)* 3.9 (-4.3; 12.1) -1.1 (-7.8; 5.6) -1.4 (-8.0; 5.3)
Women 15.7 (8.7; 22.7)* 6.6 (0.7; 12.6)* 3.4 (-2.0; 8.7) 2.8 (-2.6; 8.2)
Fish
Total 30.5 (13.4; 47.5)* 6.1 (-5.8; 18.1) 3.7 (-6.8; 14.2) 6.2 (-4.7; 17.1)
Men 14.6 (-8.3; 37.5) 5.2 (-14.3; 24.8) 1.9 (-15.2; 18.9) 3.0 (-14.6; 20.6)
Women 25.4 (6.8; 44.0)* 6.7 (-6.1; 19.5) 5.4 (-5.7; 16.6) 9.1 (-2.6; 20.9)
Fruit and vegetables
Total -3.1 (-4.8; -1.4) -1.7 (-3.0; -0.4)* -1.2 (-2.4; -0.0)* -1.2 (-2.4; 0.0)
Men -2.3 (-4.8; 0.2) -1.8 (-4.2; 0.5) -1.0 (-3.2; 1.2) -0.8 (-3.1; 1.4)
Women -0.4 (-2.1; 1.4) -1.6 (-2.9; -0.2)* -1.1 (-2.3; 0.1) -1.2 (-2.4; 0.1)
Sweet snacks
Total 4.3 (-0.7; 9.2) -0.3 (-4.7; 4.2) 0.9 (-3.1; 5.0) 0.2 (-3.9; 4.4)
Men -1.6 (-9.1; 5.8) -0.6 (-8.1; 7.0) 4.0 (-2.3; 10.3) 3.7 (-2.6; 10.0)
Women -0.0 (-5.0; 5.0) 0.4 (-4.8; 5.6) 0.6 (-4.5; 5.6) -0.4 (-5.7; 5.0)
Fat and oils
Total 33.5 (21.2; 45.9) -8.2 (-20.2; 3.8) -12.5 (-22.2; -2.7)* -13.9 (-23.7; -4.1)*
Men 3.7 (-12.5; 19.8) -13.1 (-30.9; 4.6) -18.3 (-31.3; -5.3)* -19.8 (-33.1; -6.4)*
Women 6.8 (-9.0; 22.6) -1.2 (-14.4; 11.9) -7.3 (-19.9; 5.3) -8.3 (-20.9; 4.3)
1Multivariable: adjusted for age, total energy intake, smoking, education, ethnicity, physical activity in leisure time, 
basal metabolic rate, menopause and energy restricted diet. Results are based on analysis weighted toward the body 
mass index distribution of the general population (n=2,304, 1191 men and 1113 women). CI, confidence interval; TBF, 
total body fat; VAT, visceral adipose tissue.
*p-value<0.05
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Table 4. Difference in VAT (cm2) with 95% confidence intervals per 100 g/day consumption of the food 
groups in of participants of the Netherlands Epidemiology of Obesity study, men and women between 
45 and 65 years of age with direct assessment of abdominal fat depots and who were not using glucose-
lowering therapy1
 
Crude Multivariable Multivariable + TBF
Multivariable + TBF + 
healthy diet
Food groups
Difference in VAT 
(cm2) with 95% CI
Difference in VAT 
(cm2) with 95% CI
Difference in VAT 
(cm2) with 95% CI
Difference in VAT (cm2) 
with 95% CI
Cheese
Total 6.9 (-4.2; 17.9) -0.2 (-8.7; 8.3) -0.1 (-7.7; 7.6) -0.2 (-7.9; 7.5)
Men 16.8 (2.2; 31.4)* 7.8 (-5.8; 21.4) 0.4 (-10.7;11.6) 0.2 (-10.9; 11.4)
Women -6.6 (-19.5; 6.3) -8.6 (-19.0; 1.9) -4.2 (-13.8; 5.4) -4.3 (-13.9; 5.3)
Milk
Total 1.5 (-0.2; 3.2) -0.3 (-1.5; 0.8) 0.2 (-0.9; 1.2) 0.1 (-0.9; 1.2)
Men 0.19 (-2.1; 2.5) -0.1 (-2.0; 1.8) 0.7 (-0.9; 2.4) 0.7 (-1.0; 2.3)
Women -0.4 (-1.9; 1.1) -0.6 (-1.7; 0.5) -0.2 (-1.4;0.9) -0.3 (-1.4; 0.8)
Yogurt
Total -8.8 (-13.1; -4.5)* -7.4 (-11.0; -3.9)* -5.2 (-7.8; -2.6)* -5.0 (-7.6; -2.4)*
Men -7.4 (-12.6; -2.2)* -6.0 (-11.3; -0.6)* -3.9 (-7.8; 0.0) -3.7 (-7.6; 0.2)
Women -5.9 (-10.0; -1.7)* -9.2 (-12.3; -6.1)* -6.6 (-9.4; -3.7)* -6.3 (-9.1; -3.4)*
Cream butter
Total -3.5 (-48.0; 40.9) -9.6 (-37.8; 18.5) -6.8 (-33.8; 20.2) -7.3 (-34.6; 20.0)
Men -29.8 (-85.7; 26.1) -43.8 (-97.2; 9.6) -30.3 (-69.7; 9.0) -27.8 (-67.0; 11.4)
Women -7.4 (-52.4; 37.5) 13.0 (-23.5; 49.5) 10.4 (-27.3; 48.1) 10.8 (-27.0; 48.7)
Fruit 
Total -5.2 (-7.7; -2.7) -2.3 (-4.2; -0.4) -1.2 (-2.9; 0.5) -1.2 (-2.9; 0.5)
Men -3.9 (-7.3; -0.4)* -2.6 (-5.9; 0.8) -0.6 (-3.5; 2.3) -0.5 (-3.4; 2.3)
Women -1.7 (-4.1; 0.8) -1.9 (-3.9; 0.0) -1.3 (-3.1; 0.5) -1.3 (-3.1; 0.5)
Vegetables
Total -0.8 (-3.6; 2.1) -1.2 (-3.3; 1.0) -1.5 (-3.4; 0.4) -1.5 (-3.4; 0.4)
Men -0.4 (-5.0; 4.2) -0.8 (-5.0; 3.5) -2.1 (-5.9; 1.6) -1.8 (-5.6; 1.9)
Women 1.5 (-1.3; 4.3) -1.5 (-3.7; 0.7) -1.3 (-3.2; 0.7) -1.3 (-3.3; 0.8)
Cake
Total 4.7 (-4.9; 14.3) -1.8 (-9.9; 6.3) -3.3 (-10.1; 3.5) -3.8 (-10.6; 3.1)
Men -2.1 (-16.5; 12.2) 0.1 (-13.7; 13.9) -0.1 (-10.6; 10.5) 0.1 (-10.5; 10.7)
Women 3.6 (-6.8; 14.1) -1.6 (-10.4; 7.2) -2.2 (-10.3; 5.9) -3.3 (-11.5; 4.8)
Candy
Total 1.5 (-6.2; 9.2) 0.1 (-6.2; 6.5) 1.7 (-4.0; 7.4) 1.0 (-4.9; 6.9)
Men -1.4 (-12.6; 9.9) -2.4 (-14.1; 9.2) 1.9 (-7.6; 11.3) 1.6 (-7.9; 11.1)
Women -0.4 (-7.2; 6.3) 2.4 (-4.2; 9.0) 2.7 (-3.8; 9.3) 1.8 (-4.9; 8.6)
Margarine
Total 34.1 (20.0; 48.2) -10.5 (-23.0; 2.0) -14.2 (-24.3; -4.1)* -16.6 (-26.8; -6.4)*
Men -2.7 (-21.0; 15.6) -18.3 (-36.3;-0.4)* -19.2 (-32.6; -5.8)* -21.1 (-34.9; -7.3)*
Women 11.1 (-7.1; 29.3) 2.1 (-11.7; 15.8) -7.0 (-20.1; 6.0) -9.4 (-22.5; 3.8)
Oils
Total 27.1 (-4.3; 58.5) 10.0 (-15.4; 35.4) 2.1 (-20.1; 24.3) 5.6 (-17.2; 28.3)
Men 24.0 (-14.9; 63.0) 13.2 (-23.9;50.4) -10.4 (-41.6; 20.9) -8.2 (-40.0; 23.7)
Women 4.1 (-35.1; 43.4) 5.4 (-27.6; 38.4) 9.8 (-20.3; 39.9) 13.8 (-16.5; 44.2)
1Multivariable: adjusted for age, total energy intake, smoking, education, ethnicity, physical activity in leisure time, 
basal metabolic rate, menopause and energy restricted diet. Results are based on analysis weighted toward the body 
mass index distribution of the general population (n=2304, 1191 men and 1113 women). CI, confidence interval; TBF, total 
body fat; VAT, visceral adipose tissue. 
*p-value<0.05
Substituting dairy with other food groups showed similar results as the multivariable 
analyses (Supplemental table 4), as did the analyses including participants with 
diabetes (Supplemental table 6). The results did not differ when adjusting for potential 
under- or overreporting (data not shown).
Table 3. Relative difference in HTGC with 95% confidence intervals per 100 g/day consumption of the food 
groups in of participants of the Netherlands Epidemiology of Obesity study, men and women between 
45 and 65 years of age with direct assessment of abdominal fat depots and who were not using glucose-
lowering therapy1
Crude Multivariable Multivariable + TBF
















Total 0.98 (0.95; 1.02) 0.97 (0.93; 1.00)* 0.97 (0.94; 1.01) 0.97 (0.94; 1.01)
Men 0.98 (0.94; 1.03) 0.98 (0.94; 1.03) 0.99 (0.94; 1.03) 0.99 (0.94; 1.03)
Women 0.96 (0.91; 1.02) 0.95 (0.90; 0.99)* 0.96 (0.92; 1.01) 0.96 (0.92; 1.01)
Meat
Total 1.48 (1.28; 1.71)* 1.14 (0.98; 1.33) 1.06 (0.92; 1.22) 1.05 (0.91; 1.20)
Men 1.16 (0.95; 1.41) 1.06 (0.86; 1.29) 0.97 (0.83; 1.15) 0.97 (0.82; 1.14)
Women 1.45 (1.16; 1.80)* 1.21 (0.97; 1.52) 1.10 (0.89; 1.36) 1.07 (0.87; 1.32)
Fish
Total 1.18 (0.78; 1.80) 0.82 (0.57; 1.19) 0.79 (0.58; 1.08) 0.85 (0.61; 1.16)
Men 1.03 (0.63; 1.70) 0.96 (0.57; 1.63) 0.93 (0.59; 1.47) 0.96 (0.61; 1.50)
Women 1.08 (0.61; 1.90) 0.71 (0.45; 1.14) 0.69 (0.46; 1.04) 0.76 (0.48; 1.19)
Fruit and vegetables
Total 0.95 (0.91; 0.99) 0.96 (0.92; 0.99)* 0.97 (0.93; 1.00)* 0.97 (0.94; 1.01)
Men 0.95 (0.90; 1.01) 0.97 (0.92; 1.02) 0.98 (0.94; 1.02) 0.99 (0.94; 1.03)
Women 0.98 (0.93; 1.03) 0.95 (0.91; 1.00) 0.96 (0.92; 1.00) 0.97 (0.93; 1.02)
Sweet snacks
Total 1.17 (1.03; 1.33)* 1.22 (1.05; 1.42)* 1.21 (1.06; 1.39)* 1.19 (1.04; 1.37)*
Men 1.06 (0.91; 1.22) 1.13 (0.94; 1.35) 1.17 (1.01; 1.35)* 1.16 (0.99; 1.35)
Women 1.17 (0.95; 1.44) 1.29 (1.03; 1.63)* 1.26 (1.01; 1.57)* 1.23 (0.97; 1.54)
Fats and oils
Total 1.84 (0.39; 2.44) 1.20 (0.88; 1.64) 1.16 (0.88; 1.53) 1.12 (0.85; 1.48)
Men 1.30 (0.91; 1.86) 1.26 (0.84; 1.88) 1.22 (0.86; 1.74) 1.20 (0.84; 1.71)
Women 1.42 (0.87; 2.30) 1.21 (0.75; 1.94) 1.08 (0.68; 1.70) 1.04 (0.66; 1.65)
1Multivariable: adjusted for age, total energy intake, smoking, education, ethnicity, physical activity in leisure time, 
basal metabolic rate, menopause, alcohol consumption and energy restricted diet. Results are based on analysis 
weighted toward the body mass index distribution of the general population (n=1,715, 831 men and 884 women). CI, 
confidence interval; HTGC, hepatic triglyceride content; TBF, total body fat.
*p-value<0.05
3 3
70 | CHAPTER 3 SWEET SNACKS ARE POSITIVELY AND FRUITS AND VEGETABLES ARE NEGATIVELY ASSOCIATED WITH VISCERAL OR LIVER FAT | 71
DISCUSSION
In this population-based study of participants aged 40 to 65 without contraindications 
for a MRI, we examined for the first time to what extent dietary intake of the main food 
groups was specifically associated with visceral fat and liver fat content, as assessed 
with MRI and 1H-MRS. In the total population, dietary intake of fruit and vegetables 
and plant-based fats and oils was associated with less visceral fat, and intake of sweet 
snacks was associated with more liver fat. Although confidence intervals were wide, both 
in the total population and in men and women separately, a similar pattern of positive 
associations with intake of sweet snacks and inverse associations with intake of fats and 
oils, dairy, and fruit and vegetables could be observed. 
The observed associations were largely explained by total body fat. On the one hand, 
the remaining observed associations may suffer from residual confounding due to 
imperfectly measured total body fat. On the other hand, the results of the associations 
of fruit and vegetables and plant-based fats and oils with visceral fat and that of sweet 
snacks with liver fat that remained in the total population after multivariate adjustment 
including total body fat and a marker for an (un)healthy diet, support the presence of 
specific associations of certain food groups with visceral and liver fat, and need to be 
confirmed in larger studies.
Although few studies have investigated the association between food groups and 
visceral adipose tissue and hepatic triglyceride content, our findings are in accordance 
with the current literature on food groups in relation to cardiometabolic diseases and 
the current food group-based dietary guidelines in the European region (25) and they 
support the dietary patterns of the DASH diet and Alternative Healthy Eating Index 
(AHEI) (43). Dietary intake of meat and sugar-sweetened beverages has been associated 
with an increased risk of type 2 diabetes (28, 44) and intake of dairy and fruits with a lower 
risk of type 2 diabetes (28, 45). In a recent meta-analysis, dietary intake of fish and fruit and 
vegetables has also been associated with a decreased risk of all-cause mortality, whereas 
red meat and processed meat were associated with an increased risk (46). 
Dairy was negatively associated with visceral fat in women, and this association was 
mostly driven by yogurt, which supports previous results from the Women’s Health 
Initiative Observational Study showing that high yogurt consumption significantly 
decreased diabetes risk (47). When butter was excluded from the dairy food group, the 
associations remained similar, indicating that butter intake did not contribute to the 
inverse association. 
Table 5. Relative difference in HTGC with 95% confidence intervals per 100 g/day consumption of the food 
groups groups in of participants of the Netherlands Epidemiology of Obesity study, men and women 
between 45 and 65 years of age with direct assessment of abdominal fat depots and who were not using 
glucose-lowering therapy1
 
Crude Multivariable Multivariable + TBF
Multivariable + TBF + 
healthy diet
Food groups
Relative difference in 
HTGC with 95%CI
Relative difference in 
HTGC with 95%CI
Relative difference in 
HTGC with 95%CI
Relative difference in 
HTGC with 95%CI
Cheese
Total 1.11 (0.85; 1.46) 1.01 (0.78; 1.32) 1.01 (0.80; 1.29) 1.00 (0.79; 1.28)
Men 1.34 (0.94; 1.89) 1.34 (0.96; 1.86) 1.10 (0.82; 1.48) 1.09 (0.81; 1.47)
Women 0.94 (0.64; 1.38) 0.82 (0.56; 1.20) 0.98 (0.67; 1.44) 0.97 (0.67; 1.43)
Milk
Total 1.00 (0.95; 1.05) 0.97 (0.94; 1.01) 0.98 (0.95; 1.01) 0.98 (0.95; 1.01)
Men 0.99 (0.93; 1.05) 0.98 (0.93; 1.04) 0.99 (0.94; 1.04) 0.99 (0.94; 1.04)
Women 0.98 (0.92; 1.04) 0.97 (0.92; 1.02) 0.98 (0.93; 1.02) 0.97 (0.93; 1.02)
Yogurt
Total 0.89 (0.81; 0.97) 0.89 (0.82; 0.98)* 0.91 (0.85; 0.99) 0.92 (0.85; 1.00)*
Men 0.91 (0.84; 0.99)* 0.94 (0.85; 1.04) 0.95 (0.87; 1.03) 0.95 (0.88; 1.03)
Women 0.88 (0.77; 1.02) 0.82 (0.72; 0.94)* 0.87 (0.76; 0.99)* 0.88 (0.78; 1.01)
Cream butter
Total 0.58 (0.25; 1.34) 0.75 (0.38; 1.46) 0.79 (0.43; 1.47) 0.79 (0.43; 1.46)
Men 0.57 (0.13; 2.41) 0.90 (0.20; 4.11) 1.07 (0.26; 4.41) 1.09 (0.23; 5.08)
Women 0.50 (0.20; 1.22) 0.74 (0.34; 1.59) 0.72 (0.37; 1.39) 0.69 (0.35; 1.35)
Fruit
Total 0.94 (0.89; 0.99)* 0.96 (0.92; 1.01) 0.98 (0.94; 1.03) 0.98 (0.94; 1.03)
Men 0.94 (0.89; 1.00) 0.96 (0.90; 1.02) 0.98 (0.93; 1.04) 0.99 (0.93; 1.04)
Women 0.98 (0.91; 1.06) 0.96 (0.89; 1.03) 0.98 (0.90; 1.05) 0.98 (0.91; 1.06)
Vegetables
Total 0.94 (0.88; 1.01) 0.94 (0.88; 1.00)* 0.93 (0.88; 0.98) 0.94 (0.89; 1.00)*
Men 0.96 (0.85; 1.07) 0.98 (0.89; 1.07) 0.97 (0.89; 1.05) 0.98 (0.90; 1.07)
Women 0.96 (0.89; 1.05) 0.93 (0.85; 1.00) 0.92 (0.86; 0.99)* 0.93 (0.86; 1.00)
Cake
Total 1.28 (1.00; 1.62)* 1.21 (0.96; 1.51) 1.11 (0.91; 1.37) 1.10 (0.89; 1.35)
Men 1.05 (0.78; 1.42) 1.09 (0.78; 1.53) 1.00 (0.76; 1.32) 1.00 (0.76; 1.33)
Women 1.38 (0.97; 1.96) 1.24 (0.91; 1.69) 1.19 (0.88; 1.60) 1.15 (0.85; 1.55)
Candy
Total 1.18 (0.97; 1.43) 1.20 (0.98; 1.47) 1.23 (1.03; 1.46)* 1.20 (1.00; 1.44)
Men 1.12 (0.92; 1.37) 1.11 (0.88; 1.39) 1.20 (1.00; 1.45)* 1.19 (0.99; 1.44)
Women 1.21 (0.88; 1.67) 1.26 (0.93; 1.71) 1.21 (0.91; 1.61) 1.18 (0.87; 1.58)
Margarine
Total 2.02 (1.47; 2.79)* 1.19 (0.85; 1.68) 1.15 (0.86; 1.53) 1.09 (0.81; 1.47)
Men 1.28 (0.84; 1.96) 1.15 (0.72; 1.82) 1.18 (0.80; 1.72) 1.14 (0.77; 1.69)
Women 1.64 (0.99; 2.71) 1.22 (0.75; 1.98) 1.03 (0.66; 1.61) 0.97 (0.61; 1.52)
Oils
Total 1.18 (0.54; 2.53) 1.03 (0.49; 2.17) 0.88 (0.47; 1.65) 0.96 (0.51; 1.82) 
Men 1.20 (0.46; 3.08) 1.26 (0.47; 3.41) 0.88 (0.39; 2.02) 0.92 (0.40; 2.11)
Women 0.98 (0.32; 3.01) 1.06 (0.37; 3.07) 1.10 (0.40; 2.99) 1.29 (0.47; 3.56)
1Multivariable: adjusted for age, total energy intake, smoking, education, ethnicity, physical activity in leisure time, 
basal metabolic rate, menopause, alcohol consumption and energy restricted diet. Results are based on analysis 
weighted toward the body mass index distribution of the general population (n=1,715, 831 men and 884 women). CI, 
confidence interval; HTGC, hepatic triglyceride content; TBF, total body fat.
*p-value>0.05
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and unhealthy products. As we could not distinguish between white meat, red meat 
and processed meat, this might have attenuated our associations due to regression 
dilution. Moreover, the observational cross-sectional design of this study precludes 
any causal inference, and residual confounding, for example due to unmeasured or 
insufficiently measured lifestyle factors, may still be present despite our efforts to 
minimize confounding as much as possible. Additionally, potential selection bias might 
have occurred due to missing data. However, the number of participants excluded due 
to missing data was limited (n=96) and the failure rate of liver fat measurement was 
not dependent on sex, age or body fat measurements, so we do not expect this factor to 
substantially alter our results. Lastly, our study population consisted primarily of white, 
middle-aged participants, and there might be differences in dietary habits (54) and visceral 
adipose tissue (55) and hepatic triglyceride content accumulation (56) between different 
ethnic populations. Therefore, our findings need to be confirmed in prospective studies 
and in other ethnic groups.
 
In conclusion, in this population-based study in middle-aged men and women without 
contra-indications of an MRI, dietary intake of plant-based fats and oils and fruits and 
vegetables was associated with less visceral adipose tissue. Intake of sweet snacks was 
associated with more liver fat. Larger prospective studies on the relation between a 
food group and ectopic fat accumulation are needed to confirm whether associations 
between dietary intake of certain food groups are specifically associated with visceral 
fat or liver fat. In addition, intervention studies are needed to establish to what extent 
dietary changes can specifically reduce ectopic fat accumulation and the risk of 
cardiometabolic disease.
In our study, we did not observe an association between fish intake and liver fat or visceral 
fat. Although the point estimate for fish intake and visceral adipose tissue was positive, 
confidence intervals were very wide. It must be noted that we could not distinguish 
between fresh fish and fried fish on the basis of our food frequency questionnaire, and 
thus, this food group was relatively heterogeneous. However, a recent meta-analysis 
showed that fish intake was inversely associated with diabetes in Asian populations but 
positively associated with diabetes in Western populations, in which no distinction was 
made between fresh and fried fish (48). 
In this study, meat was not associated with visceral or liver fat. However, our food 
frequency questionnaire did not make a distinction between poultry, red meat or 
processed meat. Associations with red meat and processed meat might potentially be 
stronger than those observed with total meat. Even though the exact mechanism remains 
unidentified, the dietary cholesterol, protein, heme-iron, advanced glycation products 
or preservatives such as sodium and nitrites/nitrates in meat have been hypothesized 
to be responsible for the positive association with visceral adipose tissue and diabetes 
(49). Regarding dairy, calcium, vitamin D, magnesium, fatty acids, protein and the effect 
on satiety are hypothesized to underlie the beneficial effect (45). However, dairy products 
are often differentially categorized across different studies (23), making it difficult to 
compare. Different dairy products, such as fermented dairy or low- and high-fat dairy, 
might be associated differently with cardiometabolic outcomes, but all are categorized 
as dairy. Other nutrients and dietary aspects have already been shown to be associated 
with measures of adiposity, such as dietary fiber with less visceral adipose tissue (50), high-
glycemic index diets with higher waist circumference (51) and high protein (either animal 
or plant) and n-6 polyunsaturated fatty acids with less hepatic triglyceride content (52, 53). 
However, food groups instead of single nutrients in relation to visceral adipose tissue 
and hepatic triglyceride content have not yet been studied. 
Strengths of this study include the direct assessment of visceral fat and hepatic 
triglyceride content by MRI and 1H-MRS, respectively, in a relatively large sample size. 
Additionally, the extensive phenotypic measurements allowed adjustment for many 
potential confounding factors, and the large study population enabled us to investigate 
possible sex differences. A limitation of this study is that the FFQ was self-administered 
and therefore prone to measurement error. When assessing reproducibility in a random 
subsample, the ICCs of fruit and vegetables and sweet snacks were moderate to low, 
which could be due to seasonal variation, but might also indicate potential over- or 
underreporting. Furthermore, a limitation of studying food groups may be that they 
cover a broad range of food products and might comprise both relatively healthy 
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INTRODUCTION
The prevalence of obesity is increasing worldwide. In particular abdominal obesity 
is a well-established risk factor for the metabolic syndrome, diabetes mellitus and 
cardiovascular diseases (1, 2). The excess risk of abdominal obesity is hypothesized to 
be due to the accumulation of fat in the visceral area and in and around the organs 
(ectopic fat) (2), such as in the liver. Visceral adipose tissue (VAT) and hepatic triglyceride 
content (HTGC) have been associated with insulin resistance, metabolic risk factors and 
cardiovascular disease (3-6). Due to these multiple health-related consequences, visceral 
fat and liver fat are important targets for battling cardiometabolic diseases.
Together with physical activity, diet is an essential modifiable risk factor for obesity and 
obesity-related chronic diseases (7). Recently, dietary guidelines have started to shift from 
nutrient-based to food-based and dietary patterns, as humans do not consume separate 
nutrients but rather combinations of foods (8-10). Also, some nutrient effects might be too 
small to detect separately (11) and different nutrients might be strongly correlated or even 
interact with each other, making it hard to disentangle their effects. As nutrient intakes 
are often associated with certain dietary patterns, analyses including only one nutrient 
might therefore be confounded by dietary patterns (9).
Numerous dietary indices of adherence to a healthy diet have been developed over 
the last two decades, among which the (Alternative) Healthy Eating Index (HEI)(12), the 
Healthy Diet Indicator (HDI)(13) and the Diet Quality Index (DQI)(14). The HDI has been 
associated with both all-cause and cardiovascular disease mortality and the DQI with 
circulatory disease mortality in women (15). The HEI has also been associated with obesity 
(16), which might be an underlying mechanism for the association between the HEI and 
cardiovascular disease, as shown in previous research (15).
However, it remains unknown whether adherence to dietary guidelines has specific 
effects on visceral fat and hepatic triglyceride content or merely on overall body fat. 
Therefore, we aimed to study the association between the Dutch Healthy Diet Index 
(DHD-index) and total body fat (TBF), visceral adipose tissue and liver fat. In addition, 
we explored which components of the DHD-index contributed most to the associations 
with total body fat, visceral fat and liver fat.
ABSTRACT 
Background
It is unclear to what extent adherence to dietary guidelines may specifically affect 
visceral fat and liver fat. We aimed to study the association between the Dutch Healthy 
Diet Index (DHD-index) and total body fat, visceral adipose tissue (VAT) and hepatic 
triglyceride content (HTGC) in middle-aged men and women. 
Design
In this cross-sectional study, VAT was assessed by magnetic resonance imaging (MRI) in 
2 580 participants, and HTGC by proton-MR spectroscopy in 2 083 participants. Habitual 
dietary intake and physical activity were estimated by questionnaire. Adherence to 
the current Dutch dietary guidelines was estimated by the 2015 DHD-index score based 
on thirteen components (vegetables, fruit, wholegrain products, legumes, nuts, dairy, 
fish, tea, liquid fats, red meat, processed meat, sweetened beverages and alcohol). The 
DHD-index ranges between 0 and 130, with a higher score indicating a healthier diet. We 
used linear regression to examine associations of the DHD-index with VAT and HTGC, 
adjusted for age, smoking, education, ethnicity, basal metabolic rate, energy restricted 
diet, menopausal state, physical activity, total energy intake, and total body fat. We 
additionally excluded the components one by one to examine individual contributions 
to the associations.
Results
Included participants (43% men) had a mean (SD) age of 56 (6) years and DHD-index score 
of 71 (15). A 10-point higher DHD-index score was associated with 2.3 cm2 less visceral fat 
(95% CI; -3.5; -1.0 cm2) and less liver fat (0.94 times, 95% CI; 0.90; 0.98). Of all components, 
exclusion of dairy attenuated the associations with TBF and VAT. 
Conclusions
Adherence to the dietary guidelines as estimated by the DHD-index was associated with 
less total body fat, and with less visceral and liver fat after adjustment for total body fat. 
These findings might contribute to better understanding of the mechanisms underlying 
associations between dietary habits and cardiometabolic diseases.
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system and grouped into high (including higher vocational school, university, and 
post-graduate education) versus low education (reference). Participants reported their 
medical history of diabetes and cardiovascular diseases. Pre-existing cardiovascular 
disease was defined as myocardial infarction, angina, congestive heart failure, stroke, or 
peripheral vascular disease. Body weight was measured without shoes and one kilogram 
was subtracted from the body weight. Percent body fat was estimated using bioelectrical 
impedance analysis (BIA) with the Tanita foot-to-foot (FF) BIA system TBF-300A Body 
Composition Analyzer (18). BMI was calculated by dividing the weight in kilograms by the 
height in meters squared. Menopausal state was categorized in pre-, and postmenopausal 
state according to information on ovariectomy, hysterectomy and self-reported state of 
menopause in the questionnaire. Basal metabolic rate was calculated based on age, sex, 
height and weight according to the Mifflin-St Jeor equation (19). Participants reported the 
frequency, duration and intensity of their habitual physical activity during leisure time 
using the Short QUestionnaire to ASsess Health-enhancing physical activity, which was 
expressed in hours per week of metabolic equivalents (MET-h/week) (20). 
Dutch Healthy Diet Index
Habitual dietary intake of all participants was estimated using a semi-quantitative self-
administered 125-item food frequency questionnaire (FFQ)(21, 22). In this questionnaire, 
participants reported their frequency of intake of foods during the past month (times 
per day, week, month, never). This was combined with the assessment of serving size 
(spoons of potatoes, pieces of fruit, etc). Dietary intake of nutrients and total energy was 
estimated using the Dutch Food Composition Table (NEVO-2011). 
Based on the FFQ , we calculated the DHD-index for each participant, which is a 
continuous score and represents the adherence to the Dutch Guidelines for Healthy Diet 
of 2015 as described by the Health Council of the Netherlands and originally consists of 
fifteen components (23). Every index component has a maximum of 10 points, depending 
on the cut-off as described by the guidelines for each component: vegetables (≥200 
grams per day), fruit (≥200 grams per day), wholegrain products (ratio of whole grains to 
refined grains ≥11), legumes (≥10 grams per day), unsalted nuts (≥ 15 grams per day), dairy 
(between 300 and 450 grams per day), fish (≥ 15 grams per day), tea (≥450 grams per day), 
replacing hard fats by liquid fats (ratio of liquid to solid fats ≥13), coffee (consumption 
of only filtered coffee), red meat (≤ 45 grams per day), processed meat (0 grams per day), 
sweetened beverages (0 grams per day), alcohol (≤10 grams per day) and salt (≤1.9 grams 
of sodium per day). Assessing the adherence to these guidelines is based on five types 
of components in the Dutch Healthy Diet Index: 1) adequacy components (minimum 
consumption recommended, e.g. vegetables, fruit, wholegrain products, legumes and 
METHODS
Study design and study population
The Netherlands Epidemiology of Obesity (NEO) study is a population-based prospective 
cohort study in 6 671 individuals aged 45 to 65 years, with an oversampling of persons 
with a BMI of 27 kg/m2 or higher. Detailed information about the study design and data 
collection has been described elsewhere (17). Men and women aged between 45 and 65 
years with a self-reported BMI of 27 kg/m2 or higher living in the greater area of Leiden (in 
the West of The Netherlands) were eligible to participate in the NEO study. In addition, 
all inhabitants aged between 45 and 65 years from one municipality (Leiderdorp) were 
invited irrespective of their BMI, allowing for a reference distribution of BMI.
Participants visited the NEO study center of the Leiden University Medical Center after 
an overnight fast. Prior to the NEO study visit, participants completed a questionnaire 
about demographic, lifestyle, and clinical information, in addition to a food frequency 
questionnaire. At the study center, the participants completed a screening form, asking 
about anything that might create a health risk or interfere with magnetic resonance 
imaging (MRI) (most notably metallic devices, claustrophobia, or a body circumference 
of more than 1.70 m). Of the participants who were eligible for MRI, approximately 35% 
were randomly selected to undergo direct assessment of abdominal fat. 
The present study is a cross-sectional analysis of the baseline measurements. We 
excluded participants with implausibly low or high total energy intake (<600 kcal or >5 
000 kcal/day), which are somewhat less conservative cut-off points for high energy intake 
than other cohort studies (12) because of our smaller sample size. Moreover, we excluded 
participants with missing data on dietary intake or potential confounding factors. For 
the analyses on liver fat, we additionally excluded participants who consumed more 
than four standard units of alcohol per day. 
 
The study was approved by the medical ethics committee of the Leiden University 
Medical Center and conducted according to the declaration of Helsinki. All participants 
gave written informed consent. 
Data collection
On the questionnaire, participants reported ethnicity by self-identification in eight 
categories which we grouped into white (reference) and other. Tobacco smoking was 
reported in the three categories current, former, and never smoking (reference). Highest 
level of education was reported in 10 categories according to the Dutch education 
84 | CHAPTER 4 ADHERENCE TO DIETARY GUIDELINES IN RELATION TO VISCERAL FAT AND LIVER FAT IN MIDDLE-AGED MEN AND WOMEN | 85
4 4
municipality (27), whose BMI distribution was similar to the BMI distribution of the 
general Dutch population (28). All results were based on weighted analyses. Consequently, 
the results apply to a population-based study without oversampling of individuals with 
a BMI ≥ 27 kg/m2. As a result of the weighted analyses, percentages and proportions are 
given instead of numbers of participants. Other baseline characteristics are expressed as 
mean with standard deviation. 
We performed linear regression analyses with multiple models. First, we studied the 
association between the DHD-index (per 10 points) with overall adiposity, as measured 
by total body fat (%). We performed both a crude model, and a multivariable model 
adjusted for age, sex, smoking, education, ethnicity, basal metabolic rate, menopausal 
state, physical activity, adherence to an energy restricted diet and total energy intake. 
After this, we examined the associations between the DHD-index with visceral fat and 
liver fat content. To examine whether the associations were specific for visceral fat 
and liver fat instead of merely representing effects on total adiposity, we additionally 
corrected for total body fat in a separate model. For this, we calculated variance inflation 
factors (VIFs) to check for multicollinearity in our models between visceral fat or liver 
fat and total body fat. The VIF values were below 10 in all models and were considered 
appropriate. Correlation coefficients between total body fat and visceral fat (0.13) and 
total body fat and liver fat (0.17) were also low, indicating that additional adjustment for 
total body fat does not lead to multicollinearity.
Lastly, to examine which component most strongly contributed to the associations of the 
DHD-index with visceral fat or liver fat, we performed analyses in which we subsequently 
left out one component at the time and additionally adjusted for that component. We 
reasoned that a component has an important contribution to the association if the 
association attenuates towards the null after leaving that component out. Linearity of 
the DHD-index and its components with visceral fat and liver fat was checked by adding 
a quadratic term to the main multivariable model and visual inspection of scatter plots.
We performed several subgroup analyses. Because total body fat and visceral adipose 
tissue and hepatic triglyceride content may differ greatly between persons with and 
without obesity (29), between men and women, and between pre- and postmenopausal 
women (30), we stratified the multivariable model not including total body fat by these 
variables. We additionally stratified the multivariable models for liver fat by the rs738409 
single nucleotide polymorphism in the patatin-like phospholipase domain containing 3 
(PNPLA3) gene, because carriers might have, in part, genetically induced liver fat which 
might be less strongly related to dietary habits (31).
nuts), 2) moderation components (limited consumption recommended, e.g. red meat, 
processed meat, sweetened beverages, alcohol and salt), 3) optimum components 
(consumption between certain limits recommended, e.g. dairy), 4) qualitative 
components (recommended consumption depending on quality of product, e.g. coffee), 
and 5) ratio components (a certain ratio of consumption is recommended, e.g. fats and 
oils and wholegrain products) (23). As a result, the total score can range between 0 and 
150. A higher score means a better adherence to the 2015 Dutch Guidelines for a Healthy 
Diet. For the present study, we used an adapted version of the DHD-index with thirteen 
components instead of the original fifteen because we were not able to estimate the two 
components consumption of unfiltered coffee, and of sodium on the basis of the FFQ 
used in our study. As a result, the DHD-index in our study ranges between 0 and 130. 
Visceral fat area and hepatic triglyceride content by imaging techniques
Imaging was performed on a 1.5 Tesla MR system (Philips Medical Systems, Best, the 
Netherlands). Visceral adipose tissue (VAT) was quantified by a turbo spin echo imaging 
protocol using MRI. At the level of the fifth lumbar vertebra, three transverse images 
each with a slice thickness of 10 mm were obtained during a breath-hold. Visceral fat 
area was converted from the number of pixels to centimeters squared using in-house-
developed software (MASS, Medis, Leiden, the Netherlands) and the average of three 
slices was used in the analyses (17). 
Hepatic triglyceride content was quantified by proton-MR spectroscopy (1H-MRS) of the 
liver (24). An 8 ml voxel positioned in the right lobe of the liver, avoiding gross vascular 
structures and adipose tissue depots. Sixty-four averages were collected with water 
suppression. Spectra were obtained with an echo time of 26 ms and a repetition time 
of 3,000 ms. Data points (1,024) were collected using a 1,000 Hz spectral line. Without 
changing any parameters, spectra without water suppression, with a repetition time of 
10 s, and with four averages were obtained as an internal reference. 1H-MRS data were 
fitted using Java-based magnetic resonance user interface software (jMRUI version 2.2, 
Leuven, Belgium), as described previously (25). Hepatic triglyceride content relative to 
water was calculated the sum of signal amplitudes of methyl and methylene divided by 
the signal amplitude of water and then multiplied by 100.
Statistical analyses
In the NEO study there is an oversampling of persons with a BMI of 27 kg/m2 or higher. 
To correctly represent associations in the general population (26), adjustments for 
the oversampling of individuals with a BMI ≥ 27 kg/m2 were made. This was done by 
weighting individuals towards the BMI distribution of participants from the Leiderdorp 
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visceral adipose tissue (89 cm2 versus 94 cm2) or the DHD-index (59.5 versus 58.8 points). 
Lastly, we excluded participants who consumed 40 grams of alcohol or more (4 standard 
glasses) per day (n=176) and one participant for whom the natural logarithm of HTGC 
could not be calculated, leaving a total of 1 809 participants.
The baseline characteristics of the total population for the analyses on total body fat 
stratified by tertiles of the DHD-index are shown in Table 1. Participants in the highest 
tertile and thus who adhere the most to the dietary guidelines, more often had a high 
education, were female, and non-smoking. 
Dutch Healthy Diet Index in relation to total body fat
After adjustment for potential confounding factors, 10 points higher on the DHD-
index was associated with 0.2 % less total body fat (95% CI -0.3; -0.1 %) (Table 2). Of all 
components, leaving out the processed meat component attenuated the association, as 
did dairy and fruit (Figure 1). Results were similar in men and women (data not shown). 
After stratification by BMI, results were similar for both groups (Supplemental table 
1). The association between the DHD-index and total body fat was somewhat stronger in 
postmenopausal women than in premenopausal women (Supplemental table 1).
Dutch Healthy Diet Index in relation to visceral adipose tissue
After adjustment for potential confounding factors and total body fat, the DHD-index 
was inversely associated with visceral adipose tissue (-2.2 cm2 per 10-points higher on 
the DHD-index, 95% CI -3.5; -1.0 cm2) (Table 2). Of all components, leaving out the dairy 
component of the DHD-index slightly attenuated the association (Figure 2). Results 
were similar in men and women (data not shown). 
When stratified by BMI, the association between the DHD-index and VAT was similar 
in participants with or without obesity and in post- and premenopausal women 
(Supplemental table 1). 
Due to a skewed distribution of HTGC, we used the natural logarithm of this variable 
in the analyses. For interpretation of the results, we back transformed the regression 
coefficients of HTGC towards a ratio with 95% confidence interval, which is associated 
with a 10 points higher DHD-index. Such ratio, for example a ratio of 1.2, can be interpreted 
as each five points higher DHD-index being associated with a 1.2-fold increased HTGC, 
which would reflect an increase in liver fat from, for example, 5% to 6%. Regression 
coefficients of total body fat represent an absolute difference in TBF in % per 10 points 
higher DHD-index, and those of VAT an absolute difference in VAT in cm2.
 
As participants with diabetes might have altered their diet as a result of the diagnosis, we 
repeated all analyses excluding participants with a medical history of diabetes mellitus.
We performed all analyses using STATA statistical Software (Statacorp, College Station, 
Texas, USA), version 14.
RESULTS
A total of 6 671 participants were included in the NEO study between September 2008 
and October 2012. For the analyses with total body fat as an outcome, we excluded 
participants without a body fat assessment (n=31), implausible energy intake (n=62) 
or missing energy intake (n=4), an incomplete food frequency questionnaire (n=23) or 
missing data on smoking (n=7), education (n=62), ethnicity (n=8) or physical activity 
(n=114), leaving a total of 6,630 participants. 
 
For the analyses on VAT, we additionally excluded participants without an MRI of the 
abdomen (n=3 912), which was performed in a random subsample of participants without 
contraindications. As a result, those who underwent the MRI have a slightly lower BMI 
(25.9 kg/m2 versus 26.6 kg/m2) and slightly less often a medical history of cardiovascular 
disease (4.1% versus 6.6%) than those without MRI. All other characteristics were similar. 
The total study population for the analyses on VAT contained 2 450 participants. 
For the analyses with HTGC as an outcome, we additionally excluded participants 
without HTGC measurement (n=464). The majority of this missing values was due to 
technical failure, as it was not possible to check the spectra and repeat the measurement 
in the limited time available per participant. However, the failure rate of the MR 
spectroscopy was not related to age (55 years for participants with hepatic triglyceride 
content measurement versus 56 years for participants without hepatic triglyceride 
content measurement), sex (47% men versus 48%), BMI (25.9 kg/m2 versus 26.2 kg/m2), 
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Table 2. Difference in measure of body fat with 95% confidence intervals per 10 points higher on the DHD-
index in participants of the Netherlands Epidemiology of Obesity study, men and women between 45 and 
65 years of age
  Total body fat (N=6,360)
Visceral adipose tissue 
(N=2,450)
Hepatic triglyceride content 
(N=1,809) 
 
Difference in TBF (%) 
(95% CI)
Difference in VAT (cm2)
Relative change in HTGC (95% CI)
(95% CI)
Crude      
Total 0.5 (0.3; 0.7) -6.7 (-8.5; -4.9) 0.90 (0.86; 0.94)
Men -0.6 (-0.8; -0.4) -5.6 (-8.6; -2.7) 0.93 (0.87; 1.00)
Women -0.4 (-0.6; -0.2) -1.6 (-3.5; 0.4) 0.93 (0.87; 0.99)
Multivariable1      
Total -0.2 (-0.3; -0.1) -3.2 (-4.7; -1.8) 0.92 (0.88; 0.96)
Men -0.3 (-0.4; -0.1) -4.3 (-6.9; -1.8) 0.93 (0.88; 1.00)
Women -0.2 (-0.3; -0.1) -2.2 (-3.7; -0.6) 0.91 (0.85; 0.96)
Multivariable + TBF      
Total   -2.3 (-3.5; -1.0) 0.94 (0.90; 0.98)
Men   -2.3 (-4.4; -0.2) 0.96 (0.91; 1.00)
Women   -1.4 (-2.8; -0.1) 0.92 (0.87; 0.98)
Results are based on analysis weighted toward the body mass index distribution of the general population. 
1Adjusted for age, total energy intake, smoking, education, ethnicity, basal metabolic rate, menopause and energy 
restricted diet
CI, confidence interval; DHDI, Dutch Healthy Diet Index, TBF, total body fat; VAT, visceral adipose tissue.
Figure 1. Association between 10 points on the Dutch Healthy Diet Index and total body fat when leaving 
one component out at the time (N=6,361), adjusted for sex, age, smoking status, education, ethnicity, 
basal metabolic rate, menopausal state, energy restricted diet, total energy intake and component left 
out. Results are based on analyses weighted toward the body mass index distribution of the general 
population. DHDI, Dutch Healthy Diet Index.
Table 1. Baseline characteristics stratified by tertiles of the DHD-index of participants of the Netherlands 
Epidemiology of Obesity study, men and women between 45 and 65 years of age
  DHD-index
Tertile 1 (19.6-64.3) Tertile 2 (≥64.3-77.8) Tertile 3 (≥77.8-119.1)
Demographic variables
Age (year) 55 (7) 56 (6) 56 (5)
Sex (% men) 55.6 43.7 31.0
Ethnicity (% white) 94.5 95.4 94.9
Education level (% high)1 37.1 46.2 54.8
Tobacco smoking (% current) 28.8 13.1 6.6
Menopausal state (% post in women)2 56.6 57.4 65.4
Physical activity in leisure time (MET h/wk) 26.3 [12.0-44.3] 30.0 [16.9-50.5] 32.7 [18.5-52.3]
Dietary variables
DHD-index 54.4 (7.8) 71.0 (4.0) 87.3 (6.7)
Fruit and vegetable intake (g/d) 235 (142) 322 (154) 419 (142)
Alcohol intake (g/d) 18.2 [4.0-31.3] 9.2 [2.6-20.8] 7.5 [2.0-14.3]
Energy restricted diet (%) 9.4 11.6 14.5
Basal metabolic rate (MJ/d) 6.6 (1.2) 6.4 (1.1) 6.0 (0.9)
Body fat measures
BMI (kg/m2) 26.9 (4.8) 26.5 (4.5) 25.5 (3.9)
Total body fat (%)
 Men 25.7 (6.6) 25.1 (6.0) 23.7 (5.3)
 Women 37.4 (7.3) 37.3 (6.6) 36.3 (5.7)
Visceral adipose tissue (cm2)3
 Men 123.7 (67.4) 114.6 (59.1) 104.0 (51.4)
 Women 69.7 (44.2) 68.3 (46.2) 63.3 (34.2)
Hepatic triglyceride content (%)4
 Men 4.9 [2.0-13.1] 3.7 [2.2-7.8] 3.2 [1.9-6.2]
 Women 2.2 [1.2-5.8] 1.8 [1.1-5.1] 1.6 [1.1-3.3]
Waist circumference (cm)
 Men 99.7 (12.2) 98.5 (11.2) 96.0 (9.7)
 Women 88.9 (14.3) 87.8 (13.2) 85.7 (11.0)
CVD risk factors
CVD (%) 5.8 5.9 5.0
Lipid lowering medication (%) 11.2 10.6 9.3
Total cholesterol (mmol/L) 5.7 (1.1) 5.7 (1.1) 5.6 (0.9)
Fasting triglycerides (mmol/L) 1.4 (1.1) 1.3 (0.9) 1.1 (0.6)
HDL cholesterol (mmol/L) 1.5 (0.5) 1.5 (0.4) 1.6 (0.4)
Results are based on analyses weighted toward the BMI distribution of the general population (n=6,360). Data are 
shown as mean (standard deviation), median [interquartile range] or percentage.
1Low education: none, primary school, or lower vocational education as highest level of education.
2Proportion menopausal state only estimated in women (n=3,352)
3Mean VAT only calculated in persons with VAT measurement (n=2,450)
4Mean HTGC only calculated in persons with HTGC measurement (n=1,809)
BMI, body mass index; CVD, cardiovascular disease; HDL, high-density lipoproteins; MET, metabolic equivalent of task.
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Dutch Healthy Diet Index in relation to hepatic triglyceride content
After adjustment for potential confounding factors and total body fat, 10 points higher 
on the DHD-index was associated with less liver fat (0.94 times, 95% CI 0.90; 0.98). (Table 
3). Leaving out components did not alter the association. Associations were comparable 
for men and women (data not shown). Associations between the DHD-index and liver 
fat were comparable in participants with or without obesity (Supplemental table 1). 
When stratified by menopausal state, associations were only present in postmenopausal 
women. Associations were similar in both carriers and non-carriers of the PNPLA3 risk 
allele (Supplemental table 1). 
DISCUSSION
In this population-based study of middle-aged men and women, we aimed to study 
the association between adherence to the Dutch Guidelines for a Healthy Diet 2015 and 
total body fat, visceral fat and liver fat, as assessed with bio impedance analysis, MRI and 
1H-MRS. After adjustment for potential confounding factors, a higher score on the DHD-
index, and therefore a greater adherence, was associated with less total body fat, less 
visceral fat and less liver fat. Associations with visceral fat and liver fat remained present 
after adjustment for total body fat, indicating specific associations with visceral fat and 
liver fat rather than with overall adiposity. When leaving all the thirteen components 
out one by one to examine which component contributes the most to the association, 
all components seemed similarly important. No clear overall differences were observed 
between BMI categories, post- and premenopausal women or between carriers and non-
carriers of the PNPLA3 risk allele.
Several previous studies have shown associations between diet quality indices with 
a moderate protective effect regarding multiple health outcomes, as reduced risks of 
cardiovascular disease and mortality (15). In a meta-analysis, adherence to high-quality 
diets as assessed by the (Alternative) Healthy Eating Index and the Dietary Approaches 
to Stop Hypertension were associated with decreased risks of all-cause mortality (22%), 
CVD (22%), cancer (15%) and of type 2 diabetes (22%) (32). Although the 2015 DHD-index is 
relatively new, a higher adherence to the 2015 Dutch Guidelines for a Healthy Diet has 
been associated with a decreased risk of stroke, chronic obstructive pulmonary disease 
(COPD), colorectal cancer and all-cause mortality (33).
In another recent systematic review on diet quality indices in relation to measures 
of obesity it has been shown that adherence to the Healthy Eating Index, the Dietary 
Figure 2. Association between 10 points on the Dutch Healthy Diet Index and visceral adipose tissue 
when leaving one component out at the time (N=2,449), adjusted for sex, age, smoking status, education, 
ethnicity, basal metabolic rate, menopausal state, energy restricted diet, total energy intake, total 
body fat and component left out. Results are based on analyses weighted toward the body mass index 
distribution of the general population. DHDI, Dutch Healthy Diet Index.
Figure 3. Association between 10 points on the Dutch Healthy Diet Index and hepatic triglyceride content 
when leaving one component out at the time (N=1,809), adjusted for sex, age, smoking status, education, 
ethnicity, basal metabolic rate, menopausal state, energy restricted diet, total energy intake, total body fat 
and component left out. Results are based on analyses weighted toward the body mass index distribution 
of the general population. DHDI, Dutch Healthy Diet Index.
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A limitation of our study is that dietary intake of food products is measured with a self-
administered FFQ , making it prone to measurement error. Potential social desirability 
might have overestimated the average score. Although this might have affected 
associations with total body fat, it is less likely that this would affect associations with 
visceral fat or liver fat because people are not aware of the amount of visceral fat or liver 
fat they have. Moreover, total body fat has been estimated using BIA with the Tanita foot-
to-foot BIA system. Although it has been suggested that foot-to-foot BIA might give an 
overestimation of the amount of fat mass (38), another study found a strong correlation 
(r = 0.84) between foot-to-foot and hand-to-foot BIA with regards to total body fat 
percentages (18). Furthermore, a strong correlation (r = 0.89) was also found in a study 
comparing resistance measurements provided by foot-to-foot BIA with measurements 
from dual-energy X-ray absorptiometry and underwater weighing (39). Additionally, 
the population of this study predominantly consisted of Caucasian, middle-aged 
participants, so results should be confirmed in other age and ethnic groups. However, a 
large prospective cohort study conducted in the South-eastern part of the United States, 
showed that associations between adherence to the Dutch Guidelines for Americans as 
assessed by the HEI-2010, were similar between African-Americans and whites (40). As the 
FFQ used in our study did not contain complete information on certain food items, we 
had to make several assumptions in order to calculate the 2015 DHD-index. For example, 
we could not make a distinction between salted and unsalted nuts. As a result, salted 
nuts and beer nuts are now included in this component, which could have influenced 
the results. Moreover, the wholegrain component is now only based on breakfast cereals, 
which may therefore result measurement error. Moreover, the wholegrain component 
is now only based on breakfast cereals, which may therefore result measurement error. 
Lastly, the observational cross-sectional design of this study precludes causal inference. 
Whereas the associations with visceral fat and liver fat content may seem weak, it must 
be noted that an increase of 10 points on the DHD-index can be easily accomplished and 
the results might therefore be considerably relevant in general practice. For example, 
consumption of one apple and one cup of broccoli per day extra adds up to a 10 points 
higher DHD-index, which was associated with more than 2 cm2 less visceral fat. As 
previous results has shown that visceral fat and liver have been associated with insulin 
resistance, metabolic risk factors and cardiovascular disease (3-6), adherence to the Dutch 
Guidelines for a Healthy Diet might ultimately be associated with a decreased risk of 
developing insulin resistance or cardiovascular disease, although direct and exact 
translation to disease risk remains difficult. 
 
In conclusion, in this population-based study in middle-aged men and women, 
Guidelines for Americans Index and the Dietary Guideline Index were associated with 
either lower BMI or waist circumference (34). Moreover, in a recent meta-analysis, healthy 
dietary patterns were inversely related to both visceral fat and subcutaneous fat (35), 
although most studies did not adjust for total body fat and therefore the associations 
might not be specific for visceral fat and subcutaneous fat. Dietary intake of fiber and 
calcium was inversely related with visceral fat, and there was a positive relation of 
unhealthy dinner-type dietary patterns and consumption of alcohol and fructose with 
visceral fat (35). Our study contributes to this knowledge by showing that adherence to 
dietary guidelines for a healthy diet as a whole, was not only associated with total body 
fat, but also specifically with visceral fat and liver fat. Our findings thereby suggest 
that next to total body fat, visceral fat and liver fat may mediate the previous observed 
associations of diet indices with cardiometabolic risk.
Improvement of diet quality in terms of an increase in the (Alternative) Healthy Eating 
Index 2010, the alternate Mediterranean Diet Score and the Dietary Approaches to Stop 
Hypertension score has been associated with decreased weight gain, especially in people 
with a BMI over 25 kg/m2 (36). This corresponds with our findings, that showed that the 
association between the DHD-index and VAT was slightly stronger in people with a BMI 
over 30 kg/m2, but not for liver fat. 
 A study on the HEI-2010 in young Americans has also demonstrated an inverse association 
with body fatness in men, after taking level of physical activity into account (37). Physical 
activity is a component of the DHD-index. However, when leaving out the physical 
activity component from the DHD-index, the associations attenuated but remained, 
suggesting the importance of both diet and physical activity in relation to TBF, VAT and 
HTGC. 
Strengths of this study are the sample size and the extensive phenotyping, allowing 
adjustment for multiple potential confounding factors and investigation of multiple 
subgroup analyses. Moreover, we directly assessed visceral adipose tissue and hepatic 
triglyceride by MRI and 1H-MRS in a relatively large subsample of the study population. 
The Dutch Healthy Diet Index is a measure of adherence to the current (2015) Dutch 
dietary guidelines and reflects the whole diet as it includes multiple food group based 
components. Multiple improvements have been made compared to the previous 2006 
guidelines and DHD-index. For example, fruit juices are now no longer included in the 
fruit component bur rather in the sweetened beverages component, and whereas the 
previous guidelines focused on saturated fat without taking the source into account, the 
new index includes a component on the solid to liquid fat ratio. 
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INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) is often defined as a hepatic triglyceride 
content of more than 5.56% not due to excessive alcohol consumption (1). NAFLD covers 
a broad clinical spectrum, ranging from the most common feature, hepatic steatosis, to 
non-alcoholic steatohepatitis (NASH), and liver cirrhosis (2), and increases the risk of end-
stage liver disease and liver-related and all-cause mortality (3-6). Although the incidence 
of NAFLD is underreported and varies widely (7), the prevalence has risen considerably 
over the last two decades (8) to 14 to 34% of the general population in Europe (9, 10), Asia (11) 
and the United States of America (7, 11). The prevalence of NAFLD in obesity might even 
be as high as 90% (12), possibly due to excessive calorie intake (13). It is the leading cause of 
chronic liver diseases worldwide (14), and is also strongly associated with the metabolic 
syndrome (15) and cardiovascular diseases (16) 
Excessive alcohol consumption(17) is a well-established risk factor of both hepatic 
steatosis (liver fattening) and liver disease. Current guidelines to prevent or reduce 
liver fat accumulation therefore recommend that heavy alcohol consumption should 
be discouraged (18). However, there is much controversy whether moderate alcohol 
consumption should also be discouraged, as there are studies indicating that light to 
moderate alcohol consumption might be protective in relation to fatty liver and (extra)
hepatic complications (18-23), whereas in a mendelian randomization study it has been 
suggested there is no beneficial effect of moderate alcohol consumption on the severity 
of nonalcoholic fatty liver disease (24). Moreover, it has been shown that liquid food leads 
to less satiety and more postprandial hunger (25). Particularly alcohol is very inefficient in 
activating the satiety mechanism, and consuming alcohol during meals might lead to 
higher food consumption (26). 
In addition, sugar sweetened beverages (SSB), but not diet sodas have been associated 
with fatty liver (27). This suggests that energy-containing drinks in general, or specifically 
dietary sugars may increase liver fat as well (28, 29). As the relative contributions of different 
types of non-alcoholic and alcoholic beverages consumption to liver fat accumulation 
remain unclear, we aimed to directly compare the associations of consumption of 
alcoholic beverages and non-alcoholic energy-containing and non-energy containing 
beverages with hepatic triglyceride content in a large sample of the general population. 
Insight in these associations may contribute to lifestyle guidelines, especially with 
regard to beverages, for both primary and secondary prevention aims. 
ABSTRACT 
Background
Fatty liver is the leading cause of chronic liver diseases and increases the risk of 
cardiovascular disease. Besides alcohol consumption, energy-containing non-alcoholic 
beverages may contribute to liver fat accumulation. 
Objective
We aimed to study the consumption of alcoholic and non-alcoholic beverages and their 
mutual replacement in relation to hepatic triglyceride content (HTGC) in middle-aged 
men and women. 
Methods
In this cross-sectional analysis, HTGC was assessed by 1H-MRS. Habitual consumption 
of alcoholic and non-alcoholic beverages was assessed using a validated food frequency 
questionnaire. All beverages were converted to standard servings and to percent of 
total energy intake (En%). We performed linear regression to examine the association 
of alcoholic and non-alcoholic beverages with HTGC, adjusted for age, sex, smoking, 
education, ethnicity, physical activity, total energy intake and total body fat. We studied 
replacement of alcoholic beverages with non-alcoholic beverages per serving/d and per 
5 En%/d. 
Results
After exclusion of individuals with missing values, 1,966 participants (47% men) were 
analyzed, with a mean ± SD age of 55 ± 6 years, BMI of 26 ± 4 kg/m2, and HTGC of 5.7 ± 7.9 %. 
Each extra alcoholic serving per day was associated with more liver fat (1.09 times, 95% CI: 
1.05, 1.12). Replacing 5 En% of alcoholic beverages with milk was associated with less liver 
fat (0.89 times, 95% CI: 0.81, 0.98), whereas replacement with 5 En% of sugar sweetened 
beverages was associated with liver fat to a similar extent as the alcoholic beverages (1.00 
times, 95% CI: 0.91, 1.09).
Conclusion
In a population-based cohort, consumption of each extra daily alcoholic beverage was 
associated with more liver fat. In isocaloric replacement, milk was associated with less 
liver fat, whereas sugar sweetened beverages were equally associated with liver fat. This 
suggests that intake of alcohol and sugars may contribute to liver fat accumulation. 
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We assessed the reproducibility of the habitual consumption of different beverages 
in a random subgroup of 100 participants who completed the FFQ for a second time 
approximately three months after the baseline measurement. The individual measurement 
intraclass correlation coefficients of the different beverages were 0.63 for sugar sweetened 
beverages, 0.81 for milk, 0.82 for coffee, 0.91 for tea, 0.79 for beer, 0.82 for wine, 0.67 for mixed 
drinks and 0.89 for liquor, which can be considered good to excellent(33). 
1H-MR spectroscopy of liver fat content
1H-MR spectroscopy of the liver was performed on a 1.5 Tesla whole-body MR scanner 
(Philips Medical Systems, Best, the Netherlands), and spectra were obtained as described 
previously (34). 1H-MRS data were fitted using Java-based magnetic resonance user 
interface software (jMRUI version 2.2, Leuven, Belgium) (35). Hepatic triglyceride content 
relative to water was calculated as (signal amplitude of triglyceride) / (signal amplitude 
of water) x 100. 
Data collection of covariates
In the baseline questionnaire, participants reported smoking behaviour in three 
categories: current, former or never smoking (reference group). Ethnicity was reported 
by self-identification in eight categories which we grouped into white (reference group) 
and other. Highest level of education was reported in 10 categories according to the 
Dutch education system and grouped into high (including higher vocational school, 
university, and post-graduate education) versus low education (reference group). 
Physical activity during leisure time was reported using the Short Questionnaire to 
Assess Health-enhancing physical activity and was expressed in MET-hours per week 
(36). Data collection on other covariates has been described previously (30). 
Statistical analyses
In the NEO study there is an oversampling of persons with a BMI of 27 kg/m2 or higher. 
To correctly represent associations in the general population (37), adjustments for this 
oversampling were made. This was done by weighting individuals towards the BMI 
distribution of participants from the Leiderdorp municipality (38), whose BMI distribution 
was similar to the BMI distribution of the general Dutch population (39) (Supplemental 
table 1). All results were based on weighted analyses. Consequently, the results apply to 
a population-based study without oversampling of individuals with a BMI ≥ 27 kg/m2. 
As a result of the weighting, only percentages and proportions can be given instead of 
numbers of participants. Baseline characteristics are displayed in percentages or means 
(standard deviations) for the total population, and stratified by sex and categories of 
alcohol consumption. 
METHODS
Study design and study population
The Netherlands Epidemiology of Obesity (NEO) study is a population-based cohort study 
in 6671 individuals aged 45 to 65 years, with an oversampling of persons with a BMI of 27 
kg/m2 or higher. Men and women aged between 45 and 65 years with a self-reported BMI 
of 27 kg/m2 or higher living in the greater area of Leiden (in the West of The Netherlands) 
were eligible to participate in the NEO study. In addition, all inhabitants aged between 
45 and 65 years from one municipality (Leiderdorp) were invited irrespective of their 
BMI, allowing for a reference distribution of BMI. Detailed information about the study 
design and data collection has been described elsewhere (30).
The present study is a cross-sectional analysis of the baseline measurements of the 
participants with a measurement of hepatic triglyceride content (HTGC). For our 
analyses we excluded participants with an implausibly high or low total energy intake 
(<600kcal or >5000kcal) and missing data on beverage consumption or potential 
confounding factors. The study was approved by the medical ethics committee of the 
LUMC and all participants gave written informed consent.
Beverage consumption
Habitual consumption of beverages of all participants was estimated using a semi-
quantitative food frequency questionnaire, which was originally designed to study dietary 
fat intake (31, 32). Consumption of alcoholic and non-alcoholic beverages was assessed 
in absolute frequency (times per day, week, month). Participants were asked about 
consumption of different alcoholic beverages (beer, wine, liquor and mixed drinks (such 
as cocktails). For each alcoholic beverage we used a standard serving as based on the Dutch 
Food Composition Database (NEVO-2011): 200 grams for beer, 110 for wine, 50 for liquor and 
258 for mixed long drinks so that each consumption contained 10 grams of alcohol. Non-
alcoholic beverages were also converted to standard servings: 200 grams for non-alcoholic 
beers, 125 grams for coffee and tea, 150 grams for milk and 150 grams for sugar-sweetened 
beverages (NEVO-2011). Non-alcoholic beverages were divided into energy-containing 
(non-alcoholic beers, milk and sugar sweetened beverages) or non-energy containing (tea 
and coffee without milk) beverages. No information on water consumption or diet sodas 
was collected using the FFQ . After the conversion to standard servings, all non-alcoholic 
beverages were also summed up into one variable. The same was done for all alcoholic 
beverages. Total alcoholic beverage consumption was divided into subcategories: 0 to 0.5 
grams of alcohol per day (g/d) (including abstainers), 0.5 to 5 g/d, 5 to 15 g/d for women and 
5-30 g/day for men and lastly >15 g/d for women and >30 g/d for men. 
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milk, and non-alcoholic beer) in relation to HTGC, to examine to what extent the caloric 
content contributes to liver fat content. To study whether the associations are specific 
for liver fat, we additionally adjusted all three models for total body fat.
 
To examine to what extent consumption of alcoholic beverages was associated with liver 
fat content in participants without a fatty liver, we stratified the analyses by the arbitrary 
cut-off point of 5.56% which indicates a fatty liver. Next to that, we stratified by the 
rs738409 single nucleotide polymorphism (SNP) in the PNPLA3 gene that is associated 
with diffuse fat deposition in the liver and may promote NASH, fibrosis and cirrhosis 
throughout the liver (40), to investigate whether the associations differ between carriers 
and non-carriers of the SNP. 
As a means of sensitivity analysis, we repeated the substitution analysis based on 
servings after taking into account the milk and sugar potentially added to coffee and 
tea. In the analyses with categories of alcohol consumption, we repeated the analyses 
after excluding alcohol abstainers (0 g/d) from the reference group. Additionally, 
we performed the models after exclusion of participants with diabetes type 2 or 
cardiovascular disease, as they might have changed their drinking habits after being 
diagnosed, or might potentially react differently to sugars. 
All above mentioned analyses were pre-defined, and analyses not pre-specified are 
considered exploratory. We performed all analyses using STATA statistical Software 
(Statacorp, College Station, Texas, USA), version 14.
RESULTS
In total, 6,671 participants were included in the NEO study between September 2008 and 
October 2012, of whom 2,580 underwent a liver fat measurement by 1H-MRS. However, 
due to the limited time slot that was available per participants did not allow time 
for a repeat examination when technical failures were present (n=497), leaving 2,083 
participants with a successful liver fat measurement. After exclusion of participants 
with extreme energy intake (n=18), missing dietary data (n=26), missing data on 
potential confounding factors (n=1 for smoking, n=16 for education, n=2 for ethnicity, 
n=44 for physical activity in leisure time, n=3 for total body fat and n=6 for visceral 
adipose tissue) and one participant for whom the log transformation of the liver fat 
could not be calculated, 1,966 participants were included in the analyses. Baseline 
characteristics of these participants are presented in table 1. Participants with higher 
We performed linear regression analyses to examine the association between alcohol 
consumption and liver fat. We performed three different models and also stratified each 
model by sex, due to the known differences in both alcohol consumption and liver fat 
content between men and women. Because of the skewed distribution of HTGC, we 
used the natural logarithm of this variable in the analyses. For an easier interpretation 
of these results, we back transformed the regression coefficients towards a ratio (using 
exp(beta)) with 95% confidence interval. Such ratio, for example 1.2, can be interpreted 
as 1.2 times HTGC for each extra serving per day, which would reflect an increase in HTGC 
from, for example, 5% to 6%.We first performed linear regression analysis to examine the 
association of alcohol consumption as a categorical variable (0 to 0.5 g/d (reference),≥0.5 
to 5 g/d, ≥5 to 15 g/d for women and ≥5 to 30 g/d for men, and ≥15 g/d for women and≥30 
g/d for men) with HTGC. We tested for a linear trend (p=0.01) and also added a quadratic 
term (p=0.49) to the model to check for non-linearity. 
Then, we studied alcohol consumption as a continuous outcome in three different 
ways. Firstly, we studied the association between one serving of alcohol (total alcohol, 
beer, wine, mixed drinks and liquor) and one serving of non-alcoholic beverages (sugar 
sweetened beverages, milk, coffee, tea and non-alcoholic beer) per day and liver fat 
content. This was done in both a crude model and a multivariable linear regression 
model, which was adjusted for age, sex, smoking, education, ethnicity, physical activity 
and total energy intake. Models studying separate alcoholic beverages were additionally 
adjusted for all other alcoholic beverages, and models on non-alcoholic beverages were 
additionally adjusted for all other non-alcoholic beverages. 
Secondly, we studied the effect of substituting one serving of an alcoholic beverage 
with one serving of a non-alcoholic beverage. In these substitution models we included 
a sum variable of all beverages, in addition to each beverage separately, except for the 
beverage to be substituted, in this case alcoholic beverages. Instead of total energy 
intake, these substitution models were adjusted for caloric intake from food only, to 
adjust for possible confounding when substituting different beverages. Accordingly, the 
regression coefficients can be interpreted as the relative change in HTGC if one serving/d 
of an alcoholic beverage was substituted by one serving/d of a non-alcoholic beverage. 
Third, in addition to the substitution analyses based on servings, we also performed 
an isocaloric substitution model of alcoholic beverages with energy-containing non-
alcoholic beverages. This model was adjusted for both caloric intake from beverages 
and caloric intake from food. In these analyses 5 En% of alcoholic beverages is replaced 
with 5 En% of energy containing non-alcoholic beverages (sugar-sweetened beverages, 
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Table 2 displays the association between different categories of alcohol consumption 
and liver fat content. Despite a linear trend (P for trend 0.01), light and moderate 
consumption were not significantly associated with liver fat (Table 2). Compared with 
no alcohol consumption (0-0.5 g/d), high alcohol consumption (>15 g/d for women 
and >30 g/d for men) was associated with more liver fat, for total alcohol consumption 
(1.28 times, 95% CI: 1.06, 1.55), beer consumption (1.39 times, 95% CI: 1.08, 1.80) and wine 
consumption (1.28 times, 95% CI: 1.04, 1.58) (Table 2). Results were similar when excluding 
alcohol abstainers (0g/d) from the reference group (data not shown). 
Table 3 shows the associations between consumption of different alcoholic beverages as 
continuous variables and liver fat content. Each extra alcoholic serving was associated 
with more liver fat (1.09 times, 95% CI: 1.06; 1.13). When additionally adjusted for total 
body fat to examine whether the associations were specific for liver fat, associations 
attenuated for liquor and mixed drinks, although total alcoholic beverages remained 
associated with more liver fat (1.09 times, 95% CI: 1.05, 1.12). 
The associations of non-alcoholic beverages are shown in table 4. In the total population, 
each extra serving of non-alcoholic beverages was associated with less liver fat (0.97 
times, 95% CI: 0.95, 0.99). Consumption of coffee (0.96 times for each extra serving, 95% 
CI: 0.93, 0.99), tea (0.97 times, 95% CI: 0.94; 1.00) and milk (0.95 times, 95% CI: 0.89; 1.00) 
was also associated with less liver fat. Results did not differ after exclusion of participants 
with diabetes type 2 or cardiovascular disease or when taking the milk and sugar added 
to coffee and tea into account (data not shown). 
Table 5 shows that substituting one alcoholic serving with one non-alcoholic serving 
was associated with less liver fat (0.90 times, 95% CI: 0.86, 0.94) in the total population 
after adjustment for potential confounding factors and total body fat. Of the different 
non-alcoholic beverages, replacement with milk (0.88 times, 95% CI: 0.82, 0.95), tea (0.89 
times; 95% CI: 0.85; 0.94) and coffee (0.88 times, 95% CI: 0.84; 0.92) was associated with less 
liver fat. Results were similar when taking the milk and sugar added to coffee and tea 
into account (data not shown). 
Isocaloric substitution of 5 En% of alcoholic beverages with 5 En% of non-alcoholic 
beverages (table 6) showed that substitution of alcohol with milk was associated with 
less HTGC (0.89 times, 95% CI: 0.81, 0.98) in the total population. Replacing 5 En% of 
alcohol with 5 En% of sugar sweetened beverage was associated with liver fat equally 
strong as with alcohol (1.00 times, 95% CI: 0.91, 1.09). 
alcohol consumption were more often smokers and had on average a higher education. 
Hepatic triglyceride content and the prevalence of a fatty liver was also higher in the 
categories with higher alcohol consumption. Whereas men on average have a higher 
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After stratifying the analyses by the cut-off point of fatty liver (HTGC>5.56%), associations 
between alcohol consumption and liver fat were similar in both groups (Supplemental 
table 2). Regarding the PNPLA3 polymorphism, the association between each alcoholic 
beverage and HTGC was similar in both groups (1.14 times for each alcoholic serving extra; 
95% CI: 1.07, 1.21 for GC and GG carriers and 1.09 times; 95% CI: 1.04, 1.15 for CC carriers). 
Table 4. Relative change in HTGC and 95% confidence intervals per 1 serving/d higher consumption of non-
alcoholic beverages in participants of the Netherlands Epidemiology of Obesity study, men and women 
between 45 and 65 years of age with direct assessment of hepatic triglyceride content by 1H-MRS1
    Crude Multivariable Multivariable + TBF
Relative change (95% CI) Relative change (95% CI) Relative change (95% CI)
Non-alcoholic beverages (total)
Total 0.98 (0.95; 1.00) 0.97 (0.94; 0.99) 0.97 (0.95; 0.99)
Men 0.98 (0.95; 1.01) 0.99 (0.95; 1.02) 0.98 (0.95; 1.01)
Women 0.95 (0.91; 0.98) 0.94 (0.91; 0.97) 0.95 (0.92; 0.98)
SSB2
Total 1.07 (1.01; 1.14) 1.05 (0.99; 1.11) 1.03 (0.98; 1.08)
Men 1.04 (0.97; 1.12) 1.07 (0.99; 1.15) 1.02 (0.96; 1.09)
Women 1.05 (0.96; 1.14) 1.02 (0.93; 1.11) 1.03 (0.95; 1.11)
Milk2
Total 1.00 (0.94; 1.07) 0.94 (0.88; 1.00) 0.95 (0.89; 1.00)
Men 0.92 (0.86; 1.00) 0.91 (0.84; 0.99) 0.92 (0.86; 0.99)
Women 1.02 (0.91; 1.13) 0.96 (0.87; 1.07) 0.97 (0.89; 1.06)
Coffee (without sugar or milk)2
Total 1.01 (0.98; 1.04) 0.96 (0.93; 0.99) 0.96 (0.93; 0.99)
Men 1.00 (0.96; 1.04) 0.99 (0.95; 1.03) 0.99 (0.95; 1.02)
Women 0.95 (0.91; 0.99) 0.92 (0.88; 0.96) 0.92 (0.88; 0.96)
Tea (without sugar or milk)2
Total 0.92 (0.89; 0.95) 0.96 (0.92; 0.99) 0.97 (0.94; 1.00)
Men 0.96 (0.92; 1.02) 0.98 (0.93; 1.03) 1.00 (0.94; 1.05)
Women 0.95 (0.92; 0.99) 0.94 (0.90; 0.98) 0.95 (0.91; 0.99)
Non-alcoholic beer2
Total 1.35 (0.99; 1.84) 1.13 (0.88; 1.45) 1.09 (0.86; 0.99)
Men 1.22 0.90; 1.65) 1.18 (0.89; 1.57) 1.17 (0.90; 1.52)
Women 0.82 (0.40; 1.70) 0.88 (0.49; 1.59) 0.73 (0.49; 1.10)
1Multivariable: adjusted for age, sex, smoking, education, ethnicity, physical activity in leisure time and total energy 
intake. Results are based on analyses weighted towards the body mass index distribution of the general population 
(n=1,966), and derived from beta coefficients with 95% confidence intervals from linear regression analyses and expressed 
as a relative change. Such ratio, for example 1.2, can be interpreted as 1.2 times HTGC for each extra serving per day, which 
would reflect an increase in HTGC from, for example, 5% to 6%. CI, confidence interval; HTGC, hepatic triglyceride content; 
TBF, total body fat.
2Additionally adjusted for all other non-alcoholic beverages. Servings equal 150 grams for SSB, 150 grams for milk, 125 
grams for tea and coffee, and 200 grams for non-alcoholic beer. 
Table 2. Relative change in HTGC and 95% confidence intervals for different categories of alcohol 
consumption in participants of the Netherlands Epidemiology of Obesity study, men and women between 
45 and 65 years of age with direct assessment of hepatic triglyceride content by 1H-MRS
0 to 0.5 g/d ≥0.5 to 5 g/d
≥5 to 15 g/d women







1 (ref) 1.05 (0.87, 1.25) 1.07 (0.90, 1.28) 1.28 (1.06, 1.55) 0.01




1 (ref) 0.94 (0.83, 1.08) 1.10 (0.93, 1.29) 1.39 (1.08, 1.80) 0.03




1 (ref) 1.01 (0.88, 1.16) 1.02 (0.89, 1.18) 1.28 (1.04, 1.58) 0.16
% 23.3 32.7 34.8 9.3
1Adjusted for age, sex, smoking, education, ethnicity, physical activity in leisure time, total energy intake and total body 
fat. Results are based on analyses weighted towards the body mass index distribution of the general population (n=1,966), 
and derived from beta coefficients with 95% confidence intervals from linear regression analyses and expressed as a 
relative change compared with the reference category. Such ratio, for example 1.2, can be interpreted as 1.2 times HTGC for 
each extra serving per day, which would reflect an increase in HTGC from, for example, 5% to 6%.CI, confidence interval; 
HTGC, hepatic triglyceride content.
2Additionally adjusted for other alcoholic beverages. Servings equal 200 grams for beer and 110 grams for wine. 
Table 3. Relative change in HTGC and 95% confidence intervals per 1 serving/d higher consumption of 
alcoholic beverage in participants of the Netherlands Epidemiology of Obesity study, men and women 
between 45 and 65 years of age with direct assessment of hepatic triglyceride content by 1H-MRS1
Crude Multivariable Multivariable + TBF
Relative change (95% CI) Relative change (95% CI) Relative change (95% CI)
Alcohol (total)
Total 1.15 (1.11; 1.19) 1.09 (1.06; 1.13) 1.09 (1.05; 1.12)
Men 1.11 (1.07; 1.15) 1.11 (1.07; 1.15) 1.09 (1.05; 1.13)
Women 1.05 (1.07; 1.15) 1.09 (1.00; 1.18) 1.10 (1.02; 1.19)
Beer2
Total 1.14 (1.09; 1.19) 1.07 (1.02; 1.11) 1.08 (1.03; 1.13)
Men 1.08 (1.04; 1.13) 1.08 (1.04; 1.13) 1.09 (1.04; 1.15)
Women 0.95 (0.84; 1.07) 1.02 (0.89; 1.17) 1.06 (0.96; 1.17)
Wine2
Total 1.13 (1.06; 1.20) 1.13 (1.06; 1.21) 1.11 (1.05; 1.18)
Men 1.13 (1.06; 1.21) 1.13 (1.06; 1.21) 1.08 (1.02; 1.15)
Women 1.12 (1.02; 1.24) 1.13 (1.02; 1.26) 1.15 (1.04; 1.28)
Liquor2
Total 1.64 (1.45; 1.86) 1.22 (1.08; 1.38) 1.06 (0.93; 1.21)
Men 1.33 (1.17; 1.50) 1.24 (1.10; 1.40) 1.10 (0.97; 1.26)
Women 1.28 (0.66; 2.48) 0.95 (0.52; 1.73) 0.62 (0.37; 1.04)
Mixed drinks2
Total 1.56 (1.34; 1.83) 1.18 (1.00; 1.40) 0.97 (0.83; 1.15)
Men 1.26 (1.09; 1.47) 1.18 (1.00; 1.40) 0.98 (0.83; 1.16)
Women 1.74 (0.95; 3.20) 1.53 (0.86; 2.71) 1.12 (0.63; 1.97)
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Table 6. Relative change in HTGC and 95% confidence intervals per 5 En% of alcoholic beverage substitution 
by non-alcoholic beverages in participants of the Netherlands Epidemiology of Obesity study, men and 
women between 45 and 65 years of age with direct assessment of hepatic triglyceride content by 1H-MRS1
Crude Multivariable Multivariable + TBF
Relative change (95% CI) Relative change (95% CI) Relative change (95% CI)
Non-alcoholic beverages (total)
Total 0.91 (0.83; 0.98) 0.94 (0.87; 1.02) 0.94 (0.87; 1.01)
Men 0.90 (0.81; 1.00) 0.90 (0.81; 1.01) 0.88 (0.81; 0.97)
Women 0.99 (0.86; 1.14) 0.96 (0.84; 1.10) 0.96 (0.85; 1.09)
Milk
Total 0.86 (0.77; 0.97) 0.88 (0.79; 0.98) 0.89 (0.81; 0.98)
Men 0.82 (0.71; 0.95) 0.80 (0.69; 0.92) 0.82 (0.72; 0.93)
Women 0.98 (0.82; 1.17) 0.94 (0.79; 1.13) 0.94 (0.81; 1.10)
SSB 
Total 0.95 (0.85; 1.06) 1.01 (0.91; 1.12) 1.00 (0.91; 1.09)
Men 1.00 (0.86; 1.17) 1.04 (0.89; 1.22) 0.97 (0.85; 1.10)
Women 1.01 (0.87; 1.19) 0.98 (0.85; 1.14) 0.99 (0.86; 1.13)
1Multivariable: adjusted for age, sex, smoking, education, ethnicity, physical activity in leisure time, total energy 
intake of beverages, total energy intake from food, and all beverages except for alcohol and itself. Results are based on 
analyses weighted towards the body mass index distribution of the general population (n=1,966), and derived from beta 
coefficients with 95% confidence intervals from linear regression analyses and expressed as a relative change. Such ratio, 
for example 1.2, can be interpreted as 1.2 times HTGC for each extra serving per day, which would reflect an increase in 
HTGC from, for example, 5% to 6%. CI, confidence interval; HTGC, hepatic triglyceride content; SSB, sugar sweetened 
beverage; TBF, total body fat.
DISCUSSION
In this population-based cohort of 1,966 middle aged men and women with directly 
assessed liver fat content, consumption of each extra alcoholic serving per day was 
associated with more liver fat, with larger increases in liver fat with excessive alcohol 
consumption. Replacing one alcoholic beverage by one non-alcoholic beverage was 
associated with less liver fat. Whereas isocaloric replacement of alcohol with milk was 
associated with less liver fat, isocaloric replacement with sugar sweetened beverages was 
equally associated with liver fat. 
This study was conducted within a large cohort study, in which hepatic triglyceride 
content has been directly assessed by 1H-MRS. We used substitution analysis to directly 
compare different types of beverages and their association with liver fat to each other. 
The comparative nature of our study can contribute to translation to recommendations 
in clinical practice, as we have shown that consumption of both alcohol and sugar 
sweetened beverages is associated with more liver fat, whereas milk, tea and coffee are 
associated with less liver fat. More importantly, replacing alcohol with sugar sweetened 
beverages is therefore equally associated with liver fat, and replacing it with milk, tea 
Table 5. Relative change in HTGC and 95% confidence intervals per 1 serving/d of alcoholic beverage 
substitution by non-alcoholic beverage in participants of the Netherlands Epidemiology of Obesity study, 
men and women between 45 and 65 years of age with direct assessment of hepatic triglyceride content by 
1H-MRS1
Crude Multivariable Multivariable + TBF
Relative change (95% CI) Relative change (95% CI) Relative change (95% CI)
Non-alcoholic beverages (total)
Total 0.85 (0.81; 0.88) 0.89 (0.85; 0.93) 0.90 (0.86; 0.94)
Men 0.89 (0.85; 0.93) 0.90 (0.86; 0.95) 0.91 (0.87; 0.96)
Women 0.91 (0.83; 0.99) 0.87 (0.79; 0.95) 0.86 (0.80; 0.94)
Tea (without sugar or milk)1
Total 0.81 (0.78; 0.85) 0.87 (0.83; 0.92) 0.89 (0.85; 0.94)
Men 0.88 (0.82; 0.94) 0.90 (0.84; 0.96) 0.92 (0.86; 0.99)
Women 0.88 (0.79; 0.97) 0.86 (0.78; 0.94) 0.86 (0.79; 0.94)
Coffee (without sugar or milk)1
Total 0.85 (0.81; 0.89) 0.88 (0.84; 0.92) 0.88 (0.84; 0.92)
Men 0.89 (0.84; 0.94) 0.90 (0.85; 0.95) 0.91 (0.86; 0.96)
Women 0.88 (0.79; 0.97) 0.84 (0.76; 0.92) 0.83 (0.77; 0.91)
Milk1
Total 0.86 (0.80; 0.92) 0.87 (0.81; 0.93) 0.88 (0.83; 0.94)
Men 0.83 (0.77; 0.91) 0.84 (0.77; 0.91) 0.86 (0.80; 0.92)
Women 0.94 (0.82; 1.09) 0.90 (0.78; 1.03) 0.89 (0.79; 1.00)
SSB1
Total 0.93 (0.87; 1.00) 0.98 (0.92; 1.04) 0.96 (0.91; 1.02)
Men 0.96 (0.89; 1.03) 1.00 (0.92; 1.08) 0.96 (0.90; 1.03)
Women 0.99 (0.88; 1.11) 0.95 (0.84; 1.06) 0.94 (0.85; 1.04)
1Multivariable: adjusted for age, sex, smoking, education, ethnicity, physical activity in leisure time, total energy intake of 
food, a sum variable of all beverages and all beverages except for alcohol and itself. Results are based on analyses weighted 
towards the body mass index distribution of the general population (n=1,966), and derived from beta coefficients with 
95% confidence intervals from linear regression analyses and expressed as a relative change. Such ratio, for example 1.2, 
can be interpreted as 1.2 times HTGC for each extra serving per day, which would reflect an increase in HTGC from, for 
example, 5% to 6%.CI, confidence interval; HTGC, hepatic triglyceride content; SSB, sugar sweetened beverages; TBF, total 
body fat.
1Servings equal 125 grams for tea and coffee, 150 grams for milk and 150 grams for SSB. 
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in a recent review an association between moderate alcohol consumption and decreased 
NASH and fibrosis was shown, it was also observed that heavy episodic drinking may 
accelerate fibrosis progression (49). Most of the studies on alcohol consumption, 
however, including ours, did not take drinking habits into account, only habitual total 
amount of alcohol consumed. However, even though certain drinking patterns such 
as drinking outside mealtimes and drinking multiple different alcoholic beverages 
lead to an increased risk of developing alcohol related liver damage (50), it seems to be 
the cumulative consumption that is most strongly associated with the progression of 
alcoholic fatty liver disease (42). Although current literature is in disagreement about the 
role of moderate alcohol consumption, none of these studies performed substitution 
analysis to take into account that a person does not simply stop drinking alcohol but 
may replace the alcoholic beverages with other drinks. Moreover, results from a recent 
mendelian randomization suggest that there is no beneficial effect of moderate alcohol 
consumption on the severity of non-alcoholic fatty liver disease (24). In our study, light 
and moderate alcohol consumption were not associated with less liver fat, which is in 
line with these findings. 
Additionally, isocaloric replacement of alcohol with milk was associated with less 
liver fat in our study. This indicates that it is not caloric intake per se that leads to liver 
fat accumulation. The exact mechanism behind the seemingly negative association 
between dairy and liver fat remains unknown, although it is in agreement with current 
literature. Established biomarkers of dietary dairy fat intake have been associated with 
higher hepatic and systemic insulin sensitivity, lower fasting glucose concentrations 
and less liver fat (51). Moreover, higher low-fat fermented dairy product consumption has 
also been associated with a decreased risk of developing type 2 diabetes in a prospective 
study (52). 
  
Importantly, isocaloric replacement of alcohol with sugar sweetened beverage 
consumption was equally associated with liver fat. Taken together with our results on 
substitution with milk, this suggest a role for sugars in liver fat accumulation. Our 
results are in line with recent findings from the Framingham Heart Study that showed 
a significant dose-response relationship between sugar sweetened beverages and fatty 
liver disease, but not for diet soda intake (27). However, replacement of sugar sweetened 
beverages with other beverages was not investigated in this study. 
Multiple underlying mechanisms have been proposed through which sugar sweetened 
beverages might contribute to the development of diabetes and cardiometabolic 
diseases not only via overall weight gain, but also independently through the metabolic 
or coffee is associated with less liver fat. This can be translated into clear advice for 
patients diagnosed with fatty liver and who are advised to stop consuming alcohol. 
Lastly, extensive phenotype measurements have been performed, allowing adjustment 
for many potential confounding factors. However, inherent to the observational, cross-
sectional design we cannot exclude residual confounding by lifestyle factors.
Due to the cross-sectional design, a limitation of this substitution analysis is that 
it is modelled on a group level rather than on an individual level. All participants 
completed a semi-quantitative FFQ , based on which we estimated the habitual beverage 
consumption. Although alcohol consumption might have been misreported, intra-
class correlations of the beverages showed good to excellent reproducibility. Moreover, 
by adjusting our analyses for total energy intake we partly corrected for potential 
misreporting. A limitation of the FFQ is that it did not take drinking habits into account, 
so we cannot make any statements on the potential role of drinking patterns. Also no 
information on diet sodas or water was available, so no statements on these beverages 
can be made. Nevertheless, this will not have influenced the isocaloric substitution 
models, as only energy-containing beverages were taken into account in this analysis. 
Results from these isocaloric substitution models suggest that it is not energy per se, but 
possibly sugars that contribute to liver fat accumulation.
Alcohol is mainly metabolized in the liver (41), and can induce fatty liver by increasing 
the fatty acid synthesis in the liver. Together with the impaired oxidation of these 
compounds caused by an increased accumulation of the reduced form of nicotinamide 
adenine dinucleotice (NADH), alcohol consumption may lead to increased triglyceride 
synthesis, which is the main form of stored fat stored in the liver (42). Although many 
studies investigated the association between light to moderate alcohol consumption 
and liver fat, results have been inconsistent and inconclusive, and the exact mechanism 
remains unidentified. A prospective randomized study concluded that moderate red 
wine consumption during three months increased HTGC in subjects without steatosis 
at baseline (43), whereas red wine consumption during four weeks in another randomized 
controlled trial did not significantly increase liver fat compared to de-alcoholized 
red wine (44). Additionally, Ekstedt et al. concluded from their long-term follow-up 
study that moderate alcohol consumption was associated with fibrosis progression in 
patients with NAFLD and that they should be advised to refrain from heavy episodic 
drinking (45). Modest wine consumption has been associated with reduced prevalence of 
suspected (NA)FLD in other studies (19, 21, 46, 47). In another study, light to moderate alcohol 
consumption had a potentially protective effect against insulin resistance in severely 
obese patients, but not on the severity of activity and stage of liver disease (48). Although 
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with sugar sweetened beverages.
116 | CHAPTER 5 CONSUMPTION OF ALCOHOLIC AND SUGAR-SWEETENED BEVERAGES IS ASSOCIATED WITH INCREASED LIVER FAT CONTENT | 117
5 5
32. Verkleij-Hagoort AC, de Vries JH, Stegers MP, Lindemans J, Ursem NT, Steegers-Theunissen RP. Validation of the 
assessment of folate and vitamin B12 intake in women of reproductive age: the method of triads. Eur J Clin Nutr 
2007;61(5):610-5.
33. Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment 
instruments in psychology. Psychol Assess 1994;6(4):284.
34. Van Der Meer RW, Hammer S, Lamb HJ, Frolich M, Diamant M, Rijzewijk LJ, De Roos A, Romijn JA, Smit JW. Effects 
of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men. J Clin 
Endocrinol Metab 2008;93(7):2702-8.
35. Naressi A, Couturier C, Devos J, Janssen M, Mangeat C, De Beer R, Graveron-Demilly D. Java-based graphical user 
interface for the MRUI quantitation package. Magnetic Resonance Materials in Physics, Biology and Medicine 
2001;12(2-3):141-52.
36.  Wendel-Vos GW, Schuit AJ, Saris WH, Kromhout D. Reproducibility and relative validity of the short questionnaire 
to assess health-enhancing physical activity. J Clin Epidemiol 2003;56(12):1163-9.
37.  Korn EL, Graubard BI. Epidemiologic studies utilizing surveys: accounting for the sampling design. Am J Public 
Health 1991;81(9):1166-73.
38. Lumley T. Analysis of complex survey samples. Journal of Statistical Software 2004;9(1):1-19.
39. Ministerie van VWS. Internet: https://www.volksgezondheidenzorg.info/onderwerp/overgewicht/cijfers-context/
huidige-situatie (accessed February 20 2017).
40. Speliotes EK, Butler JL, Palmer CD, Voight BF, Hirschhorn JN. PNPLA3 variants specifically confer increased risk for 
histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 2010;52(3):904-12. doi: 10.1002/
hep.23768.
41. Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Research 2006;29(4):245.
42. Liu J. Ethanol and liver: Recent insights into the mechanisms of ethanol-induced fatty liver. World Journal of 
Gastroenterology : WJG 2014;20(40):14672-85. doi: 10.3748/wjg.v20.i40.14672.
43. Kechagias S, Zanjani S, Gjellan S, Leinhard OD, Kihlberg J, Smedby O, Johansson L, Kullberg J, Ahlstrom H, Lindstrom 
T, et al. Effects of moderate red wine consumption on liver fat and blood lipids: a prospective randomized study. 
Ann Med 2011;43(7):545-54. doi: 10.3109/07853890.2011.588246.
44. Beulens JW, Beers RM, Stolk RP, Schaafsma G, Hendriks HF. The effect of moderate alcohol consumption on fat 
distribution and adipocytokines. Obesity 2006;14(1):60-6.
45. Ekstedt M, Franzen LE, Holmqvist M, Bendtsen P, Mathiesen UL, Bodemar G, Kechagias S. Alcohol consumption 
is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scand J Gastroenterol 
2009;44(3):366-74. doi: 10.1080/00365520802555991.
46. Moriya A, Iwasaki Y, Ohguchi S, Kayashima E, Mitsumune T, Taniguchi H, Ikeda F, Shiratori Y, Yamamoto K. Alcohol 
consumption appears to protect against non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2011;33(3):378-
88. doi: 10.1111/j.1365-2036.2010.04520.x.
47. Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M, Kato T. Protective effect of alcohol consumption for fatty 
liver but not metabolic syndrome. World J Gastroenterol 2012;18(2):156-67. doi: 10.3748/wjg.v18.i2.156.
48.  Cotrim HP, Freitas LA, Alves E, Almeida A, May DS, Caldwell S. Effects of light-to-moderate alcohol consumption on 
16. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl 
J Med 2010;363(14):1341-50. doi: 10.1056/NEJMra0912063.
17. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. 
Alcohol 2004;34(1):9-19.
18. Liangpunsakul S, Chalasani N. What should we recommend to our patients with NAFLD regarding alcohol use? 
Am J Gastroenterol 2012;107(7):976-8. doi: 10.1038/ajg.2012.20.
19.  Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty 
liver disease. Hepatology 2008;47(6):1947-54. doi: 10.1002/hep.22292.
20. Dunn W, Sanyal AJ, Brunt EM, Unalp-Arida A, Donohue M, McCullough AJ, Schwimmer JB. Modest alcohol 
consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver 
disease (NAFLD). Journal of Hepatology 2012;57(2):384-91. doi: http://dx.doi.org/10.1016/j.jhep.2012.03.024.
21. Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, Urabe A. Light and Moderate Alcohol 
Consumption Significantly Reduces the Prevalence of Fatty Liver in the Japanese Male Population. Am J 
Gastroenterol 2009;104(9):2189-95.
22. Fan J-G, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. Journal of Hepatology 2009;50(1):204-
10. doi: http://dx.doi.org/10.1016/j.jhep.2008.10.010.
23. Schrieks IC, Heil AL, Hendriks HF, Mukamal KJ, Beulens JW. The effect of alcohol consumption on insulin sensitivity 
and glycemic status: a systematic review and meta-analysis of intervention studies. Diabetes Care 2015;38(4):723-32.
24. Sookoian S, Flichman D, Castano GO, Pirola CJ. Mendelian randomisation suggests no beneficial effect of moderate 
alcohol consumption on the severity of nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2016;44(11-
12):1224-34. doi: 10.1111/apt.13828.
25. Leidy HJ, Apolzan JW, Mattes RD, Campbell WW. Food form and portion size affect postprandial appetite sensations 
and hormonal responses in healthy, nonobese, older adults. Obesity 2010;18(2):293-9.
26. Yeomans MR. Alcohol, appetite and energy balance: is alcohol intake a risk factor for obesity? Physiol Behav 
2010;100(1):82-9.
27. Ma J, Fox CS, Jacques PF, Speliotes EK, Hoffmann U, Smith CE, Saltzman E, McKeown NM. Sugar-sweetened 
beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts. J Hepatol 2015;63(2):462-9. doi: 
10.1016/j.jhep.2015.03.032.
28.  Lanaspa MA, Ishimoto T, Li N, Cicerchi C, Orlicky DJ, Ruzycki P, Rivard C, Inaba S, Roncal-Jimenez CA, Bales ES, et 
al. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic 
syndrome. Nat Commun 2013;4:2434. doi: 10.1038/ncomms3434.
29. McDevitt RM, Bott SJ, Harding M, Coward WA, Bluck LJ, Prentice AM. De novo lipogenesis during controlled 
overfeeding with sucrose or glucose in lean and obese women. Am J Clin Nutr 2001;74(6):737-46.
30. de Mutsert R, den Heijer M, Rabelink TJ, Smit JW, Romijn JA, Jukema JW, de Roos A, Cobbaert CM, Kloppenburg 
M, le Cessie S, et al. The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection. Eur J 
Epidemiol 2013;28(6):513-23. doi: 10.1007/s10654-013-9801-3.
31. Feunekes GI, Van Staveren WA, De Vries J, Burema J, Hautvast J. Relative and biomarker-based validity of a food-
frequency questionnaire estimating intake of fats and cholesterol. Am J Clin Nutr 1993;58(4):489-96.
118 | CHAPTER 5 CONSUMPTION OF ALCOHOLIC AND SUGAR-SWEETENED BEVERAGES IS ASSOCIATED WITH INCREASED LIVER FAT CONTENT | 119
5 5
steatosis and steatohepatitis in severely obese patients. Eur J Gastroenterol Hepatol 2009;21(9):969-72. doi: 10.1097/
MEG.0b013e328328f3ec.
49.  Ajmera VH, Terrault NA, Harrison SA. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A 
critical review. Hepatology 2017;65(6):2090-9. doi: 10.1002/hep.29055.
50. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria Croce L, Sasso F, Pozzato G, Cristianini 
G, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 
1997;41(6):845-50.
51. Kratz M, Marcovina S, Nelson JE, Yeh MM, Kowdley KV, Callahan HS, Song X, Di C, Utzschneider KM. Dairy fat intake 
is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function 
in humans–. Am J Clin Nutr 2014;99(6):1385-96.
52. O’Connor LM, Lentjes MA, Luben RN, Khaw K-T, Wareham NJ, Forouhi NG. Dietary dairy product intake and incident 
type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia 2014;57(5):909-17.
53. Malik VS. Sugar sweetened beverages and cardiometabolic health. Curr Opin Cardiol 2017;32(5):572-9.
54. Malik VS, Popkin BM, Bray GA, Després J-P, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic 
syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010;33(11):2477-83.
55. Sluik D, Engelen AI, Feskens EJ. Fructose consumption in the Netherlands: the Dutch National Food Consumption 
Survey 2007-2010. Eur J Clin Nutr 2015;69(4):475-81. doi: 10.1038/ejcn.2014.267.
56. Bray GA. How bad is fructose? Am J Clin Nutr 2007;86(4):895-6.
57. Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, Nakagawa T, Kuwabara M, Sato Y, Kang DH, 
et al. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J Hepatol 2018;68(5):1063-75. doi: 
10.1016/j.jhep.2018.01.019.
58. Taskinen MR, Soderlund S, Bogl LH, Hakkarainen A, Matikainen N, Pietilainen KH, Rasanen S, Lundbom N, Bjornson 
E, Eliasson B, et al. Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in 
subjects with abdominal obesity. J Intern Med 2017;282(2):187-201. doi: 10.1111/joim.12632.
59. Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC, Bremer AA, Berglund L, McGahan JP, Havel PJ, et 
al. Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure 
in overweight/obese men and women. Eur J Clin Nutr 2012;66(2):201-8. doi: 10.1038/ejcn.2011.159.
120 | CHAPTER 5 CONSUMPTION OF ALCOHOLIC AND SUGAR-SWEETENED BEVERAGES IS ASSOCIATED WITH INCREASED LIVER FAT CONTENT | 121
5 5
SUPPLEMENTARY FILES
Supplemental table 1. Body Mass Index distribution of participants of the Netherlands Epidemiology of 
Obesity study from the Leiderdorp municipality and the resulting weighting factors for the different BMI 
categories as used in the statistical analyses
Body Mass Index n (%) Weighting factor
≥30 kg/m2 268 (16.0) 1
≥29-30 kg/m2 83 (5.0) 1.304461
≥28-29 kg/m2 103 (6.2) 1.472934
≥27-28 kg/m2 151 (9.0) 2.458912
≥26-27 kg/m2 172 (10.3) 4.445434
≥25-26 kg/m2 190 (11.4) 8.668198
<25 kg/m2 704 (42.0) 10.26279
Total 1,671
Supplemental table 2. Relative change in HTGC and 95% confidence intervals in stratifications on HTGC, 
alcohol consumption and PNPLA3 gene in participants of the Netherlands Epidemiology of Obesity study, 
men and women between 45 and 65 years of age with direct assessment of hepatic triglyceride content by 
1H-MRS1
Multivariable Multivariable + TBF
Relative change (95% CI) Relative change (95% CI)
Alcohol (total) - per 1 unit/day higher consumption
HTGC<5.56% 1.05 (1.01; 1.09) 1.04 (1.00; 1.08)
HTGC≥5.56% 1.01 (0.99; 1.04) 1.02 (1.00; 1.05)
PNPLA3 II 1.09 (1.04; 1.15) 1.06 (1.02; 1.11)
PNPLA3 IM+MM 1.14 (1.07; 1.21) 1.12 (1.06; 1.19)
Non-alcoholic (total) - per 1 unit/day higher consumption
HTGC<5.56% 0.97 (0.95; 0.99) 0.97 (0.95; 0.99)
HTGC≥5.56% 1.00 (0.98; 1.02) 1.00 (0.98; 1.02)
PNPLA3 II 0.96 (0.92; 0.99) 0.95 (0.92; 0.98)
PNPLA3 IM+MM 0.99 (0.95; 1.03) 0.99 (0.96; 1.03)
Non-alcoholic (total) - per 1 unit/day of alcoholic beverage substitution
HTGC<5.56% 0.93 (0.89; 0.97) 0.94 (0.90; 0.97)
HTGC≥5.56% 0.99 (0.95; 1.02) 0.98 (0.95; 1.01)
PNPLA3 II 0.89 (0.84; 0.95) 0.91 (0.87; 0.96)
PNPLA3 IM+MM 0.87 (0.81; 0.93) 0.89 (0.83; 0.95)
Non-alcoholic (total) - per 5 En% of alcoholic beverage substitution
HTGC<5.56% 0.94 (0.88; 1.01) 0.95 (0.90; 1.02)
HTGC≥5.56% 0.98 (0.91; 1.06) 0.97 (0.90; 1.04)
PNPLA3 II 0.98 (0.88; 1.08) 0.99 (0.90; 1.08)
PNPLA3 IM+MM 0.87 (0.74; 1.01) 0.87; 0.77; 0.99)
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Reallocating sedentary time to 
moderate to vigorous physical 
activity is associated with 
reduced total body fat, 
visceral fat and liver fat
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INTRODUCTION
Abdominal obesity is a well-established risk factor for diabetes mellitus, the metabolic 
syndrome and cardiovascular diseases (1, 2). In particular accumulation of fat in the visceral 
area and in and around the organs (2), such as the liver, carries extra risk. Both visceral 
fat and liver fat have been associated with metabolic risk factors, insulin resistance and 
cardiovascular diseases (3-6), making these adipose depots important targets to prevent 
cardio metabolic diseases. 
 
Meta-analyses have shown that exercise can reduce both visceral fat (7) and liver fat (8). 
However, the included studies focused on structured exercise rather than habitual daily 
activities and sedentary time, and evidence on the association between habitual daily 
activity and different adipose depots is lacking. Most European guidelines on physical 
activity advise to perform at least 150 minutes per week of moderate to vigorous physical 
activity and to limit sedentary time (9), as sedentary behaviour has been associated 
with increased risk of type 2 diabetes, cardiovascular disease, and cancer, even after 
adjustment for physical activity (10). Obviously, less time spent sedentary implies more 
time spent in other activities. For assessment of the association of one particular type 
of activity with a certain outcome, it is therefore important to take into account with 
which activity this is replaced, e.g., whether sedentary time is replaced with the same 
time spent while physically active. Although most studies that applied such isotemporal 
substitution analysis to examine replacement of sedentary time by time spent on other 
activities in relation to body fat used objectively assessed physical activity, most used 
surrogate outcomes for adiposity such as body mass index or waist circumference (11) 
instead of direct measures of adipose tissue. Only one study on isotemporal substitution 
of habitual activities used direct measurements of both physical activity and visceral 
fat, and it was reported that replacing sedentary time with time spent on moderate 
physical activity was associated with a reduction in visceral fat (12). However, liver fat was 
not assessed in this study and adjustment for total body fat was not performed, which 
may attenuate associations.
Knowledge on how different types of daily activities and their mutual substitutions are 
associated with different adipose depots, such as total body fat, visceral and liver fat, helps 
elucidating the underlying mechanism of how sedentary time or physical inactivity can 
lead to multiple adverse health outcomes. This may lead to more specified guidelines 
on sedentary time and physical activity. We therefore aimed to study the association 
between substitution of sedentary time with other daily activities and total body fat, 
visceral fat and liver fat in a population-based cohort of middle-aged participants. 
ABSTRACT
Background
It is unclear how habitual physical activity and sedentary time are associated with the 
amount of visceral fat and liver fat. We therefore aimed to study substitution of sedentary 
time with other daily activities and total body fat (TBF), visceral adipose tissue (VAT) and 
hepatic triglyceride content (HTGC) in middle-aged men and women. 
Methods
In this cross-sectional analysis of the NEO study, we objectively assessed physical activity 
in 932 participants using a combined heart rate monitor and accelerometer (Actiheart). 
Of those with a valid physical activity measurement, total body fat was assessed by bio 
impedance balance, VAT by magnetic resonance imaging (MRI) in 317 participants, and 
HTGC by proton-MR spectroscopy in 265 participants. Activities were categorized as 
sedentary time, light physical activity (LPA) or moderate to vigorous physical activity 
(MVPA) and expressed in blocks of 30 minutes. We performed isotemporal substitution 
analyses adjusted for sex, age, ethnicity, education, Dutch Healthy Diet index, and 
smoking to estimate associations of replacing 30 minutes/day of sedentary time with 30 
minutes/day of other activities. 
Results
Participants (41% men) had a mean (SD) age of 56 (6) years and performed 82 (55) 
minutes of MVPA and spent 9.1 hours (2.1) sedentary per day. Replacing 30 minutes/day 
of sedentary time with 30 minutes of MVPA was associated with 0.5% less TBF (95% CI: -0.9, 
-0.1), 7.2 cm2 less VAT (-10.7, -3.6) and with less HTGC (0.89 times; 0.82, 0.97). Replacement 
with LPA was not associated with TBF (-0.17 %; -0.45, 0.11), VAT (0.4 cm2; -2.1, 2.9) or HTGC 
(0.98; 0.92, 1.04). 
Conclusions
Replacing sedentary time with MVPA, but not with LPA, was negatively associated with 
total body fat, and visceral and liver fat. These findings contribute to the development of 
more specified guidelines on sedentary time and physical activity.
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to wear the monitor continuously for four consecutive days and nights, except when 
showering, bathing or swimming, and to carry on with all normal activities during this 
time. The monitor was set-up to record at 15 s epochs. 
A Gaussian process regression method was applied to the heart rate data to handle 
potential measurement noise (14). Using a branched equation algorithm the acceleration 
and heart rate information was summarised into calibrated estimates of physical activity 
energy expenditure (PAEE) and time spent at different activity intensities expressed as 
metabolic equivalents of task (MET) (15, 16). When summarising the data we accounted 
for non-wear time and any potential diurnal imbalance of wear time by weighting all 
hours of the day equally in the summation (17). In a subgroup of 132 participants who 
were equipped with an Actiheart monitor, an 8-min ramped step test was performed 
to calibrate the individual heart rate response to activity intensity. In addition, a group 
calibration equation was applied to the results of the other participants, which was 
derived from the valid step tests in this population (18).
Sedentary time was defined as time spent in activities with an intensity ≤1.5 MET, 
excluding sleep time. Sleep time was assumed as the time between 23:00h and 07:30h 
on weekdays and between 23:30h and 07:30h on weekend days unless Actiheart detected 
activity took place. Light intensity physical activity (LPA) was defined as any activity 
during wear time with an intensity >1.5 and ≤3 MET. Moderate-to-vigorous physical 
activity (MVPA) was defined as any activity >3 MET (19). Participants with a valid wear time 
<24 hours were excluded from the analyses. No minimum bout duration was set for the 
activity intensity categories.
Assessment of body fat 
Body weight and percent body fat were assessed by a Tanita bio impedance balance 
(TBF-310, Tanita International Division, UK) without the participant wearing shoes and 
one kilogram was subtracted from the body weight. BMI was calculated by dividing the 
weight in kilograms by the height in meters squared. In a random subgroup without 
contraindications, imaging was performed on a 1.5 Tesla MR system (Philips Medical 
Systems, Best, the Netherlands). Visceral adipose tissue (VAT) was quantified by a turbo 
spin echo imaging protocol using MRI. At the level of the fifth lumbar vertebra, three 
transverse images each with a slice thickness of 10 mm were obtained during a breath-
hold. Visceral fat area was converted from the number of pixels to centimeters squared 
using in-house-developed software (MASS, Medis, Leiden, the Netherlands) and the 
average of three slices was used in the analyses (13). Hepatic triglyceride content (HTGC) 
was quantified by proton-MR spectroscopy (1H-MRS) of the liver (20). An 8 ml voxel was 
METHODS
 
Study design and study population
The Netherlands Epidemiology of Obesity (NEO) study is a population-based, prospective 
cohort study designed to investigate pathways that lead to obesity-related diseases. 
The NEO study started in 2008 and includes 6,671 individuals aged 45–65 years, with 
an oversampling of individuals with overweight or obesity. The study design and data 
collection are described in detail elsewhere (13). Men and women living in the greater area 
of Leiden (in the West of the Netherlands) were invited to participate if they were aged 
between 45 and 65 years and had a self-reported BMI of 27 kg/m2 or higher. In addition, 
all inhabitants aged between 45 and 65 years from one municipality (Leiderdorp) were 
invited to participate irrespective of their BMI, allowing for a reference distribution of 
BMI. The Medical Ethical Committee of the Leiden University Medical Center (LUMC) 
approved the design of the study. All participants gave their written informed consent. 
 
Participants were invited to a baseline visit at NEO study center of the LUMC after an 
overnight fast. Prior to this study visit, participants collected their urine over 24 hours and 
completed a general questionnaire at home to report demographic, lifestyle and clinical 
information. The participants were asked to bring all medication they were using to 
the study visit. At the study center, the participants completed a screening form, asking 
about anything that might create a health risk or interfere with magnetic resonance 
imaging (MRI) (most notably metallic devices, claustrophobia, or a body circumference 
of more than 1.70 m). Of the participants who were eligible for MRI, approximately 35% 
were randomly selected to undergo direct assessment of abdominal fat. Another random 
subsample (n=955) received the Actiheart device (Actiheart, CamNtech Ltd, UK) to carry 
for four days to objectively assess daily levels of physical activity.
The present study is a cross-sectional analysis of the baseline measurements of the NEO 
study. We excluded participants with missing data on objectively assessed physical 
activity, body fat measurements or potential confounding factors. 
Objective assessment of daily activities
Daily levels of physical activity were objectively assessed the NEO study participants 
(n=955) who carried the Actiheart device, a uniaxial activity monitor capable of 
measuring acceleration and heart rate (Actiheart, CamNtech Ltd, UK). The device weighs 
less than 8 g and is worn directly onto the skin. Two standard ECG electrodes (H98SG, Tyco 
Healthcare, Germany) were placed at the level of the second intercostal space; one on 
the sternum and one 10 cm to the left of the first electrode. Participants were instructed 
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given instead of numbers of participants. Other baseline characteristics are expressed 
as mean with standard deviation. 
 
We performed linear regression analyses and fitted several models. First, we examined 
the association between 30 minutes of daily activities (i.e. sedentary time, light, and 
moderate to vigorous physical activity) and total body fat, visceral fat and liver fat in a 
crude model. Second, a multivariable model was applied that was adjusted for sex, age, 
ethnicity, education, DHD-index, and smoking. This model describes the association 
between 30 minutes/day of each of the daily activities on top of the regular activity 
pattern for each outcome. Third, we performed an isotemporal substitution approach in 
our final model including waking time and excluding sedentary time. Consequently, the 
regression coefficients of each activity represent the estimated difference in measure 
of body fat associated with replacing 30 minutes of sedentary time with 30 minutes 
spent on this type of activity. This isotemporal substitution model on visceral fat and 
liver fat was additionally adjusted for total body fat to study whether physical activity 
is associated with visceral fat and liver fat beyond effects via total body fat. Regression 
coefficients of total body fat represent an absolute difference in TBF in % per 30 minutes 
of a certain activity, and those of VAT an absolute difference in VAT in cm2 per 30 minutes 
of a certain activity per day.
Due to a skewed distribution of HTGC, we used the natural logarithm of this variable 
in the analyses. For interpretation of the results, we back-transformed the regression 
coefficients of HTGC towards a ratio with 95% confidence interval, which indicates the 
relative excess liver fat content for each 30 minutes per day spent additionally on a 
certain activity. This ratio, for example a ratio of 1.2, can be interpreted as each 30 minutes 
per day of sedentary time replaced with similar time spent performing moderate to 
vigorous physical activity being associated with a 1.2-fold HTGC. This would reflect an 
increase in liver fat from, for example, 5% to 6% . 
Data was analyzed using STATA v.14 (StataCorp LP, College Station, TX, USA).
RESULTS 
Physical activity was objectively assessed in 955 participants, of whom 932 had a valid 
measurement. The group of participants with a physical activity assessment was 
similar in sex distribution, age, and BMI to the group without an objective assessment 
of physical activity, but were slightly less likely to have a history of CVD (5.6% versus 
positioned in the right lobe of the liver, avoiding gross vascular structures and adipose 
tissue depots. Sixty-four averages were collected with water suppression. Spectra were 
obtained with an echo time of 26 ms and a repetition time of 3,000 ms. Data points (1,024) 
were collected using a 1,000 Hz spectral line. Without changing any parameters, spectra 
without water suppression, with a repetition time of 10 s, and with four averages were 
obtained as an internal reference. 1H-MRS data were fitted using Java-based magnetic 
resonance user interface software (jMRUI version 2.2, Leuven, Belgium), as described 
previously (21). Hepatic triglyceride content relative to water was calculated as the sum 
of signal amplitudes of methyl and methylene divided by the signal amplitude of water 
and then multiplied by 100. 
Confounding factors 
On the questionnaire, participants reported ethnicity by self-identification in eight 
categories which we grouped into white (reference) and other. Tobacco smoking was 
reported in the three categories current, former, and never smoking (reference). Highest 
level of education was reported in 10 categories according to the Dutch education 
system and grouped into high (including higher vocational school, university, and 
post-graduate education) versus low education (reference). Participants reported their 
medical history of diabetes and cardiovascular diseases. Pre-existing cardiovascular 
disease was defined as myocardial infarction, angina, congestive heart failure, stroke, 
or peripheral vascular disease. Habitual dietary intake of all participants was estimated 
using a semi-quantitative self-administered 125-item food frequency questionnaire 
(FFQ) (22, 23). Based on these variables, an adapted version of the Dutch Healthy Diet Index 
(DHD-index) 2015 was calculated which consisted of 13 components (vegetables, fruit, 
wholegrain products, legumes, unsalted nuts, dairy, fish, tea, liquid to solid fat ratio, 
red meat, processed meat, sweetened beverages and alcohol). The DHD-index ranges 
between 0 and 130, in which a higher score reflects better adherence to the Dutch 
Guidelines for a Healthy Diet of 2015 (24).
Statistical analysis 
In the NEO study there is an oversampling of persons with a BMI of 27 kg/m2 or higher. 
To correctly represent associations in the general population (25), adjustments for 
the oversampling of individuals with a BMI ≥ 27 kg/m2 were made. This was done by 
weighting individuals towards the BMI distribution of participants from the Leiderdorp 
municipality (26), whose BMI distribution was similar to the BMI distribution of the 
general Dutch population (27). All results were based on weighted analyses. Consequently, 
the results apply to a population-based study without oversampling of individuals with 
a BMI ≥ 27 kg/m2. Because of the weighted analyses, percentages and proportions are 
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Table 1. Characteristics of participants of the Netherlands Epidemiology of Obesity study , men and 
women between 45 and 65 years of age with objectively assessed physical activity stratified by tertiles of 
moderate to vigorous physical activity
Tertiles of moderate to vigorous physical activity (min/d)
T1 (0.2-44.8) T2 (45.4-85.5) T3 (85.6-394.8)
Age (y) 57 (6) 56 (6) 55 (6)
Sex (% men) 37 32 53
Ethnicity (% white) 95 95 97
Education level (% high)1 33 45 42
BMI (kg/m2) 27.4 26.2 25.4
Tobacco smoking (% current) 22 15 12
Dutch Healthy Diet Index 69.0 (16.1) 72.0 (13.6) 71.7 (13.7)
HDL-Cholesterol (mmol/l) 1.5 (0.5) 1.6 (0.5) 1.6 (0.4)
Triglycerides (mmol/l) 1.4 (0.9) 1.2 (0.7) 1.1 (0.7)
CVD (%) 12 2 6
Sedentary time while awake (min/day) 523 (76) 445 (70) 362 (80)
LPA (min/day) 256 (93) 325 (92) 369 (98)
MPA (min/day) 27 (13) 61 (12) 120 (47)
VPA (min/day) 1 (3) 4 (6) 14 (16)
Total body fat (%)
 Men 25.6 (7.2) 26.0 (5.9) 23.7 (5.5)
 Women 38.3 (7.8) 37.2 (5.8) 34.7 (5.5)
Visceral fat (cm2)2
 Men 118.9 (73.8) 122.4 (62.2) 103.6 (53.1)
 Women 88.6 (52.6) 73.3 (35.0) 46.2 (22.7)
Liver fat (%)3
 Men 7.8 (7.7) 10.3 (15.1) 6.7 (8.2)
 Women 5.9 (9.6) 5.2 (8.3) 1.9 (2.5)
From this population, 294 participants had a measurement of visceral fat by MRI. These 
294 participants were similar in age (mean 56, SD 6) to those without an MRI of the 
abdomen (mean 56, SD 6) and CVD history (both 6%), but were more often men (45% 
versus 39%) and had a slightly lower BMI (25.7 kg/m2 versus 26.5 kg/m2). 
Lastly, for the analyses on liver fat, we additionally excluded participants without 1H-MRS 
measurement (n=45) and those who consumed 40 grams of alcohol or more (4 standard 
glasses) per day (n=21), leaving a total of 228 participants. 
  
Sedentary time and physical activity in relation to total body fat
After adjustment for confounding, 30 minutes per day of sedentary time was associated 
with 0.27% more total body fat (95% CI 0.11, 0.43), whereas 30 minutes per day of light 
physical activity (-0.25%, 95% CI -0.49, -0.02) and moderate to vigorous physical activity 
(-0.61%, 95% CI -0.97, -0.25) were associated with less total body fat. In the isotemporal 
6.1%). We excluded participants with fewer than 24 hours of measurement (n=39) or for 
whom daily activities could not be estimated (n=32). For the analyses on total body fat, 
we excluded participants with missing data on smoking status (n=1), education (n=7) 
and ethnicity (n=1), leaving a total of 852 participants.
These participants (41% men) had a mean (SD) age of 56 (6) years and BMI of 26 kg/m2 
(4). Participants had a mean (SD) valid Actiheart wear time of 83 (12) hours and 80% of 
participants had more than 72 hours of valid wear time. Most waking time was spent 
sedentary, and least time performing vigorous physical activity (Figure 1). The baseline 
characteristics of the total population for the analyses on total body fat stratified by 
tertiles of moderate to vigorous physical activity are shown in Table 1. Participants in 
the highest tertile of activity were slightly younger, more often men, more often non-
smokers, had a lower BMI and spent less time in sedentary time than participants in the 
lowest tertile of MVPA. 
Figure 1. Distribution of daily activities during an average 24-hour period in participants with a physical 
activity and total body fat measurement in the Netherlands Epidemiology of Obesity study (N=852)
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Table 3. Associations of daily activities per 30 minutes with visceral fat (cm2) in participants with a direct 






Per 30 min/day cm2 VAT (95% CI) cm2 VAT (95% CI) cm2 VAT (95% CI) cm2 VAT (95% CI)
Sedentary time 3.7 (2.0; 5.4) 2.0 (0.1; 3.9) substituted substituted
Light physical activity -3.2 (-5.1; -1.2) -1.0 (-3.4; 1.3) 0.4 (-2.1; 2.9) 0.4 (-1.6; 2.4)
Moderate to vigorous physical activity -8.2 (-11.8; -4.6) -6.7 (-10.3; -3.1) -7.2 (-10.7; -3.6) -0.6 (-3.9; 2.7)
Results are based on analyses weighted toward the BMI distribution of the general population (n=294).
1Adjusted for sex, age, ethnicity, education, DHD-index and smoking
2Additionally adjusted for all other daily activities 
2Additionally adjusted for total time awake, and for all other daily activities but not for sedentary time. Coefficients 
represent the association between substitution of 30 minutes sedentary time with 30 minutes of either light or 
moderate to vigorous physical activity and visceral fat (cm2).
3Additionally adjusted for total body fat
Table 4. Associations of daily activities per 30 minutes with hepatic triglyceride content (%) in participants 






Per 30 min/day Relative change 
in HTGC (95% CI)
Relative change 
in HTGC (95% CI)
Relative change 
in HTGC (95% CI)
Relative change 
in HTGC (95% CI)
Sedentary time 1.08 (1.03; 1.12) 1.05 (1.01; 1.10) Substituted Substituted
Light physical activity 0.94 (0.89; 0.99) 0.96 (0.91; 1.02) 0.98 (0.92; 1.04) 0.98 (0.94; 1.03)
Moderate to vigorous physical activity 0.87 (0.80; 0.94) 0.88 (0.81; 0.96) 0.89 (0.82; 0.97) 1.00 (0.92; 1.09)
Results are based on analyses weighted toward the BMI distribution of the general population (n=228).
1Adjusted for sex, age, ethnicity, education, DHD-index and smoking
2Additionally adjusted for all other daily activities 
2Additionally adjusted for total time awake, and for all other daily activities but not for sedentary time. Coefficients 
represent the association between substitution of 30 minutes sedentary time with 30 minutes of either light or 
moderate to vigorous physical activity and hepatic triglyceride content.
3Additionally adjusted for total body fat
DISCUSSION
In this population-based cohort study of middle-aged men and women, more sedentary 
time was associated with more total body fat, visceral fat and liver fat, whereas moderate 
to vigorous physical activity was associated with less total body fat, visceral fat and 
liver fat. Replacing 30 minutes of sedentary time with moderate to vigorous physical 
activity was associated with reduced total body fat, visceral fat and liver fat. Replacing 30 
minutes of sedentary time with light physical activity was not associated with total body 
fat, visceral fat or liver fat. These associations with visceral fat and liver fat attenuated 
after additional adjustment for total body fat. 
substitution model, replacing 30 minutes of sedentary time per day with 30 minutes of 
moderate to vigorous physical activity was associated with less total body fat (-0.51%, 95% 
CI -0.94, -0.07), whereas light physical activity (-0.17%, 95% CI -0.45, 0.11) was not (Table 2). 
Table 2.Associations of daily activities per 30 minutes with total body fat (%) in participants with a 
measurement of total body fat by bioimpedance analysis and physical activity by Actiheart
Crude Multivariable1 Substitution model2
Per 30 min/day % TBF (95% CI) % TBF (95% CI) % TBF (95% CI)
Sedentary time 0.15 (-0.06; 0.36) 0.27 (0.11; 0.43) substituted
Light physical activity 0.04 (-0.22; 0.30) -0.25 (-0.49; -0.02) -0.17 (-0.45; 0.11)
Moderate to vigorous physical activity -1.15 (-1.58; -0.72) -0.61 (-0.98; -0.25) -0.51 (-0.94; -0.07)
Results are based on analyses weighted toward the BMI distribution of the general population (n=852).
1Adjusted for sex, age, ethnicity, education, DHD-index and smoking
2Additionally adjusted for total time awake, and for all other daily activities but not for sedentary time. Coefficients 
represent the association between substitution of 30 minutes sedentary time with 30 minutes of either light or 
moderate to vigorous physical activity and total body fat (%). 
Sedentary time and physical activity in relation to visceral fat
In adjustment analyses, 30 minutes per day of sedentary time was associated with 
2.0 cm2 more visceral fat (95% CI 0.1, 4.9), whereas 30 minutes per day of moderate to 
vigorous physical activity was associated with 6.7 cm2 less (95% CI -10.3, -3.1) visceral fat. 
Light physical activity was not associated with visceral fat (-1.0 cm2, 95% CI -3.4, 1.3). In the 
isotemporal substitution model, replacing 30 minutes per day of sedentary time with 
30 minutes per day of moderate to vigorous physical activity was associated with 7.2 cm2 
less (95% CI -10.7, -3.6) visceral fat, whereas replacement with light physical activity was 
not associated with visceral fat (0.4 cm2, 95% CI -2.1, 2.9). This association attenuated after 
additional adjustment for total body fat (Table 3). 
Sedentary time and physical activity in relation to liver fat
In adjusted analyses, 30 minutes per day of sedentary time was associated with more liver 
fat in adjusted analyses (1.05-fold, 95% CI 1.01, 1.10) whereas 30 minutes per day of moderate 
to vigorous physical activity was associated with less liver fat (0.88-folds, 95% CI 0.81, 0.96). 
Light physical activity seemed not or only marginally associated with liver fat (0.96-fold, 
95% CI 0.91, 1.02). In the isotemporal substitution model, replacing 30 minutes per day 
of sedentary time with 30 minutes per day of moderate to vigorous physical activity was 
associated with less liver fat (0.89-fold, 95% CI 0.82, 0.97), whereas replacement with light 
physical activity showed little association with liver fat (0.98-fold, 95% CI 0.92, 1.04). This 
association attenuated after additional adjustment for total body fat (Table 4). 
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habitual physical activity potentially prevents accumulation of visceral and ectopic fat 
(33). These findings are consistent with our results, which show that sedentary time was 
positively associated with visceral fat and liver fat, and moderate to vigorous activity 
negatively. Prospective studies with objective assessment of physical activity and 
sedentary time are needed to confirm these associations. 
Besides abdominal adiposity, sedentary time has also been associated with other adverse 
metabolic consequences. Recent studies have shown that a high amount of time spent 
in sedentary time is associated with multiple adverse health outcomes, among which 
type 2 diabetes (34). This association was also present in fit individuals (35). Furthermore, 
time spent sedentary predicts higher levels of fasting insulin independent of time spent 
performing moderate to vigorous physical activity (36), indicating that the detrimental 
effects of sedentary time are not merely due to a lack of sufficient physical activity. Large 
meta-analyses have also shown that high sedentary time was associated with all-cause 
mortality (37), type 2 diabetes incidence, and cardiovascular disease and cancer risk, even 
after adjustment for physical activity (10). However, the underlying biological pathways via 
which sedentary time may lead to disease remain largely unknown, although it has been 
suggested that replacing sitting with standing and LPA improves insulin sensitivity and 
decreases plasma triglycerides, thereby leading to a decrease in intrahepatic triglyceride 
storage (38, 39). In our study, we observed that replacing standing with light or moderate 
to vigorous physical activity was not associated with liver fat after adjustment for total 
body fat, suggesting that the association is mainly driven by overall adiposity. 
Important strengths of this study are the objective assessment of physical activity and 
sedentary time using an Actiheart monitor that combines a heart rate monitor and an 
accelerometer into a single device, which has been shown to classify physical activity 
more accurately than individual measures (40-42), and the direct assessment of visceral 
adipose tissue and hepatic triglyceride using MRI and 1H-MRS. Another strength is that 
we applied isotemporal substitution analysis to be able to investigate replacement 
of sedentary time with light and moderate to vigorous physical activity in relation to 
measures of body fat. Finally, the extensive phenotyping allowed detailed adjustment 
for confounding factors.
A few limitations should also be discussed. Because both the physical activity 
measurements and the body fat measurements were performed in a random subset 
of the participants of the Netherlands Epidemiology of Obesity study, the number of 
participants in the analyses on visceral fat and liver fat were relatively small. Our results 
apply only to people without contraindications for MRI and with a valid Actiheart 
To our knowledge, there is only one previous study that reported isotemporal substitution 
analysis with objectively measured physical activity in combination with direct measures 
of adiposity (12). There, isotemporal substitution of 1 hour per day of sedentary and light 
intensity physical activity with other types of physical activity was associated with less 
visceral fat (12), which is in line with our findings. However, in this study liver fat was not 
assessed and analyses were adjusted for BMI rather than for objectively measured total 
body fat. Our study adds to this that we also assessed associations with liver fat, and were 
able to additionally adjust for total body fat. Our results show that replacing sedentary 
time with moderate to vigorous physical activity is associated with less total body fat, 
visceral fat and liver fat, whereas replacing sedentary time with light physical activity 
has no or minimal effect. The intensity of light physical activity appears to be too low . 
A recent systematic literature review has shown that multiple studies have investigated 
physical activity in relation to adiposity by means of isotemporal substitution analyses. 
However, most use body mass index or waist circumference as an outcome (11). This 
review described that replacing 30 min/day of sedentary time with moderate to vigorous 
physical activity resulted in a decreased waist circumference, body mass index and body 
fat percentage in healthy adult populations (11). Moreover, reallocating sedentary time to 
light or moderate to vigorous physical activity was associated with multiple favourable 
cardiometabolic biomarkers, such as insulin sensitivity (11), which may possibly be due to 
the associated lower body fat percentage we observed in our study. 
In our study, we observed that replacing sedentary time with moderate to vigorous 
physical activity was associated with less total body fat, visceral fat and liver fat. However, 
the associations with visceral fat and liver fat attenuated when total body fat was included 
in the model. This attenuation for associations between physical activity and visceral fat 
and liver fat was also observed in other studies that included BMI into the model (12, 28). It 
therefore seems that there is no extra effect on visceral fat beyond effects via total body 
fat.
Several previous studies reported associations between time spent in sedentary time 
and the risk of non-alcoholic fatty liver (29-32), although in only few studies sedentary 
time was measured objectively (32). In one study researchers aimed to assess whether 
objectively measured levels of sedentary time and physical activity correlated with levels 
of directly assessed visceral fat and liver fat in 82 overweight or obese adults, but found 
no relationship between physical activity and liver fat and a weak positive association 
between time spent in moderate physical activity and visceral fat (28). Contrastively, a 
twin study of both monozygotic and dizygotic twins who were discordant for physical 
activity based on questionnaires during a follow-up of more than 30 years showed that 
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are indeed specific for visceral and liver fat rather than merely representing associations 
with overall adiposity. We observed that associations were not driven by one component 
in particular, but rather that all components seemed important.
Besides food items or food groups, excessive alcohol consumption is a well-known risk 
factor for liver fattening and liver disease. However, it was unknown whether moderate 
alcohol consumption is also associated with liver fat content, and energy-containing 
non-alcoholic beverages might also contribute to liver fat accumulation. In Chapter 5 we 
report that each additional serving of alcoholic beverages per day was indeed associated 
with more liver fat. Light and moderate consumption were not associated with liver 
fat. Nevertheless, replacing one alcoholic serving with one non-alcoholic serving was 
associated with less liver fat. Isocaloric replacement (5 En%) of alcoholic beverages with 
sugar sweetened beverages was equally associated with liver fat, whereas substitution of 
5 En% alcohol with 5 En% milk was associated with less liver fat. 
In addition to dietary habits, physical activity is an important cornerstone in the 
prevention of obesity. Not only exercise, but also habitual, unstructured activity is 
essential. In Chapter 6 we studied different objectively measured activity levels of 
physical activity (sedentary behaviour, light, moderate and vigorous activity) in relation 
to total body fat, visceral fat and liver fat. We observed that sedentary time was associated 
with more total body fat, visceral fat and liver fat, whereas moderate to vigorous physical 
activity was associated with less total body fat, visceral fat and liver fat. Replacing 30 
minutes of sedentary time per day with moderate to vigorous physical activity was 
associated with less total body fat, visceral fat and liver fat. These associations with 
visceral fat and liver fat disappeared after additional adjustment for total body fat. It 
therefore seems that there is no extra effect on visceral fat and liver fat beyond effects 
via total body fat.
METHODOLOGICAL CONSIDERATIONS 
Before we can causally interpret the findings described in this thesis, several 
methodological considerations need to be discussed. For Chapters 3 to 6, baseline 
measurements of the Netherlands Epidemiology of Obesity study were used. This study 
has been set up in 2008 to investigate pathways that lead to obesity-related diseases. 
A strength of this population based study is that the large study population has been 
extensively phenotyped, which allowed us to adjust for multiple confounding factors 
and to study possible sex differences. Moreover, physical activity has been measured 
The main aim of this thesis was to study the role of dietary habits and physical activity 
in the accumulation of visceral fat and liver fat. The majority of the studies described in 
this thesis were performed in the Netherlands Epidemiology of Obesity study, in which 
middle-aged participants underwent deep phenotyping, including measures of visceral 
adipose tissue by magnetic resonance imaging (MRI) and hepatic triglyceride content 
by magnetic resonance spectroscopy (MRS). We used the baseline measurement of NEO 
participants to investigate the association between dietary habits or physical activity 
patterns and visceral fat volume and liver fat content. In this general discussion we 
summarize our main findings, discuss their interpretation and address implications for 
future research. 
SUMMARY OF MAIN FINDINGS
In Chapter 2 we show the results of our systematic review and meta-analysis of 
randomized controlled trials and provide a summary of the evidence on the effect of 
dietary macronutrient composition on liver fat content as assessed by 1H-MRS, MRI, 
CT or liver biopsy in adults. We concluded that a diet high in saturated fat leads to 
more liver fat accumulation than a diet high in unsaturated fat. When a diet high in 
protein is compared with a diet high in carbohydrates, replacing carbohydrates with 
proteins decreases liver fat content. Exchanging carbohydrates for dietary fats did not 
lead to changes in liver fat, although results of different trials were in conflict. Since 
only a limited number of eligible trials could be included in these meta-analyses, we 
have identified an essential gap in knowledge on the effect of dietary macronutrient 
composition on liver fat content. 
In Chapter 3 we describe the relation between dietary intake of multiple food groups 
and measures of visceral adipose tissue and hepatic triglyceride content. Consumption 
of fruit and vegetables and plant-based fats and oils was associated with less visceral fat, 
whereas consumption of sweet snacks was associated with more liver fat in the total 
study population. Patterns of were similar in men and women. Associations were partly 
explained by total body fat, as they attenuated after additional adjustment for total body 
fat, but remained present. 
In Chapter 4 we show that a higher score on the Dutch Healthy Diet Index, which reflects 
a better adherence to the 2015 Dutch dietary guidelines, was associated with less total 
body fat, less visceral fat and less liver fat. The associations with visceral fat and liver fat 
remained present after adjustment for total body fat, indicating that the associations 
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From origin, substitution analyses have been used to study and compare the effects 
of different macronutrients on multiple health outcomes in an isocaloric manner 
(3). This statistical method has become increasingly used throughout the entire field 
of nutritional epidemiology, and also in the field of physical activity (4). It entails a 
statistical technique to mimic a trial in which the dietary composition is altered, 
without changing the total caloric intake. In this thesis, we used substitution analyses 
to study replacement of dairy with other food groups, replacement of alcoholic by 
non-alcoholic beverages, and replacement of sedentary time with time spent on other 
types of physical activity. However, compared with the study of macronutrients, that of 
substitution of food groups or items leads to additional methodological considerations 
(5). Firstly, the results are dependent on the reference group that is chosen. Although 
theoretically any two food groups could be chosen for substitution analysis, results will 
become meaningless without cautious considerations (5). For instance, the replacement 
of a food group with detrimental health effects to a food group with even worse health 
effects will yield an association that appears beneficial, and results could be misleading. 
Therefore, it is advised that food items or groups used for substitution analysis should 
be part of a well-defined category and commonly consumed within the population 
under study. They should also be relevant for replacement, with desirably a fair inverse 
correlation (5). Furthermore, substitution analyses with food items or food groups may 
amplify confounding (5). In contrast to nutrients, which are mainly consumed to meet 
the body’s energy requirements, consumption of food items or groups is strongly 
influenced by health-related behaviours. For example when meat is substituted with 
fish: consumption of meat may be more associated with unhealthy behaviour, whereas 
fish consumption with healthy behaviours. An analysis in which meat is substituted for 
fish may therefore not only represent an exchange of food products, but also indirectly 
an exchange of behaviours, and the net effect of the substitution is overestimated. 
This also holds true when using substitution analysis for physical activity. Adequate 
adjustment for lifestyle factors is therefore of great importance. Nonetheless, results 
of the substitution analyses described in this thesis may be overestimated despite our 
efforts to minimize confounding and need to be interpreted cautiously. It should be 
noted that even if we interpret the substitution analysis causally, which means that if 
individuals had replaced item A with item B, they would have had less, say, liver fat, this 
does not mean that substitution would lead to a reduction of liver fat. 
Measurement error
Most large epidemiological cohort studies rely on self-reported body mass index or waist 
circumference as an indication of adiposity. In the NEO study, however, body weight and 
percent body fat were assessed by the Tanita foot-to-foot bio impedance balance system 
objectively, and direct imaging of visceral fat and liver fat has been performed. A 
limitation, however, is the observational and cross-sectional nature of the analyses 
performed on the baseline measurements. Residual confounding due to unmeasured 
lifestyle factors might be present despite our efforts to minimize confounding as 
much as possible. Moreover, the cross-sectional design and possible reverse causation 
precludes causal inference. In the following paragraphs we will discuss these and other 
limitations regarding the study design and data collection from the NEO study, and how 
we attempted to minimize the potential bias and confounding that might have resulted 
from those limitations. 
Internal validity: bias and confounding by lifestyle
During the past year, a substantial amount of criticism on nutritional epidemiology 
has been expressed. Whereas results from nutritional epidemiological studies are often 
presented as causal ones, most risks or benefits associated with dietary habits are said to 
mainly reflect the magnitude of different types of bias and residual confounding, since 
most of the studies are of an observational nature (1). Furthermore, most nutritional 
variables are correlated with each other and therefore associations between one specific 
dietary variable and health outcomes might not be specific, but rather represent 
associations between other dietary variables and health outcomes (1). By combining 
multiple food items into food groups and also studying dietary quality as measured by 
the Dutch Healthy Diet Index, we have aimed to minimize this problem. Furthermore, 
when studying food groups, we also adjusted for a marker of a healthy diet in order to 
adjust for potential correlations between the food group under study and overall diet. 
The study of an association between consumption of foods or food groups in relation 
to visceral fat or liver fat poses problems. In free-living populations, consumption of 
most nutrients and thereby food items is positively correlated with total caloric intake 
(2). Increased consumption of a certain food item means that the total caloric intake 
also increases due to the caloric contribution of the macronutrients from that specific 
food item. Moreover, large persons, or those who are more physically active, on average 
consume more of everything and therefore even food items with very low to no caloric 
value are correlated with total energy intake (2). If caloric intake is also associated with the 
outcome, for example total body fat, this may overestimate the association between the 
food item and the outcome. In order to control for this, an increase in consumption of a 
certain food item must be accompanied by a decrease in consumption of another food 
item to keep total caloric intake similar. This can be modelled using substitution analyses, 
by defining the contrast of which food item is to be replaced by the food item under study. 
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between healthy dietary habits an adiposity measures are likely underestimations of 
reality (18).
Reverse causation
In Chapters 3 to 6 we performed cross-sectional analyses to study the association 
between diet and physical activity and body fat distribution. These analyses were 
based on the baseline measurements of the NEO study, meaning that the exposure and 
the outcome variables were measured at the same time. This poses difficulties in the 
interpretation of results, as we cannot always tell with certainty which came first: the 
exposure, or the outcome. For example, people who are told by their general practitioner 
that they have an increased risk of having a myocardial infarction due to their current 
lifestyle, are more likely to change their lifestyle and develop healthier dietary habits 
than the general population. However, while their diet might be healthier due to these 
changes, they are still more likely to suffer from a myocardial infarction than the general 
population. When studying the association between dietary habits and the risk of 
myocardial infarction, it might therefore appear as if a healthier diet is associated with 
an increased risk of having a myocardial infarction. 
 
In Chapters 3, 4, 5 and 6 this would mean that participants with a higher body fat 
percentage, or more visceral fat or liver fat, might have altered their dietary habits or 
physical activity patterns as a result of their adiposity. A higher body fat percentage 
or more ectopic fat has been associated with cardiovascular disease and diabetes, and 
worrying about this increased risk might have resulted in a change of lifestyle. If reverse 
causation was present in our analyses, this would have led to an underestimation of the 
associations, as it would appear that a healthy diet or time spent performing physical 
activity is not associated with less total body fat or ectopic fat. For that reason, we have 
repeated our analyses described in these chapters after exclusion of participants with a 
history of cardiovascular disease and participants who had been diagnosed with type 2 
diabetes, as they might have changed their dietary habits after being diagnosed. After 
exclusion of these participants, results remained similar. This suggests that reverse 
causation did not bias our associations to a large extent. 
External validity 
In the NEO study, we have included 5,000 participants with a BMI of 27 kg/m2 or higher, 
and a reference group of 1,671 participants irrespective of their BMI. This reference 
group has a normal BMI distribution, similar to and thus representative of the general 
Dutch population (19). Thus, although the majority of the participants has been selected 
based on their body weight and therefore possibly also other weight-related factors, this 
(TBF-310, Tanita International Division, UK). Although it has been suggested that foot-to-
foot BIA might give an overestimation of the amount of fat mass (6), a strong correlation 
(r = 0.84) has been shown between foot-to-foot and hand-to-foot BIA with regard to 
total body fat percentages (7). Furthermore, a strong correlation (r = 0.89) was also 
found in a study comparing resistance measurements provided by foot-to-foot BIA with 
measurements from dual-energy X-ray absorptiometry and underwater weighing (8). 
Additionally, a unique feature of the NEO study is that abdominal adipose tissue was 
assessed using imaging techniques in a random subsample of the total NEO population 
without contra-indications to MRI (9). In total, abdominal adiposity was assessed in 2,580 
participants using a turbo spin echo imaging protocol. At the level of the 5th lumbar 
vertebra 3 transverse images each with a slice thickness of 10 mm were obtained during 
a breath-hold (10). Hepatic triglyceride content was assessed using proton MRS of the liver 
in the same subset of participants. However, the number of participants with technical 
failures for liver fat measurement was relatively high because only a limited time slot 
was available per participant and therefore it was not possible check the spectra during 
the measurement and repeat the measurement when technical failures were present. 
However, the failure rate was not related to age, sex, waist circumference, BMI, total body 
fat or amount of visceral fat (11). Based on this information, we can conclude that the group 
in which the liver fat assessment was successful was a completely random subgroup of 
the total group of participants who underwent the proton MRS. 
In Chapters 3, 4 and 5 we used a food frequency questionnaire to estimate dietary 
habits. Although such questionnaires are suited for large epidemiological studies, they 
are notorious for their risk of bias, and estimates of intake may be subject to substantial 
error, which in turn may affect the interpretation of epidemiological studies (12-14). Social 
desirability in the way respondents fill in items can result in an overestimation of intake 
of healthy foods, and an underestimation of intake of unhealthy foods (15). Especially 
obese participants may underreport their total energy intake (16) and fatty foods or 
foods rich in carbohydrates (17), but no major differences were found between men and 
women (17). Kipnis and colleagues have described two types of dietary measurement 
error that can occur when a food frequency questionnaire is used: intake-related bias, 
which represents the correlation between the error and true intake, and person-specific 
bias, which is independent of the true intake and reflects measurement error related 
to personal characteristics of the participant. The latter can be reduced considerably 
by energy adjustment, which is why we adjusted all our dietary models for total energy 
intake, but will nonetheless remain present to a certain extent. With respect to the three 
studies in this thesis using a food frequency questionnaire, it means that the associations 
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index, meaning it increases the blood glucose level rapidly, and stimulates production 
of insulin directly. Glucose is transported into cells throughout the body by the glucose 
transport type-4 (GLUT-4), which is an insulin-dependent transporter. A second common 
carbohydrate, fructose, has a low glycaemic index and does not stimulate the secretion of 
insulin. It is almost entirely cleared by the liver and does not signal the brain when satiety 
is reached, leading to an increased food consumption. Moreover, fructose is transported 
into cells by the glucose transporter type-5 (GLUT-5), of which most cells only have low 
amounts, and it is poorly absorbed by the gastrointestinal tract. The metabolism of 
fructose, which takes place in the liver, stimulates lipogenesis and high consumption 
is therefore associated with an increased hepatic de novo lipogenesis, an increased 
concentration and secretion of triglycerides and also with a decrease in the clearance 
of very low density lipoprotein triglycerides. Several studies have shown that excessive 
dietary fructose consumption is associated with non-alcoholic fatty liver disease (24-26). 




In this thesis, we aimed at answering the question to what extent dietary habits and 
physical activity are associated with ectopic fat. The main conclusions of this thesis are 
that dietary macronutrient composition is likely to play a role in the accumulation of 
liver fat, and that diets high in saturated fat lead to more liver fat than diets high in 
unsaturated fat. Increased consumption of dietary protein at the expense of carbohydrates 
results in less liver fat. However, our study identified an important gap in the current 
knowledge, and we therefore recommend that more and larger randomized controlled 
dietary trials should be performed in which the source and type of macronutrients 
should be taken into account. More specifically, trials on the exchange between dietary 
protein and fat should be conducted, as evidence on this comparison was completely 
lacking. We furthermore showed that consumption of sweet snacks was associated 
with increased liver fat, and consumption of fruit and vegetables with less visceral fat. 
Additionally, a higher score on the Dutch Healthy Diet Index was associated with less 
total body fat, as well as less visceral and liver fat. Consumption of alcoholic and sugar 
sweetened beverages was associated with more liver fat, and replacement of alcoholic 
beverages with milk was associated with less liver fat. Replacement of alcohol with sugar 
sweetened beverages was associated with an equal amount of liver fat. Replacement of 
30 minutes of sedentary time per day with moderate to vigorous physical activity was 
associated with less total body fat, visceral fat and liver fat. In the paragraph below we 
is countered by weighting our analysis towards the BMI distribution of the reference 
population. After weighting, results represent characteristics and associations in the 
general population (19).
Furthermore, visceral fat and liver fat were assessed in a random subgroup of participants 
without contraindications (e.g. claustrophobia, metallic devices or a body circumference 
of more than 1.70 meter). As a result, on average participants who underwent an MRI/MRS 
measurement had a slightly lower BMI and were somewhat less likely to have a history 
of cardiovascular disease. Results described in this thesis are therefore applicable to the 
general, middle-aged Dutch population without contraindications for an MRI, and may 
not be representative for extremely obese persons with a body circumference of more 
than 1.70 meter. 
POTENTIAL UNDERLYING MECHANISM
After a careful review of our results and the methodological considerations that come 
with them, it is interesting to think about an underlying mechanism. Based on the 
current literature, fructose consumption might be a potential underlying mechanism 
that explains several of our findings in relation to liver fat as described in this thesis. 
In Chapter 2 we showed that dietary macronutrient composition and the quality of 
those macronutrients affects liver fat content. Whereas there was no effect of total fat 
with carbohydrates, the type of fat did matter: consumption of saturated fat leads to 
an increased liver fat content as compared with unsaturated fat, which is in line with a 
previous review on macronutrient composition in relation to liver fat accumulation (20). 
As not all included studies in our meta-analysis provided information on which type of 
fat was replaced with carbohydrates, we could not assess whether replacing saturated 
fat with carbohydrates affects liver fat differently than replacing unsaturated fat with 
carbohydrates. However, the three studies that found that a low-carbohydrate high-
fat diets decreases liver fat as compared with a high-carbohydrate low-fat diet all used 
unsaturated fat for this comparison (21, 22). Previous research has shown that consumption 
of carbohydrates is a major stimulus for hepatic de novo lipogenesis and might even 
contribute to non-alcoholic fatty liver disease to a greater extent than dietary fat (23). 
The type of carbohydrates also plays a role in the effect on liver fat. Most carbohydrates 
that are consumed, will enter the blood as glucose. Glucose serves as an energy source 
for the body and can be used by all the cells in a human body. It has a high glycaemic 
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Figure 1. Dietary recommendations from the Netherlands Nutrition Center
FUTURE PERSPECTIVES 
Although the results described in this thesis contribute to current knowledge on 
determinants of body fat distribution, they need to be confirmed in larger prospective 
studies, or in randomized controlled trials. Below we describe recommendations for 
future research in the field of nutritional epidemiology. 
Mendelian randomization: the solution to confounding and reverse causation? 
As described above, results from observational epidemiological studies might 
sometimes be confounded and not completely accurate, despite our best efforts to 
minimize confounding by improving the design and statistical analyses from the study. 
A potential solution for this problem is to perform a Mendelian randomization study. 
This type of study, based on Mendel’s laws of inheritance, uses genetic variants that are 
associated with the exposure rather than the exposure itself (27). Genes are randomly 
will translate our findings to implications for clinical practice and to recommendations 
for future research.
Clinical implications
As described in the introduction of this thesis, body fat or body mass index is not a good 
indicator when it comes to the risk of cardiometabolic diseases. Rather, one should 
focus on the amount of ectopic fat as this proves to be a more pronounced risk factor for 
chronic diseases. In this thesis, we have shown that dietary habits and physical activity 
are associated with both visceral fat and liver fat. Even after additional adjustment for 
total body fat most associations remained present, indicating that most exposures we 
studied in this thesis are specifically associated with both visceral fat and liver fat. Future 
research should aim to study whether these associations are indeed, as we believe, causal, 
and whether changes in diet and physical activity indeed lead to beneficial changes in 
ectopic fat accumulation. Nevertheless, our findings are promising and hint towards the 
importance of considering diet as a whole, instead of separate components, which is in 
line with the current changes in dietary guidelines throughout the world. 
 
Based on the results described in this thesis, we are able to make some recommendations 
with regard to diet and physical activity. Firstly, our results are in line with the 
recommendations made by the Netherlands Nutrition Center, which state that 
consumption of sweet snacks such as chocolate or cake should be limited and consumption 
of fruit and vegetables should be encouraged. In line with this recommendation, people 
should adhere to the 2015 Dutch Dietary Guidelines for a Healthy Diet, which entails 
following a dietary pattern that involves more plant-based and less animal-based foods. 
Consumption of carbohydrates should be limited and if possible replaced with dietary 
protein, and saturated fat should be replaced with unsaturated fat. Consumption of 
alcoholic beverages should be limited. What we have added to this, is that for those who 
wish to limit their alcohol consumption, it is recommended to not replace this with 
sugar sweetened beverages. Consuming a glass of milk, tea, coffee or water instead of a 
glass of alcohol appears to be better. Our results are also in line with the Dutch physical 
activity guidelines, which state that sufficient physical activity should be performed 
and sedentary time should be limited. Our results indicate that, preferably, sedentary 
behaviour should be replaced with moderate to vigorous physical activity rather than 
light physical activity.
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have been used to collect information on incident diabetes, cardiovascular events or 
mortality. Moreover, it is planned that participants of the Netherlands Epidemiology of 
Obesity study will be invited to the study center for a second visit, during which multiple 
measurements and questionnaires will be taken and administered. Future research with 
these data will reveal whether changes in dietary intake or physical activity habits, the 
risk factors studied in this thesis, are also longitudinally associated with changes in 
visceral fat and liver fat, and the occurrence of cardiometabolic disease. 
 
assorted from parents to offspring, a process that occurs during the formation of 
gametes and conception. Inheritance of a certain genetic variant is therefore completely 
random and does not, for example, depend on lifestyle decisions made later on in life. 
This way, the association between the genetic variant and the disease resembles the 
association between an exposure and the disease, but it does not suffer from reverse 
causation or confounding to which a conventional observational study might be 
susceptible (27). Whereas randomized trials can often only assess short term effects, a 
Mendelian randomization study is particularly useful for studying lifetime exposures, 
such as dietary intake. Several previous studies have therefore used this concept in 
order to study causal effects of lifestyle factors such as consumption of dairy, cruciferous 
vegetables and alcohol on varying health outcomes (28). As such, alcohol consumption has 
been shown to be causally related to oesophageal cancer risk by the use of genetic data 
on the aldehyde dehydrogenase 2 family (ALDH2) gene in a Mendelian randomization 
study (29). Moreover, consumption of dairy and cruciferous vegetables has been causally 
linked to cancer (30). 
Following the research outlined in this thesis, Mendelian randomization studies could 
also be used to further investigate whether the associations we described are indeed 
causal. For example, a genome wide association study on inter-individual variation in 
dietary macronutrient intake in almost 300,000 participants has been conducted and 
has identified 96 genome-wide significant loci (31). Such loci have also been reported in 
relation to dietary pattern scores, although the population was smaller (32). These loci can 
be used to investigate to what extent macronutrient intake influences liver fat content. 
By using such genetic instruments, we would be able to study the effect of dietary habits 
on adiposity while limiting reverse causation and confounding by other lifestyle factors 
such as smoking, physical activity, stress, sleep habits or culture, provided a strong genetic 
scoring instrument is available and the number of participants is sufficient. Nevertheless, 
the analogy of Mendelian randomization with randomized controlled trials has strong 
implications for the design, reporting and interpretation, and therefore the use of this 
study design has several limitations to overcome in the future (33). In the meantime, we 
have to rely on randomized controlled trials and observational studies to further explore 
the role of dietary habits and physical activity and visceral fat and liver fat. 
Future of the NEO study 
As described before, all research in this thesis has been performed in a cross-sectional 
setting and is based on the baseline measurements of all participants. The Netherlands 
Epidemiology of Obesity has been designed as a prospective cohort study and participants 
were included between 2008 and 2012. Since then, Dutch general practitioner databases 
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Overgewicht wordt gekenmerkt door een overmatige opslag van triglyceriden in 
vetcellen door een hogere inname dan verbruik van energie, wat uiteindelijk kan leiden 
tot gezondheidsproblemen. De Wereldgezondheidsorganisatie (WHO) definieert 
overgewicht op basis van de body mass index (BMI), die berekend wordt door het 
lichaamsgewicht te delen door de lengte in het kwadraat. Op basis van de BMI maakt de 
WHO onderscheid tussen verschillende categorieën van lichaamsgewicht: ondergewicht 
(BMI <18.5 kg/m2), normaal gewicht (BMI 18.5-24.99 kg/m2) en overgewicht (BMI > 25.0 
kg/m2). De laatstgenoemde categorie kan verder worden onderverdeeld in preobesitas 
(25.0-29.99 kg/m2), obesitas klasse 1 (30.0-34.99 kg/m2), obesitas klasse 2 (35.0-39.99 kg/m2) 
en obesitas klasse 3 (>40 kg/m2). 
De afgelopen decennia komt obesitas steeds vaker voor. In 1980 had wereldwijd ongeveer 
25% van alle mensen overgewicht, van wie meer dan 6% obesitas. Deze percentages zijn 
gestegen tot 34 en 12 in 2008. In absolute getallen betekent dit een toename van 572 
miljoen volwassenen met overgewicht in 1980 naar 1.46 miljard in 2008, van wie 508 
miljoen met obesitas. Dit cijfer wordt verwacht nog verder te stijgen in de toekomst, 
tot ongeveer 2.2 miljard volwassenen met overgewicht na 2020. Deze trend is ook 
zichtbaar in Nederland: in 2018 had ongeveer de helft van alle Nederlandse volwassenen 
overgewicht, en maar liefst 15% obesitas. 
Als gevolg van deze stijging van mensen met overgewicht en obesitas, is er ook een 
stijging in het voorkomen van allerlei chronische welvaartsziekten waarneembaar. 
Obesitas gaat namelijk samen met een verhoogd risico op het ontwikkelen van diabetes 
(suikerziekte) en cardiovasculaire aandoeningen zoals hoge bloeddruk, hartinfarcten 
en beroertes . Geschat wordt dat een BMI van 25 of hoger verantwoordelijk is voor 34% 
van alle gevallen van hoge bloeddruk in mannen, en maar liefst 62% in vrouwen. Een 
BMI van 40 of hoger leidt zelfs tot een zeven keer zo hoog risico op het ontwikkelen 
van diabetes type 2 als een BMI tussen de 18,5 en 25. Hiernaast kan een hoge BMI ook 
leiden tot een verhoogd risico op verschillende soorten kanker. Ook gaat het samen met 
nierziekten, artrose, dementie en allerlei angst- en gedragsstoornissen. 
Hoewel de BMI een makkelijke en veelgebruikte maat is voor de hoeveelheid 
lichaamsvet, die er enigszins mee rekening houdt dat lichaamslengte samenhangt 
met gewicht, houdt het geen rekening met de samenstelling van het lichaam. Zo wordt 
er bijvoorbeeld geen onderscheid gemaakt tussen vetmassa en vetvrije massa, zoals 
spiermassa, botmassa en water. Zo kunnen zeer getrainde mensen een relatief hoge BMI 
hebben, en toch weinig lichaamsvet. Hiernaast zegt de BMI ook niets over waar in het 
lichaam het vet precies is opgeslagen. Reeds halverwege de vorige eeuw werd duidelijk 
NEDERLANDSE SAMENVATTING
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onderzocht worden. Om te onderzoeken welke componenten van voeding precies 
verbonden zijn aan ziekte, is het van belang om naar de micro- en macronutriënten 
te kijken. Zo is de inname van fructose bijvoorbeeld geassocieerd aan vetophoping 
in de lever. Eerder is ook al aangetoond dat inname van verzadigd vet samengaat met 
meer levervet dan inname van onverzadigd vet. Voor visceraal vet bestond reeds een 
overzicht van de effecten van de macronutriëntsamenstelling van de voeding op de 
hoeveelheid visceraal vet door middel van een meta-analyse. Voor levervet bestond een 
dergelijk overzicht nog niet. In Hoofdstuk 2 beschrijven we een systematische overzicht 
en meta-analyse van gerandomiseerde gecontroleerde studies naar de effecten van de 
macronutriëntsamenstelling van de voeding op de hoeveelheid levervet. Hierin konden 
we aantonen dat het vervangen van koolhydraten door eiwitten leidt tot een afname van 
de hoeveelheid levervet. Wanneer koolhydraten echter vervangen worden door vetten 
lijkt dit geen effect te hebben op de mate van leververvetting, hoewel de resultaten 
van verschillende studies in conflict zijn met elkaar. Dit zou kunnen komen doordat 
bij veel studies niet vermeld werd welke vetsoorten werden uitgewisseld, aangezien 
verzadigd vet leidt tot meer levervet dan (enkelvoudig of meervoudig) onverzadigd vet. 
Ook de bronnen van de voedingsvetten werden vaak niet vermeld (vlees, plantaardig 
of zuivel). Binnen de voedingsvetten lijkt het type vet wel uit te maken: het vervangen 
van onverzadigd vet door verzadigd vet leidt tot een grotere mate van leververvetting. 
Aangezien slechts een beperkt aantal studies geschikt was om mee te nemen in deze 
meta-analyse, hebben we een belangrijk gat in de huidige kennis geïdentificeerd. Op 
basis hiervan adviseren we dat vooral meer studies uitgevoerd moeten worden die de 
uitwisseling van vetten en eiwitten met elkaar vergelijken, maar zeker ook onderzoeken 
die een vergelijking maken tussen zowel vetten, eiwitten als koolhydraten. Hierbij is het 
van groot belang dat rekening gehouden wordt met de bron van de macronutriënten 
(dierlijk of plantaardig) en het type ervan (meervoudig onverzadigd vet versus 
enkelvoudig onverzadigd vet). 
Vervolgens hebben we voeding op verschillende niveaus bestudeerd in de Nederlandse 
Epidemiologie van Obesitas (NEO) studie. Dit is een groot cohort van meer dan 6500 
mannen en vrouwen van middelbare leeftijd uit Leiden en omgeving. Aangezien 
voeding meer is dan enkel de som van voedingsstoffen kan het voor de klinische 
praktijk nuttig zijn om voedingspatronen als een geheel te bestuderen. Interactie tussen 
voedingsstoffen kan namelijk een rol spelen in de effecten van deze voedingsstoffen op 
de gezondheid. Deze recente inzichten hebben geleid tot voedingsrichtlijnen in zowel 
Europese landen als de Verenigde Staten, die zijn gebaseerd op voedingsproducten en 
-groepen in plaats van voedingsstoffen. Onderzoek heeft laten zien dat voedingsgroepen 
zoals vlees, zuivel en groente en fruit samengaan met lichaamsgewicht, diabetes 
dat naast de hoeveelheid vet ook de plaats waar het lichaamsvet wordt opgeslagen van 
belang is: epidemiologen namen waar dat mensen met een zogenaamd ´appelfiguur´ 
bij wie het vet voornamelijk op buikhoogte is opgeslagen, een hoger risico hebben op 
het ontwikkelen van hart- en vaatziekten dan mensen met een zogenaamd ´peerfiguur´, 
bij wie het vet voornamelijk op de heupen of bovenbenen is opgeslagen. Door middel 
van een computed tomography (CT) scan konden Japanse onderzoekers niet veel later 
onderscheid maken tussen verschillende soorten vet op buikhoogte : onderhuids vet, 
ofwel subcutaan vet, bevindt zich vlak onder het huidoppervlak, terwijl visceraal vet 
dieper in de buikholte rondom de organen ligt opgeslagen. Ongeveer 82 tot 97% van het 
lichaamsvet is subcutaan vet, en 10 tot 15% bestaat uit visceraal vet. 
Waar het lichaamsvet precies wordt opgeslagen, is afhankelijk van verscheidene factoren. 
Zo hebben vrouwen doorgaans bij eenzelfde BMI meer lichaamsvet dan mannen, maar 
minder visceraal vet. Geslachtshormonen lijken hierbij een belangrijke rol te spelen, 
aangezien bij vrouwen het visceraal vet vaak toeneemt na de overgang. Ook bepaalde 
genen, leeftijd en etniciteit gaan samen met de ophoping van visceraal vet. 
Naast opslag in het vetweefsel kan overtollig vet ook ophopen op plaatsen in het 
lichaam waar het niet hoort, bijvoorbeeld in en rond bepaalde organen, zoals de lever 
of het hart. Dit wordt ook wel ectopisch vet genoemd. Volgens de zogenaamde ‘lipid 
overflow hypothese’ wordt een overschot aan calorieën gewoonlijk in het onderhuidse 
vetweefsel opgeslagen, wat als gevolg hiervan kan uitzetten. Als dit vetweefsel echter 
niet naar behoren functioneert of onvoldoende capaciteit heeft om steeds meer vet op 
te slaan, worden de vetzuren opgeslagen in het viscerale vetdepot. Dit kan vervolgens 
leiden tot de afzetting van ectopisch vet, bijvoorbeeld in de lever. Een teveel aan vet 
in de lever zorgt voor een verstoord glucose- en vetzuurmetabolisme, wat kan leiden 
tot insulineresistentie (prediabetes) en samengaat met een verhoogd risico op type 2 
diabetes en hart- en vaatziekten. Levervet en visceraal vet lijken de grote boosdoeners 
wat betreft het verhoogde risico op cardiometabole aandoeningen dat samengaat met 
obesitas. 
Hierdoor kunnen visceraal vet en levervet ook een belangrijke rol spelen in het voorkomen 
van cardiometabole aandoeningen, namelijk wanneer we het zouden kunnen reduceren. 
Omdat er momenteel nog geen medicijnen bestaan om visceraal vet en levervet te 
verminderen, moet de nadruk hierbij liggen op leefstijlfactoren zoals gezonde voeding 
en lichamelijke beweging. Hoewel men hierbij vaak inzet op gewichtsverlies door het 
beperken van energie-inname, kan de kwaliteit van de voeding ook een belangrijke 
rol spelen. Het effect van voeding op de gezondheid kan op verschillende manieren 
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overmatig alcoholgebruik vermeden dient te worden. Echter het is nog niet bekend met 
welke non-alcoholische dranken deze alcoholische dranken het beste vervangen kunnen 
worden indien iemand wordt aangeraden om te stoppen met drinken. Energiehoudende 
dranken zoals frisdrank kunnen natuurlijk ook door een teveel aan calorieën leiden tot 
leververvetting. In Hoofdstuk 5 hebben we onderzocht hoe verschillende alcoholische 
en non-alcoholische dranken samengaan met levervet. We zagen dat ieder extra glas 
alcohol samengaat met meer levervet, en melk, koffie en thee met minder levervet. 
In een isocalorisch substitutiemodel hebben 5 energieprocent alcoholische dranken 
uitgewisseld tegen 5 energieprocent non-alcoholische dranken, en zo rekening 
gehouden met het aantal calorieën dat een bepaalde drank bevat. Uit deze analyses bleek 
dat het vervangen van alcohol door melk samengaat een relatieve afname van levervet 
van 12 procent, maar het vervangen van alcohol door suikerhoudende dranken ging niet 
samen met minder levervet. Op basis van deze resultaten lijken het vooral de suikers 
te zijn die samenhangen met levervet, meer dan de energie op zich. Op basis hiervan 
concluderen we dat het niet aan te raden is om alcohol met suikerhoudende dranken als 
sap of frisdrank te vervangen bij een advies om te stoppen met het drinken van alcohol, 
maar wel door bijvoorbeeld melk, koffie thee of water. 
Naast voeding is ook lichaamsbeweging een belangrijke te beïnvloeden risicofactor 
van de hoeveelheid visceraal vet en levervet. In verscheidene studies is aangetoond dat 
een gebrek aan lichaamsbeweging kan leiden tot een toename in lichaamsgewicht, en 
daarbij ook in visceraal vet en levervet. Teveel tijd zittend doorbrengen gaat ook samen 
met meer lichaamsvet, zelfs wanneer rekening wordt gehouden met de hoeveelheid 
lichaamsbeweging. In Hoofdstuk 6 beschrijven we hoe een subgroep van de NEO 
deelnemers gedurende enkele dagen een Actiheart monitor heeft gedragen om hun 
lichaamsbeweging en zitgedrag in kaart te brengen. Deze monitor meet de hartslag en 
de beweging van de deelnemers, die wij gecombineerd hebben tot een activiteitsscore. 
De intensiteit van lichaamsbeweging wordt weergegeven in metabool equivalenten van 
een taak (MET). Alle activiteiten onder de 1.5 MET worden als zittend gedrag beschouwd, 
activiteiten met een MET score tussen de 1.5 en 3 als lichte activiteiten, tussen de 3 en 
de 6 als gematigde activiteiten en alles boven de 6 MET als intensief. Aangezien er 24 
uren in een dag zitten, betekent minder tijd zittend doorgebracht vanzelf meer tijd 
in beweging. Of het voor het viscerale vet en levervet uitmaakt of je zitten nu met 
lichte, matige of intensieve lichaamsbeweging vervangt, is nog niet goed onderzocht. 
Om deze vraagstelling te beantwoorden, hebben we isotemporele substitutieanalyses 
uitgevoerd, waarin we het vervangen van een half uur per dag zitten door een half 
uur van lichte of gematigde tot intensieve lichaamsbeweging modelleren. Hieruit 
bleek dat het vervangen van een half uur zitten door lichte activiteit niet samenging 
en cardiometabole aandoeningen. Het is echter nog niet bekend in hoeverre deze 
voedingsgroepen ook specifiek samengaan met de hoeveelheid visceraal vet en levervet. 
Dit hebben wij in Hoofdstuk 3 onderzocht, en we beschrijven hierin onze bevindingen 
omtrent de voedingsinname van zuivel, vlees, vis, fruit en groente, plantaardige vetten 
en oliën, en zoete snacks. Aangezien visceraal vet en levervet sterk samengaan met totaal 
lichaamsvet, en bij een hogere inname uit een bepaalde voedingsgroep de toename 
van visceraal vet of levervet ook louter een resultaat kan zijn van toegenomen totaal 
lichaamsvet, is het belangrijk om hier rekening mee te houden. In onze analyses hebben 
we dan ook gecorrigeerd voor totaal lichaamsvet, zodat we konden onderzoeken in 
hoeverre de inname van bepaalde voedingsgroepen specifiek samengaan met visceraal 
vet en levervet. Zelfs na deze correctie bleek dat een toename in consumptie van 100 
gram per dag van groente en fruit samengaat met een verminderde hoeveelheid 
visceraal vet van 1.2 cm2. Hiernaast gaat een consumptie van 100 gram per dag van zoete 
snacks, bovenop de gebruikelijke voeding, samen met een relatieve toename in levervet 
van ongeveer 20 procent. 
Ook Nederland heeft naar aanleiding van de recente verschuiving van voedingsstoffen naar 
voedingsgroepen zijn voedingsrichtlijnen aangepast. In 2015 heeft de Gezondheidsraad 
nieuwe Richtlijnen Goede Voeding uitgebracht. Hierin wordt een meer plantaardige en 
minder dierlijke voeding geadviseerd, en er worden verschillende adviezen gegeven op 
basis van 15 componenten. Zo wordt onder andere geadviseerd om: minstens 200 gram 
groente en 200 gram fruit te eten, enkele porties zuivel, en de consumptie van rood 
en bewerkt vlees te beperken. Om in kaart te brengen hoe goed mensen zich aan deze 
richtlijnen houden, is de Dutch Healthy Diet (DHD) index ontwikkeld. De score op deze 
index kan uiteenlopen van 0 tot 150, waarbij een hogere score een betere naleving van 
de richtlijnen betekent. In Hoofdstuk 4 hebben we onderzocht of een betere naleving 
van de richtlijnen samengaat met minder lichaamsvet. We vonden dat 10 punten hoger 
op de index inderdaad samenging met een absolute vermindering in totaal lichaamsvet 
van 0.2 procent. Ook ging het samen met 2.3 cm2 minder visceraal vet en relatief gezien 
6 procent minder levervet, ook als we rekening hielden met de hoeveelheid totaal 
lichaamsvet. Dit verband leek niet zozeer het gevolg van één van de 15 componenten in 
het bijzonder, aangezien het één voor één weglaten van de componenten niet leidde tot 
grote veranderingen in het verband. Op basis hiervan kunnen we dan ook concluderen 
dat het belangrijk is om een algeheel gezond voedingspatroon aan te hangen zoals in de 
richtlijnen van de Gezondheidsraad wordt beschreven. 
Overmatig alcoholgebruik is een welbekende risicofactor voor leververvetting. De 
huidige richtlijnen voor het voorkomen of verminderen van leververvetting stellen dat 
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met minder lichaamsvet, visceraal vet of levervet, en het vervangen door een half uur 
gematigde tot intensieve activiteit wel. Wanneer we de verbanden echter corrigeerden 
voor totaal lichaamsvet om te onderzoeken of de verbanden specifiek waren, verdwenen 
deze voor visceraal vet en levervet. Op basis hiervan concluderen we dat er geen extra 
verband is tussen lichaamsbewegingen visceraal vet en levervet, bovenop het effect van 
lichaamsbeweging op totaal lichaamsvet. 
Tot slot bediscussiëren we de bevindingen uit dit proefschrift in Hoofdstuk 7, en de 
voor- en nadelen van de gebruikte onderzoeksopzetten. Hierbij gaan we ook in op de 
klinische implicaties en de mogelijke vooruitzichten voor toekomstig onderzoek. 
Concluderend kunnen we stellen dat het onderzoek beschreven in dit proefschrift heeft 
bijgedragen aan ons begrip over de relatie tussen leefstijl en visceraal vet en levervet, en 
op welke factoren we ons dienen te richten als het gaat om de preventie van ectopische 
vetophoping en cardiometabole aandoeningen.
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Allereerst gaat mijn dank uit naar mijn promotor Prof. dr. Rosendaal en mijn 
copromotor dr. ir. De Mutsert. Dankzij jullie heb ik de kans gekregen mij als volwaardig 
wetenschapper te ontwikkelen. Jullie inzichten samen met de adviezen van alle co-
auteurs hebben geleid tot een mooi en samenhangend proefschrift. 
Aan het NEO management team, bedankt voor al jullie harde werk om deze mooie 
studie draaiende te houden. Alle collega’s van de afdeling Klinische Epidemiologie 
wil ik bedanken voor de samenwerking en informele werksfeer. Tijdens de wekelijkse 
meetings op dinsdag heb ik van jullie allemaal mogen leren en heb ik mijn eigen blik op 
onderzoek kunnen ontwikkelen. To all my fellow PhD colleagues from the department 
of Clinical Epidemiology, thank you so much for everything. The past 4 years you always 
made me feel at home, and I’m very grateful for that. 
Al mijn vrienden en familie, bedankt voor jullie ongeveinsde interesse en het aanhoren 
van al mijn (waarschijnlijk onbegrijpelijke) verhalen over mijn werk. Bijzonder fijn om 
zo’n netwerk te hebben waar je altijd op terug kunt vallen. 
Sebastiaan, mijn hele promotietraject heb ik samen met jou doorlopen. Van Energise 
tot TKI, van cursussen tot internationale congressen en van Cambridge tot Wenen. 
Geweldig dat je ook tijdens mijn verdediging naast me wil staan, ik had me geen betere 
paranimf kunnen wensen. Cynthia, enorm bedankt voor al je hulp en afleiding wanneer 
we dit allebei even nodig hadden. Wat een geweldige afsluiting van onze promotietijd 
om elkaars paranimf te zijn. 
Hans en Angely, hoewel je je schoonouders niet kunt kiezen, had ik het niet beter 
kunnen treffen. Bedankt dat jullie mij met open armen hebben opgenomen, ik heb me 
altijd welkom gevoeld. Marjolein, wat begon als een ontmoeting in Maastricht met 
borrelhapjes, is uitgegroeid tot een geweldige band. Je bent als de zus die ik nooit gehad 
heb, en ik ben dankbaar dat je in mijn leven bent gekomen. 
Lieve papa en mama, jullie hebben altijd in mij geloofd, en steunden me bij iedere 
keuze die ik heb gemaakt. Wanneer het tegenzat kon ik altijd weer thuiskomen. Ik kan 
niet beschrijven hoeveel dit voor mij betekent. Dit proefschrift is voor jullie. 
Liefste Jan, jouw aanwezigheid maakt alles mooier. Zonder jouw steun, geduld en 
relativerende woorden had dit proefschrift er nu niet gelegen. Ik ben er trots op jou mijn 
man te mogen noemen, en kijk uit naar alles wat ons verdere leven ons te bieden heeft. 
DANKWOORD 
Graag wil ik hierbij even stilstaan bij iedereen die op welke wijze dan ook betrokken is geweest 
bij de totstandkoming van dit proefschrift.
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Esther Winters-van Eekelen werd geboren op 24 december 1992 te Breda. In 2011 
behaalde zij haar gymnasiumdiploma aan de Katholieke Scholengemeenschap Etten-
Leur, waarna zij naar Maastricht verhuisde om daar aan haar bacheloropleiding 
Gezondheidswetenschappen te beginnen aan de Universiteit van Maastricht. Gedurende 
deze opleiding volgde zij de major Preventie & Gezondheid, en heeft ze een minor in 
Psychologie afgerond. Vervolgens heeft zij aan dezelfde universiteit de masteropleiding 
Epidemiologie gevolgd en zich gedurende de masterthesis verdiept in de Genetische en 
Moleculaire Epidemiologie. In 2016 begon zij als promovenda op de afdeling Klinische 
Epidemiologie in het Leids Universitair Medisch Centra onder begeleiding van dr. ir. 
Renée de Mutsert en Prof. dr. Frits Rosendaal. Gedurende dit promotietraject werkte zij 
mee aan onderzoek binnen de Nederlandse Epidemiologie van Obesitas (NEO) studie 
en was ze actief betrokken bij het opschonen van de data hiervan. Voor de registratie 
als Epidemioloog B volgde zij verschillende cursussen en bezocht (inter)nationale 
congressen om haar werk te presenteren. Ook heeft ze verscheidene studenten begeleid, 
en was ze voorzitter van de ‘NEO journalclub’ en een lid van het Young Talent Forum 
van het Energise Consortium. Momenteel werkt ze als postdoctoraal onderzoeker op 
de afdeling Klinische Epidemiologie in Leiden en helpt bij de totstandkoming van de 
tweede meting van NEO. 
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Oral and poster presentations Year Credits 
Sweet Snacks Are Positively and Fruits and Vegetables Are 
Negatively Associated with Visceral or Liver Fat Content in 
Middle-Aged Men and Women. Papendal course from Dutch Heart 
Foundation, Papendal, the Netherlands. 
2016 0,25
Sweet Snacks Are Positively and Fruits and Vegetables Are 
Negatively Associated with Visceral or Liver Fat Content in Middle-
Aged Men and Women. ICCR Conference on Chronic Societal 
Cardiometabolic Diseases, Québec, Canada.
2017 0,50
Consumption of alcoholic and sugar sweetened beverages is 
associated with increased liver fat content in middle-aged men and 
women. ICCR Conference on Chronic Societal Cardiometabolic 
Diseases, Québec, Canada.
2017 0,50
Consumption of alcoholic and sugar sweetened beverages is 
associated with increased liver fat content in middle-aged men and 
women. WEON congress, Antwerp, Belgium. 
2017 0,50
Sweet Snacks Are Positively and Fruits and Vegetables Are 
Negatively Associated with Visceral or Liver Fat Content in 
Middle-Aged Men and Women. Invited lecture on Translational 
Cardiovascular Research Meeting, Utrecht, the Netherlands. 
2017 0,25
Consumption of alcoholic and sugar sweetened beverages is 
associated with increased liver fat content in middle-aged men and 
women. Annual Dutch Diabetes Research Meeting (NVDO-ADDRM), 
Oosterbeek, the Netherlands.
2017 0,25
Consumption of alcoholic and sugar sweetened beverages is 
associated with increased liver fat content in middle-aged men 
and women. Papendal cursus van Hartstichting, Papendal, the 
Netherlands. 
2017 0,25
Adherence to dietary guidelines in relation to visceral fat and liver 
fat in middle-aged men and women: the NEO study. WEON congres, 
Bilthoven, the Netherlands. 
2018 0,50
Adherence to dietary guidelines in relation to visceral fat and liver 
fat in middle-aged men and women: the NEO study. Translational 
Cardiovascular Research Meeting, Utrecht, the Netherlands. 
2018 0,25
Adherence to dietary guidelines in relation to visceral fat and 
liver fat in middle-aged men and women: the NEO study. Dutch 
Nutritional Science Days, Heeze, the Netherlands. 
2018 0,25
Adherence to dietary guidelines in relation to visceral fat and liver 
fat in middle-aged men and women: the NEO study. European 
Congress on Obesity (ECO), Vienna, Austria. 
2018 0,50
PORTFOLIO 
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Basic methods and reasoning in biostatistics, Boerhaave Instituut, 
Leiden, the Netherlands
2016 1,50
Nutritional Epidemiology, Epidemiology Graduate School of Life 
Sciences, Utrecht University, the Netherlands
2016 1,50
Clinical Epidemiology Schiermonnikoog, Boerhaave Instituut, 
Leiden, the Netherlands
2016 2,00
Clinical Epidemiology (Grobbee), Department of Clinical 
Epidemiology, Leiden University Medical Center, the Netherlands 
2016 3,00
Atherosclerosis and Thrombosis, Papendal Hartstichting Course, 
Papendal, the Netherlands
2016 1,50
Statistical Aspects of Clinical Trials, Boerhaave Instituut, Leiden, the 
Netherlands
2017 1,00
Survival Analyses, Boerhaave Instituut, Leiden, the Netherlands 2017 1,50
Cardiac Function and Adaptation, Papendal Hartstichting Course, 
Papendal, the Netherlands
2017 1,50
Causal Inference (Hernan), Department of Clinical Epidemiology, 
Leiden University Medical Center, Leiden, the Netherlands
2017 3,00
Systematic Reviews and Meta-analyses, Boerhaave Instituut, Leiden, 
the Netherlands
2018 1,00
Physical activity measurement seminar, Cambridge, United 
Kingdom
2018 1,50
Regression Analyses, Boerhaave Instituut, Leiden, the Netherlands 2018 1,50
Causal Inference (Hernan) Journal Club, Department of Clinical 
Epidemiology, Leiden University Medical Center, Leiden, the 
Netherlands 
2018 1,00
Weekly Research Lunch,Department of Clinical Epidemiology, 
Leiden University Medical Center, the Netherlands
2016-2019 3,00
Weekly Capita Selecta, Department of Clinical Epidemiology, 
Leiden University Medical Center, the Netherlands
2016-2019 3,00
Bi-weekly Journal Club from NEO study, Department of Clinical 
Epidemiology, Leiden University Medical Center, the Netherlands
2016-2019 3,00
Student monitoring and teaching
Master thesis Babette de Roos 2018 1,50
Supervision visiting researcher Laura Martin-Piedra 2019 1,00
Master thesis Eleonora Bassetti 2019-2020 1,00
Teacher for Introduction to Clinical Epidemiology (Rothman) for 
students, Department of Clinical Epidemiology, Leiden University 
Medical Center, the Netherlands 
2017 2,00
Various epidemiological classes for bachelor and master students 
biomedical sciences and medicine, Department of Clinical 
Epidemiology, Leiden University Medical Center, the Netherlands
2016-2020 5,00
Adherence to dietary guidelines in relation to visceral fat and liver 
fat in middle-aged men and women: the NEO study. Annual Dutch 
Diabetes Research Meeting (NVDO-ADDRM), Oosterbeek, the 
Netherlands. 
2018 0,25
Effects of dietary macronutrients on liver fat content in adults: a 
systematic review and meta-analysis of randomized controlled 
trials, WEON congres, Groningen, the Netherlands. 
2019 0,50
Reallocation of sedentary time to moderate to vigorous physical 
activity associated with reduced total body fat, visceral fat and liver 
fat. Annual Dutch Diabetes Research Meeting (NVDO-ADDRM), 
Wageningen, the Netherlands. 
2019 0,25
Consortia 
Top Kennis Instituut (TKI) liver fat in collaboration with Unilever 
and Maastricht University 
2017-2019 3,00
Energise! Consortium from the Dutch Heart Foundation 2016-2019 3,00
Congresses and symposia
Dairy Matrix Symposium 2017 0,25
ICCR Conference on Chronic Societal Cardiometabolic Diseases, 
Québec, Canada.
2017 0,75
Netherlands Association for the Study of Obesity (NASO) Spring 
meeting, Utrecht, the Netherlands. 
2017-2019 0,75
WEON congres (Antwerpen, Bilthoven, Groningen, the 
Netherlands)
2017-2019 1,50
Annual Dutch Diabetes Research Meeting, Oosterbeek, the 
Netherlands. 
2017-2019 1,00
Translational Cardiovascular Research Meeting, Utrecht, the 
Netherlands. 
2017-2018 1,00
European Congress on Obesity (ECO), Vienna, Austria. 2018 1,00
Dutch Nutritional Science Days, Heeze, the Netherlands. 2018 0,50
Courses, seminars and master classes
Introduction to Clinical Epidemiology (Rothman), Department of 
Clinical Epidemiology, Leiden University Medical Center, Leiden, 
the Netherlands
2016 2,00
Basic Course Legislation and Organization for Clinical Researchers 
(BROK/GCP), Graduate School, Leiden University Medical Center, 
the Netherlands
2016 1,00
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Other activities 
Reviewing scientific epidemiological publications 2017-2019
Chair of the NEO journal club, Leiden, the Netherlands 2017-2019
Co-organizing the 2-day bi-annual Energise! Consortium meeting, 
Leiden, the Netherlands
2018
Member of the Energise! Consortium Young Talent Forum 2018-2019
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